MikeLigalig.com

Each November, the Pulmonary Hypertension Association (PHA) launches a national campaign to raise awareness about pulmonary hypertension (PH). The progressive rare disease is defined by high blood pressure in the lungs and can cause right-heart failure and death.

SILVER SPRING, MD. (PRWEB) OCTOBER 21, 2020
Pulmonary Hypertension Awareness Month Draws Attention to Life-Threatening, Often Misdiagnosed Disease with Daily Facts
The Pulmonary Hypertension Association's Discover PH campaign strives to educate others about the disease.
Each November, the Pulmonary Hypertension Association (PHA) launches a national campaign to raise awareness about pulmonary hypertension (PH). The progressive rare disease is defined by high blood pressure in the lungs and can cause right-heart failure and death.
This year, Pulmonary Hypertension Awareness Month focuses on educating people about risk factors and symptoms through an interactive PH Awareness Month calendar. The calendar reveals a new fact or tool daily, along with downloadable resources to raise awareness of PH.
Although it is not known exactly how many people are affected, PH is a contributing factor to more than 18,000 adult deaths in the U.S. every year. It can occur among those with left-heart disease, associated conditions such as sleep apnea, chronic obstructive pulmonary disease (COPD) or scleroderma, or from congenital heart disease. It affects people of any age.
The disease is significantly underdiagnosed and misunderstood, even among health care providers. Symptoms, including shortness of breath, fatigue and chest pain, are not necessarily specific to PH and can lead to dangerous delays in a correct diagnosis. While PH is incurable, early diagnosis and proper treatment can extend and improve an individual's quality of life.
"It's critical for us to raise awareness of this rare and life-threatening disease," said Colleen Brunetti, M.Ed., C.H.C., PHA Board of Trustees chair, who was diagnosed with PH in 2008. "Educating patients, families, the medical community and policymakers about the symptoms, treatments and challenges of living with PH is essential to improving outcomes and quality of life."
PHA's outreach during November includes social media, advocacy and educational components such as Facebook Live events with PH experts to drive awareness among those at risk for PH. More information about PH, the campaign and how to spread awareness can be found at: http://www.phassociation.org/awarenessmonth.
PHA is grateful for the sponsorship support provided by Actelion Pharmaceutical U.S., Inc. for Pulmonary Hypertension Awareness Month.
About the Pulmonary Hypertension Association
Headquartered in Silver Spring, Md., the Pulmonary Hypertension Association (PHA) is the country's oldest and largest nonprofit patient association dedicated to the pulmonary hypertension (PH) community. Pulmonary hypertension is a rare, chronic and life-threatening disease of the lungs for which no cure currently exists. PHA's mission is to extend and improve the lives of those affected by PH. To achieve this mission, PHA engages people with PH and their families, caregivers, health care providers, and researchers worldwide who work together to advocate for the PH community, provide support to patients, caregivers and families, offer up-to-date education and information on PH, improve quality patient care, and fund and promote research. For more information, visit http://www.PHAssociation.org and connect with PHA on Twitter, Instagram, Facebook and LinkedIn.
Contact:
PHA Communications
communications@phassociation.org

"Educating patients, families, the medical community and policymakers about the symptoms, treatments and challenges of living with PH is essential to improving outcomes and quality of life."



START your own Wordpress site, business or personal website, or online store at www.siteground.com

In this free webinar, the featured speakers will discuss the growing threat of costly errors and recalls resulting from increasingly complex medical device innovations. Attendees will learn about the importance of well-written product requirements both for regulatory compliance and from a project management perspective. They will also gain insights into what makes an effective requirement statement and what rules to follow to reduce the risk of miscommunication.

TORONTO (PRWEB) OCTOBER 21, 2020
Why focus on product requirements?
New technology development in the medical device arena has led to increasingly complex new products. This trend will likely increase due to the increasing market of IoT, SAaMD (SW as a medical device), AI, Health Apps, etc. With increasing complexity comes the advent of errors and device failures. This industry trend is evidenced by an increase in product recalls and security issues. Projections indicate that both the frequency and severity of these problems will continue to rise.
To keep pace and maintain oversight, this has also led to the updates and increases in quality regulations and standards in the EU, USA and throughout the world. At the heart of these are proper design controls which dictate methods and traceability of how the device was developed from user requirements to final verification and validation. Clear and accurate product requirements at all stages of the project are key. It is not enough to manage them. Designers need to rethink how they are written.
Unfortunately, poorly defined requirements are a common problem with complex devices and software. Indeed, software is the number one reason for medical device product recalls and many of these can be traced to issues with the requirements. Ensuring requirements are concise, testable, and clearly understood is both more difficult, and more important than ever. Fortunately, there are established best practices and attributes of properly written requirements.
Join Verna Rodriguez, Founder and Principal, Manty Medtech, Adjunct Lecturer, Bioengineering Department, Santa Clara University and James Carr, Account Executive, QRA Corp in a live webinar on Thursday, November 5, 2020 at 12pm EST (5pm GMT/UK).
For more information or to register for this event, visit The Complexity Threat: Why Medical Device Teams Need a New Approach to Product Requirements.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Kenmode Precision Metal Stamping has expanded its capabilities to meet demand for metal stamped busbars for all-electric and autonomous vehicles and hybrid cars.

ALGONQUIN, ILL. (PRWEB) OCTOBER 21, 2020
As demand for electric vehicles has exploded in recent years, Kenmode Precision Metal Stamping has been adding new technical capabilities to produce custom busbars to transmit power in all types of electric vehicles, whether hybrid, all-electric, or autonomous (self-driving). Founded in 1960, Kenmode has produced precision metal stamped parts for the automotive and electronics industries for decades. To meet the need for new busbar designs, including larger parts, Kenmode recently added a 300-ton press for metal stamping.
For the automotive and transportation markets, custom metal stamped busbars of different sizes and complexities are required to transmit current from high-powered battery packs to a variety of electrical applications, including the engine itself and such electric-powered features as sunroofs, sensors, communications, windows, remote control, and anti-lock braking systems. Kenmode provides comprehensive services to take new busbar designs from concept to completion, including prototyping and design assistance, tool design, and precision metal stamping, as well as coordinating specialized finishing services to produce the complete busbar assembly.
"At Kenmode, we take pride in helping our customers get their new products to market as quickly and cost effectively as possible. That means we invest in new technology ahead of the curve to meet new requirements for our customers," says Kurt Moders, president. "This is absolutely critical as the demand for electric vehicles grows exponentially."
According to Bloomberg NEF market forecasts, electric cars are expected to grow from 2.7% of all global passenger vehicle sales in 2020 to 10% by 2025, rising to 28% in 2030 and 58% in 2040.
For electric vehicles, busbars must be both strong and lightweight, which allows vehicles to extend their range before recharging. The most commonly used materials for automotive metal stamped busbars are conductive alloys such as copper, bronze and aluminum. Due to the complexity of busbar assemblies for electric vehicles, many automotive OEMs and Tier 1 and 2 suppliers choose to start with a prototype busbar. Kenmode's Tech Center provides rapid prototyping services and fast turnaround on approved designs.
"Every busbar design is different from one battery to the next because of fit and function. We work with our customers' engineers to find the most economical way to produce the busbars needed," observes Kurt Meissner, sales manager for key accounts. "One recent project for an electric vehicle required 13 new tool designs for the metal stamped busbars, which were sourced and built quickly by our in-house tool design team to a very successful and on-time launch."
Kenmode also offers value-added finishing services, whether handled in-house or coordinated with our approved supply base – from complex busbar bending to metal plating, welding, hardware insertion, plastic injection molding, specialty coating for insulators, and cleaning – in order to deliver complete busbar assemblies on time and on budget.
ABOUT KENMODE PRECISION METAL STAMPING
Since its founding in the Chicago suburbs in 1960, Kenmode has built a reputation for strict adherence to uncompromised quality and performance standards in the manufacture of complex, high-precision custom metal stampings and assemblies for the automotive, busbar, electronics, consumer goods, insert molding, and medical device industries worldwide. Today, Kenmode fields one of the largest and most experienced engineering, design, and tool and die teams in the industry and employs the latest technology throughout the metal stamping design and production process. Kenmode handles a wide range of metal stamping materials and component parts, from micro-miniature medical stampings that incorporate precious metals to large automotive stampings made from steel.

Every busbar design is different from one battery to the next because of fit and function. We work with our customers' engineers to find the most economical way to produce the busbars needed



START your own Wordpress site, business or personal website, or online store at www.siteground.com

CISCRP (Center for Information and Study on Clinical Research Participation) Online Webinar and Health Fair Provides Information about How the Pandemic is Affecting Clinical Research Participation. There is no cost to register for this event.

RALEIGH, N.C. (PRWEB) OCTOBER 21, 2020
The nonprofit CISCRP is organizing a free virtual health fair and webinar to educate the public about clinical research participation. This October 22 event from 4-6pm EDT features a five-minute lung cancer risk assessment, a Shibashi movement exercise, a panel discussion with study participants and researchers, and an online virtual reality health fair with educational resources from local health and research organizations.
The AWARE for All - Raleigh program comes at a critically important time when public interest in learning about the process to advance new medical therapies, vaccines, and devices has increased dramatically. In addition, the importance of diversity and inclusion in clinical trials has intensified given the under-representation of minority patients in clinical research and the disproportionately high incidence and severity of COVID-19 cases among minority communities.
Denise Snyder, Associate Dean for Clinical Research at the Duke University School of Medicine, runs an office that supports central services for Duke University's clinical research efforts and is in the midst of launching a new community-based health clinic dedicated to clinical research.
"This is a different model for us – to be out of the hospital and into the community. When you're in the community, it is easier for people to participate in clinical research and we hope it is less intimidating," says Snyder. "We're also able to cultivate staff that is representative of the community."
Community access and transparency is key to participation in clinical research, and so is being able to answer questions and address lingering misconceptions.
"We're encouraging the general public to attend this important event," said Joan Chambers, Senior Director at CISCRP. "The online program will answer a lot of key questions about the clinical research process, what to expect as a study participant, and the benefits and risks of participation."
Stefanie Belanger, Assistant Director of Clinical Research Operations at the Clinical Protocol Office of the UNC Lineberger Comprehensive Cancer Center will give an overview presentation on clinical research. Following will be a panel discussion with study volunteers Tomma Hargraves and Sharon Dula; Pablo Graiver, vice president of patient engagement, IQVIA; Dr. Brian Rothman, associate director at Otsuka Pharmaceutical Companies; Mary Hart, director of research, Allergy & Asthma Network; and Dr. Purvi Parikh, medical director of Allergy & Asthma Associates of Murray Hill. Discussion topics will focus on clinical research, COVID-19 research and lung complications, and respiratory health.
Attendees will have an opportunity to ask questions, participate in two health exercises—Shibashi and a Lung Cancer Risk assessment, and visit a virtual health fair to connect with local and national community health advocates and researchers to learn more about their educational resources.
AWARE for All - Raleigh will be held Thursday, October 22, from 4-6 p.m. EST Attendance is free, but please reserve your spot today via Eventbrite. To learn more, visit awareforall.org or call 877-633-4376.
The AWARE for All - Raleigh supporters include Allergy & Asthma Network, Brain Injury Association of North Carolina, Debbie's Dream Foundation, Duke – Office of Clinical Research, Hemophilia of North Carolina, Javara, LGBT Center of Raleigh, Lung Cancer Initiative, Lupus Research Alliance, Parkinson Association of the Carolinas, PRA Health Sciences – Rare Disease Center, Ronald McDonald House of Chapel Hill and the AWARE Industry Consortium.
About CISCRP
The Center for Information and Study on Clinical Research Participation (CISCRP) is a 501(c)(3) non-profit organization dedicated to engaging the public and patients as partners in the clinical research process. CISCRP provides free education and outreach to the general public and patient communities. Visit http://www.CISCRP.org for more information or to participate in CISCRP's educational initiatives. For additional questions about AWARE for All, contact awareforall@ciscrp.org or call 877-633-4376.

"We're encouraging the general public to attend this important event," said Joan Chambers, Senior Director at CISCRP. "The online program will answer a lot of key questions about the clinical research process, what to expect as a study participant, and the benefits and risks of participation."



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Plastic Surgeon and Breast Reconstruction Specialist Dr. Constance Chen Weighs in on Tips about Breasts.

NEW YORK (PRWEB) OCTOBER 21, 2020
More than any other organ in the human body, the breast occupies a place in our social and cultural landscape well beyond its physiological function to nourish our offspring. "The soft tissue that we think of as a breast is actually a mammary gland, a complex system of fat cells and ducts that produce milk and deliver it to a baby via the nipple," says plastic surgeon and breast specialist Dr. Constance M. Chen. As much attention as we pay to the size, shape and appearance of a woman's breasts, there are many fascinating facts – both important and trivial – that most people don't know about breasts. Here are just a few of them.
1.    Breast size is hereditary. Genetics do play a role in determining breast size but not necessarily as you'd expect and they don't tell the whole story. We inherit half our genes from each parent, so your breasts may not resemble your mother's, her mother's, or her sister's. Your father's genes have a say. "Environmental factors also play a role," says Dr. Chen, "especially weight. Breasts are partly made up of fatty tissue so as you gain and lose weight, your breast size will change."
2.    Humans are the only primates with permanent breasts. All mammals have breasts and produce milk for their young but we are the only ones who develop breasts at puberty and keep them throughout our lives. Others are temporary, growing when needed to nurse then receding until needed again.
3.    The ancient Egyptians knew about breast cancer as far back as 1600 B.C. Writings on papyrus describe tumors consistent with modern descriptions of the disease. Over the following centuries, many causes were suggested – from imbalances of bodily fluids to compression from tight clothing – and treatments ranged from cauterization to opium to arsenic.
4.    You cannot exercise your way to bigger breasts. "Breasts are made of tissue, not muscle," says Dr. Chen. "They may change in size with hormonal and weight changes. But even exercising the underlying chest muscles won't increase the size of your breasts any more than creams or lotions will."
5.    Some animals get breast cancer. It is more common in dogs – and in some breeds - than in cats but tends to be more aggressive in cats. Spaying female dogs before their first heat dramatically reduces their risk of developing a malignant mammary tumor.
6.    Breastfeeding won't cause your breasts to sag. Droopy breasts are a natural consequence of aging as skin loses elasticity and as dense breast tissue is replaced by fat, which is more prone to sagging. Smoking and multiple pregnancies are contributing factors but breastfeeding has no effect on elasticity and will not cause breasts to sag. Only corrective surgery can lift sagging breasts.
7.    The left breast is usually slightly larger than the right one. Very few women have perfectly symmetrical breasts. Differences in size up to 20% are normal. No one knows why the left breast is usually the larger one.
8.    Larger breasts don't produce more milk. Milk production does not depend on the size of the breasts. Large breasts are often large because they contain more fat cells, not more milk-producing cells.
9.    Breasts are growing. The average bra size was 34B twenty years ago. Today, it is 34DD. Some of the change is due to companies inflating the sizes on their labels but increasing obesity, the number of women taking birth control pills, and exposure to environmental pollution are contributing factors.
10.    Breast implants won't last a lifetime. Breast augmentation is the most commonly performed cosmetic surgery in the U.S. But women who get implants in their 20s should not expect to still have them thirty years later. "Most implants have a ten-year warranty," says Dr. Chen, "but many develop problems well before then and have to be removed or replaced."
Constance M. Chen, MD, is a board-certified plastic surgeon with special expertise in the use of innovative natural techniques to optimize medical and cosmetic outcomes for women undergoing breast reconstruction. She is Clinical Assistant Professor of Surgery (Plastic Surgery) at Weill Cornell Medical College and Clinical Assistant Professor of Surgery (Plastic Surgery) at Tulane University School of Medicine. http://www.constancechenmd.com



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Center for Vein Restoration (CVR) is excited to announce its partnership with Normand Miller, MD, FACS, RPVI, RVT, owner of the Aesthetic & Vein Center MD (AVCMD).

GREENBELT, MD, (PRWEB) OCTOBER 21, 2020
Center for Vein Restoration (CVR) is excited to announce its partnership with Normand Miller, MD, FACS, RPVI, RVT, owner of the Aesthetic & Vein Center MD (AVCMD). Dr. Miller has years of experience in treating and diagnosing Venous Insufficiency, and offers an extensive array of aesthetic treatments, including Body Shaping (CoolSculpting and SmartLipo), Botox and facial fillers. His Salem and Nashua offices will be CVR's first centers in New Hampshire, expanding CVR's footprint to over 90 locations nationwide.
Dr. Miller is a Board-Certified Vascular Surgeon and is certified as a Registered Vascular Technologist (RVT) and Registered Physician in Vascular Interpretation (RPVI). These achievements exemplify how thorough Dr. Miller will be with all of his patients as a CVR provider. In addition to his commitment to achieving the best results possible, adhering to the highest safety standards, and adopting the latest technology and techniques, Dr. Miller regularly works with experts in the field and attends several venous and aesthetic conferences annually. His patient-centered ethos, tailoring vein and aesthetic treatment plans based on patients' unique needs and medical histories, is a defining feature of the AVCMD practice. His investment in education and growth aligns with CVR's culture of bringing knowledge and expertise not only to CVR's patients, but also to its network of CVR centers and providers.
The executive leadership team at CVR, including Dr. Sanjiv Lakhanpal, CEO; Dr. Khanh Q. Nguyen, Chief Medical Officer; and Ken Abod, CFO all convey extreme excitement over the collaboration. "Dr. Miller's trust in CVR is very humbling. The opportunity to learn from his diverse practice will be an incredible advantage for our mission in providing comprehensive and compassionate care, now in the fine state of New Hampshire," says Dr. Lakhanpal. Dr. Nguyen emphasizes that "having a skilled and reputable physician like Normand on our team continues to set CVR apart as the clinical leaders in vein care."
Dr. Miller received his M.D. from Laval University in Quebec City, Canada. After a surgical residency at McGill University in Montreal, he completed a two-year fellowship in Vascular Surgery at Englewood Hospital, New Jersey. He is a Fellow of the American College of Surgeons and is certified by the American Board of Laser Surgery. He also serves as a member of the American Society of Cosmetic Physicians, the American Society for Laser Medicine and Surgery, and the American Vein & Lymphatic Society.
"We've built an amazing team with so much trust throughout our community," offered Dr. Miller. "CVR brings efficiencies and expertise that will allow us to care for more patients."
ABOUT VENOUS INSUFFICIENCY
Venous insufficiency, the cause of significant suffering due to venous hypertension, most commonly arises as achy, tired and heavy legs. It may or may not be associated with varicose veins, spider veins or skin changes including venous ulcerations and indiscriminately affects between 30–40 million Americans. Numerous factors including age, weight, prolonged sitting or standing, genetics or a history of deep vein thrombosis (DVT, or blood clots) can increase the risk of developing this common and often underdiagnosed disorder. Treatment options have evolved to an array of minimally invasive procedures in an office setting.
ABOUT CENTER FOR VEIN RESTORATION
Center for Vein Restoration (CVR) is the largest physician-led practice treating vein disease in the country. Having performed its first procedure in 2007 under President and CEO Dr. Sanjiv Lakhanpal, CVR has since become nationally recognized as the clinical leader in treating chronic venous insufficiency. With 90 centers and growing, CVR has over 500 employees and conducts over 200,000 patient interactions annually. To learn more about CVR and its mission, visit http://www.centerforvein.com or by phone at 1-800-FIX-LEGS.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Virtual care pioneer brings deep experience in improving patient outcomes and revolutionizing the healthcare experience.

CHICAGO (PRWEB) OCTOBER 21, 2020
HealthJoy, the first and only benefits experience platform, today announces the appointment of Patricia Pechter MD as Chief Medical Officer. A board-certified physician with nine years of experience in primary care, telemedicine, urgent care and health management, Dr. Pechter brings to HealthJoy an extensive background in improving patient outcomes and satisfaction while minimizing unnecessary healthcare costs.
The HealthJoy mobile app gives members access to online medical providers and a team of healthcare concierges that can explain their benefits, recommend providers, resolve billing errors, and more. At the center of the experience is JOY, an AI-powered virtual assistant that helps with year-round benefits education and personalized member outreach. As Chief Medical Officer, Dr. Pechter will oversee clinical care operations and be responsible for identifying additional ways to provide proactive, high-quality care to members while mitigating their healthcare spending. She will also help integrate third-party clinical programs, assist in bringing deeper clinical capabilities to the concierge staff, and improve JOY.
"I'm honored to welcome Dr. Pechter to the HealthJoy team," Justin Holland, CEO of HealthJoy, said. "She is committed to making healthcare accessible and affordable, and our shared mission will be a major asset in creating a more meaningful healthcare experience for our members. I look forward to working together to drive new outcomes and further simplify the healthcare journey."
Dr. Pechter has been a pioneer in healthcare technology, previously serving as Medical Director of Virtual Care at Oscar where she spearheaded developing quality assurance programs, establishing onboarding and training curriculum, optimizing provider workflows, and creating personalized member experiences while adhering to clinical best practices. She joined the company as one of three original Virtual Care Physicians.
"2020 proved that consumers want and need virtual care more than ever before. HealthJoy is the perfect entry point for patients because it gives them the education and resources they need to make an informed decision and receive high-quality, affordable care," Dr. Pechter said. "I'm thrilled to contribute my experience to the HealthJoy team and look forward to accelerating healthcare innovation to create a delightful member experience."
Dr. Pechter earned a bachelor's degree from Harvard University and a medical degree from the University of Miami. She completed her residency in Family Medicine at Beth Israel Mt. Sinai Medical Center in New York City and became faculty at NYU as a clinician at their flagship Urgent Care office, leading efforts to customize the EHR for physician efficiency and patient safety.
About HealthJoy
HealthJoy is a first-of-its-kind benefits experience platform helping companies save money on their healthcare while improving employee satisfaction. Through personalized guidance and AI technology, HealthJoy empowers employees to better use and understand their benefits. HealthJoy integrates with a client's existing benefits package to deliver each employee a personalized, proactive experience. Employees gain access to on-demand medical consultations, live healthcare concierges, prescription savings, and much more. For more information, visit https://www.healthjoy.com.




START your own Wordpress site, business or personal website, or online store at www.siteground.com

Demers Ambulances, Braun Ambulances, and Crestline Coach release white paper to inform Fire/EMS organizations of best practices and recommendations to better protect patients and personnel from infectious diseases while in ambulances.

VAN WERT, OHIO (PRWEB) OCTOBER 21, 2020
Demers-Braun-Crestline (DBC) has released a 16-page white paper titled Ambulance Decontamination: Information, Resources, & Considerations for High-Risk Infection Control in an Ambulance. Fire/EMS professionals have the opportunity to download the free white paper to learn more about best practices, and recommended solutions to integrate into their own strategic plans, as they continue to combat infectious diseases.
While the worldwide emergency response community remains on the frontlines of the COVID-19 pandemic, DBC has been busy behind the scenes dedicating engineering resources to focus on ambulance decontamination. Long committed to safety and innovation, DBC evaluated a wide range of products, design options, and protocols to help protect patients and EMS personnel from infectious diseases in an ambulance setting. That collective knowledge was organized into the new white paper, which contains information, resources, and recommendations on ambulance infectious disease control measures. It should serve as an introductory guide for organizations overwhelmed by where to start with ambulance decontamination.
The 16-page white paper answers several important questions, but centers on one primary topic: What feature and design considerations should be reviewed inside an ambulance? Identifying five key areas, each section educates readers on ambulance options and features that assist in limiting the spread of viruses, bacteria, parasites, and fungi. From plexiglass dividers to HEPA filters, chemical fogging systems to self-disinfecting surfaces, and everything in-between, the white paper outlines a variety of solutions that every emergency response organization should consider for enhancing safety inside their ambulances.
Prior to the public release of the document, Demers-Braun-Crestline provided advance copies to two well-known leaders in EMS, AJ Heightman and Chief Randy Mellow. AJ Heightman, Editor Emeritus at JEMS (Journal of Emergency Medical Services) and Adjunct Instructor of Clinical Research and Leadership at George Washington University School of Medicine and Health Sciences, said, "Demers-Braun-Crestline has been one of the leaders in our industry for over 100 years, presenting customers with innovations, special design and safety features, and options. This white paper is another example of their thought leadership – focusing on management and the elimination of infectious diseases in ambulances."
Chief Randy Mellow, President of the Paramedic Chiefs of Canada and Chief of the Peterborough County/City Paramedics, said, "It is a certainty that the Paramedic community requires agility and adaptability to keep pace with the complexity and evolution of care as never seen before. The COVID-19 pandemic has demanded the attention of thoughtful leaders to reflect and refocus, to ensure that as the emergency services industry grows and evolves, so does the emerging knowledge and investment in high-risk infection control. The DBC Ambulance Decontamination white paper provides guiding principles, practical recommendations, and resources to help EMS organizations form strategies that will enhance safety for patients, responders, and our communities."
The white paper is available in several versions including a U.S. and Canadian foreword, and French translation. Individuals or organizations interested in learning more about ambulance decontamination should visit DBCAmbulances.com or download a free copy now. For more information about the white paper, please contact Vanessa Bomboir, Marketing Manager for Demers-Braun-Crestline at (306) 986-5677 or vbomboir@crestlinecoach.com.
About Demers-Braun:
Demers Ambulances, Braun Ambulances, and Crestline Coach are three distinct brands owned by Demers-Braun. The second-largest ambulance manufacturing organization in North America, Demers-Braun has been recognized for leadership in innovative design and quality products. With over 140 years of combined history meeting the needs of customers in over 42 countries, Demers Ambulances, Braun Ambulances, and Crestline Coach offer a wide-range of ambulances, specialty vehicles, and small to mid-sized buses. To learn more about the respective brands, visit their websites at Demers-Ambulances.com, BraunAmbulances.com, CrestlineCoach.com, or CCL150.com.




START your own Wordpress site, business or personal website, or online store at www.siteground.com

Push to Talk, Group Chat & Text, Dashboard Functionalities and Zone Escalation build on NOTIFY's industry-leading technologies

MINNETONKA, MINN. (PRWEB) OCTOBER 21, 2020
NOTIFY announced today the version 1.5 release of its Nurse Call mobile app, now available in both the Android and iOS app stores. The latest version marks the most significant and robust update to date and includes key functionalities to make the app even more seamless and actionable.
The latest enhancements include:

Push to Talk: The addition of Push to Talk allows caregivers to simply press a button, talk and deliver a message to one or all other caregivers. This real-time voice communication is network agnostic, works from anywhere and allows caregivers to eliminate the expensive, unreliable hardware that they normally are forced to utilize.

Group Chat and Group Text: Users have the ability to text message other caregivers either individually or as a group inside the app, making it native and secure.

Zone Escalation: Zone escalation now allows alerts to be escalated via text message, email, pager or inside the app. There are also enhanced customizations now available to direct where alerts go, where they're delivered and at what times.

Alert Reason Capture: Caregivers can now track how many alerts are health-related or not, allowing for improved workforce efficiencies and resident services.

NOTIFY Nurse Call 1.5 also includes technical improvements and enhancements to help fine-tune and streamline server synchronization, time zone configurations and more.
The release fully integrates with NOTIFY's Dashboards in order help users dig deeper into the data to provide communities with documentation and accountability and drive workforce efficiencies.
"We're thrilled to be able to offer these latest upgrades and functionalities to our customers," said NOTIFY General Manager Greg Robertson. "We continue to work tirelessly to make NOTIFY Nurse Call the nation's leading nurse call and communications system and our newest features really will help communities communicate better, work more efficiently and provide top-tier care to residents."
ABOUT NOTIFY: NOTIFY Nurse Call is a next generation mobile nurse call solution that allows your caregivers to receive and respond to alerts from wherever they are in the building. Give your staff the tools they need to provide optimal care—and give your senior community the real-time data needed to staff appropriately, assess performance and improve accountability. Utilizing world-renowned, non-proprietary Inovonics technology, NOTIFY is a complete wireless alert system solution that provides real-time communication across the full spectrum of your operation.
For further information, please contact: Greg Robertson, Senior VP/General Manager, NOTIFY: grobertson@notifync.com, (844) 666-3039
Follow NOTIFY on LinkedIn / Facebook / YouTube



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Cannabinoid Balance Original+ is a Broad Spectrum CBD Tincture with high absorption NanoZorb Technology. Cannabinoid Balance Original+ is fast-acting and efficient thanks to its use of proprietary NanoZorb Technology. By increasing the bioavailability of CBD with nano technology CBD Products Inc. are able to deliver a product that promotes enhanced interaction with the body's endocannabinoid system.*

LA JOLLA, CALIF. (PRWEB) OCTOBER 21, 2020
Cannabinoid Balance Original+ is a Broad Spectrum CBD Tincture with high absorption NanoZorb Technology. Cannabinoid Balance Original+ is fast-acting and efficient thanks to its use of proprietary NanoZorb Technology. By increasing the bioavailability of CBD with nano technology CBD Products Inc. are able to deliver a product that promotes enhanced interaction with the body's endocannabinoid system.*
So whether your symptoms be associated with MS, Parkinsons, Opioid Addiction, Epilepsy, High Blood Pressure, Stress, Anxiety, Low Energy, Arthritis, Tendonitis or something else, Cannabinoid Balance Original+ is crafted to support you.*
Like all of Cannabinoid Balance products, Cannabinoid Balance Original + is:
Crafted from registered organic USA hemp
Non-THC / Non-GMO and CO2 Extracted
Free from Winterization, Decarboxylation, and pesticides
Formulated using proprietary NanoZorb Technology
Cannabinoid Balance Original + is available in two strengths - 1,000mg and 3,000mg, so depending on the consumer's tolerance they can get pure and balanced CBD just the way they like it.
*The statements and products referred to by Cannabinoid Balance have not been evaluated by the FDA.
NOTES TO THE EDITOR
CBD Products Inc. is a multi-channel, CBD publishing and retail company established in 2018 that owns and operates cbdproducts.com, cbdworldnews.com and cbdpet.com. In the last year CBD Products Inc. has welcomed more than 25,000 people to their sites and offered information and resources across more than 100,000 page views.
CBD Products Inc. is also the owner of Cannabinoid Balance. A line of consumer products that includes Cannabinoid Balance Original+, Cannabinoid Balance Sleep+, Cannabinoid Balance CBD Gummies+, Cannabinoid Balance Pain Relief Cream and Cannabinoid Balance Pet+. These products are sold via http://www.cbdproducts.com and include proprietary NanoZorb Technology designed to make Cannabinoid Balance products more effective and efficient.
It was founded by Anthony Tribunella in 2018. Anthony has worked in all aspects of the industry from growing to production, to publishing and retailing. With more than a decade of experience in CBD and a passion to see the industry become organized and honest, Anthony is rapidly becoming a shining light, thought leader and conscience for the industry he cares so deeply about.
For more information on CBD Products Inc. please visit http://www.cbdproducts.com or email contact@cbdproducts.com.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Pairing high-quality flower with a carefully chosen extraction lab, Green RiNo is in the midst of running their in-house strain called "Chem De La Chem". Green RiNo has approached this new endeavor with one priority in mind: team up with producers to bring their top quality flower to the concentrate market.

DENVER (PRWEB) OCTOBER 21, 2020
The concentrates market is booming right now. Particularly trending in the cannabis industry is rosin production. From edibles to cartridges and from dabs to pre-rolls, cannabis enthusiasts are clamoring to get their hands on high-quality rosin.
Rosin refers to the extraction process that uses pressure and heat to yield a shatter-like concentrate. Known for its versatility, rosin can be made using either flower or hash and kief. In contrast to its concentrate counterparts, rosin is solventless, which means users do not have to worry about leftover solvents negatively affecting their health or their high.
Green RiNo has long been a proponent of growing high-quality flower that wows their customer base, knowing that it takes careful hands and a true passion to grow flower that has flavor and potency. Taking pride in cultivating the best of the best, Green RiNo has announced that they are coming out with their first batch of live rosin.
Pairing high-quality flower with a carefully chosen extraction lab, Green RiNo is in the midst of running their in-house strain called "Chem De La Chem". Green RiNo has approached this new endeavor with one priority in mind: team up with producers to bring their top quality flower to the concentrate market.
Known for its gassy flavor and high potency, Chem De La Chem was the perfect choice for their inaugural live rosin strain. Based on the structure and trichome coverage of Chem De La Chem, it provides for high yields and a strong terpene profile. Pricing will vary based on overall characteristics and yields, but should be retailing for an MSRP of $60/g.
In addition to Chem De La Chem, Green RiNo will be releasing Lemon G, Wilson Zero, White Grape Fruit Cookies and an OG to start their journey into the live rosin market. Their entire team is confident that the strategic partnership with the extraction lab will prove to be a fruitful venture for the Green RiNo brand and, more importantly, for its customers base.
As one of the purest forms of concentrated cannabis, live rosin has proven to be a force to be reckoned with in the cannabis industry. Enthusiasts are flocking to stores who carry high quality product that meets or exceeds their high expectations. In fact, High Times has referred to live rosin as the "cannabis concentrate connoisseur's choice".
As usual, Green RiNo is on the cutting-edge of the shifts in the industry. With the rosin market starting to accelerate, their ur focus has been to provide strains and flavor profiles that are either currently limited in the market or are nonexistent in the market. In doing so, they aim to offer unique product that never falters on quality.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

A total of 47 Mercy Medical Center physicians were recognized in Baltimore Magazine's November 2020 "Top Doctors" issue, representing 38 separate specialties, ranging from orthopedic surgery to weight management.

BALTIMORE (PRWEB) OCTOBER 21, 2020
A total of 47 Mercy Medical Center physicians were recognized in Baltimore Magazine's November 2020 "Top Doctors" issue, representing 38 separate specialties, ranging from orthopedic surgery to weight management, specifically:
Breast Surgery
Dr. Neil B. Friedman
Dr. Jennifer Joh
Cardiology-Non Interventional
Dr. Mark Applefeld
Dr. Frank Morris (Mercy Personal Physicians at Lutherville)
Colo-Rectal
Dr. Jeffery Nelson
Dermatology
Dr. Douglas Buethe
Emergency Medicine
Dr. Stephen Schenkel
Endocrinology
Dr. Marie Bellantoni (Mercy Personal Physicians at Overlea)
Gastroenterology
Dr. Scott Huber
Gastroenterology – Inflammatory Bowel Disease
Dr. Mary Harris
Gastroenterology – Liver Disease
Dr. Anurag Maheshwari
General Obstetrics – High Risk Obstetrics
Dr. Robert Atlas
General Pediatrics
Dr. Ashanti Woods
General Surgery
Dr. Larry Fitzpatrick
Dr. Thomas Swope
Gynecologic Oncology
Dr. Dwight Im
Dr. Teresa Diaz-Montes
Dr. Neil Rosenshein
Hematology
Dr. Sandy Kotiah
Dr. Peter (Panayotis) Ledakis
Hepatobiliary
Dr. Paul Thuluvath
Interventional Radiology
Dr. David Sill
Neurology – General
Dr. Bonnie Gerecke
Neurology – Neuromuscular
Dr. Bonnie Gerecke
Neurosurgery
Dr. Charles Park
Oncology – Breast
Dr. Neil B. Friedman
Dr. David Riseberg
Oncology – General
Dr. Sandy Kotiah
Dr. Peter Ledakis
Orthopedic – Foot & Ankle
Dr. John Campbell
Dr. Clifford Jeng
Dr. Patrick Maloney
Dr. Lew Schon
Orthopedic Surgery – Joint
Dr. Marc Hungerford
Orthopedic Surgery – Sports Medicine
Dr. John-Paul Rue
Pain Management
Dr. David Maine
Plastic Surgery – Reconstructive
Dr. Bernie Chang
Dr. Brendan Collins
Pulmonary
Dr. Michael Lansing (Mercy Personal Physicians at Reisterstown)
Dr. Albert Polito
Radiation Oncology
Dr. Maria Jacobs
Radiology
Dr. David Sill
Regional Anesthesiology
Dr. Robert Wong
Rheumatology/Clinical Immunology
Dr. Lynn Ludmer
Spine Surgery
Dr. Clayton Dean
Dr. Charles Edwards
Sports Medicine (Non Surgical)
Dr. Jessalynn Adam
Surgical Oncology
Dr. Armando Sardi
Urogynecology
Dr. R. Mark Ellerkmann
Urology
Dr. Blaine Kristo
Vascular Surgery
Dr. Paul Lucas
Weight Management
Dr. Kuldeep Singh
Each Mercy physician was recognized as among the best in the region in their respective fields.
In addition, Ashanti Woods, M.D., FAAP, who specializes in General Pediatrics at Mercy Family Care Physicians, was among several physicians photographed and profiled for the special edition. Dr. Woods is Board Certified by the American Board of Pediatrics and offers a wide spectrum of pediatric care for newborns through adolescents.
Assisting in the Baltimore magazine "Top Docs" survey were three physician advisors, including Dr. Jennifer Taylor, OB/GYN, of Mercy's Family Childbirth and Children's Center, who provided professional expertise. Board Certified in Obstetrics and Gynecology, Dr. Taylor earned her medical degree at State University of New York at Buffalo. She completed her residency in OB-GYN at the University of Maryland School of Medicine.
Founded in 1874 by the Sisters of Mercy, Mercy Medical Center is a university-affiliated medical facility with a national reputation for women's health care. Mercy is home to the renowned Weinberg Center for Women's Health and Medicine and the 20-story, $400+ million Mary Catherine Bunting Center. For more information, visit Mercy's website at http://www.mdmercy.com, visit MDMercyMedia on Facebook and Twitter, or call 1-800-MD-Mercy.
-30-



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Thanks in part to the #Creators4BIPOC initiative from Streamlabs, a Logitech company, WeXL Org presents American Wellness, a video series featuring Miss Wisconsin USA 2020 Gabriella Deyi as she explores how present-day issues affect diverse populations' mental health in the U.S.

SAN FRANCISCO (PRWEB) OCTOBER 21, 2020
WeXL Org (http://www.wexl.org), a non-profit that champions diverse people from untapped communities by elevating their stories and providing key tools to succeed, will launch the video series, American Wellness with Miss Wisconsin USA 2020 Gabriella Deyi, on Oct. 29 at 12:30 p.m. Pacific Time on the WeXL Org YouTube channel (http://www.youtube.com/WeXLorg). Funding for the series comes from #Creators4BIPOC, a new initiative by Streamlabs, a Logitech company.
American Wellness – produced at the WeXL Media Lab, which the Streamlabs grant helped establish – features WeXL Creator Gabriella Deyi, whose recent journalism fellowship at the University of Wisconsin included on-air reporting for WKOW-ABC 27. Deyi, the current Miss Wisconsin USA, uses her platform to raise awareness of mental health issues – including those that afflict her mother and brother – as she prepares for the Miss USA Pageant on Nov. 9. A first-generation American born to immigrants from Liberia and Dominican Republic, Deyi embodies WeXL's mission and that of #Creators4BIPOC.
People can vote Deyi into the Top 16 as their favorite 2020 Miss USA delegate on the Choicely app (https://bit.ly/miss_WI_gabby).
"I am excited to launch American Wellness," she said. "This could not be more timely, as we see spikes in mental health issues as a byproduct of the COVID-19 pandemic and its economic duress, plus our nation's political uncertainty and racial conflict. These circumstances weigh heavily on BIPOC communities, which are in disproportionate risk of contracting COVID-19, as they continue to suffer from the chronic stress of financial strain, lack of access to healthcare, and other socio-economic fallouts of systemic racism."
"We are grateful to receive such support to do this important work," said WeXL founder and CEO Arabella DeLucco. "The #Creators4BIPOC grant from Streamlabs enables WeXL to champion and aid talented creators, such as Gabriella. At WeXL, storytelling is one of our main values and mission drives. By producing original programs like American Wellness, we better understand complicated issues impacting diverse communities (such as mental health) while connecting them to resources and solutions. We believe when we work together, we can create a more equitable world for all."
"Streamlabs has committed a minimum of $1 million over the next ten years to address racial inequality," said Streamlabs' Chelsea Simms, who leads an entrepreneurial team building products for digital creators that empowers them to share their passion and make an impact. "We are drawn to WeXL because of their team's focus on storytelling and creators. WeXL's empowerment of Gabriella and others from diverse communities who raise their voices to speak for equity is synonymous with what Streamlabs does in terms of empowering live-streaming creators. Both of our organizations recognize that storytelling is an incredibly special part of creating impact."
Watch the American Wellness series trailer on WeXL's YouTube channel (https://www.youtube.com/watch?v=aC6AO5v9QhU).
###
WeXL.org is a 501(c)3 nonprofit based in San Francisco, Calif., with a mission to champion diverse people from untapped communities by elevating their stories and providing key tools to succeed. The organization produces original content, including the live webcast, We eXceL daily hosted by WeXL CEO and founder Arabella DeLucco, and the limited video series, American Wellness with Miss Wisconsin USA 2020, Gabriella Deyi. WeXL also provides programs for educators and companies. Currently in beta at the Girls Prep Bronx Elementary Charter School in New York, Boundless is an immersive distance learning program teaching fourth graders video storytelling. For corporate diversity, equity, and inclusion needs and hiring, WeXL provides a mentorship program and the WIN Diverse Workforce Development System. In September 2020, WeXL became one of the first grant recipients of the #Creators4BIPOC initiative from Streamlabs, a Logitech company.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

A national leader in fertility research, SGF's full-time research team seeks to understand disparities in fertility treatment access and outcomes in service to all patients experiencing infertility.

ROCKVILLE, MD. (PRWEB) OCTOBER 21, 2020
Shady Grove Fertility's (SGF) physician-scientists presented exciting, new research findings during the 2020 American Society for Reproductive Medicine (ASRM) Scientific Congress & Expo as part of the practice's commitment to advancing knowledge and improving assisted reproductive technology (ART) treatment outcomes. Hosted virtually this year, the 2020 Scientific Congress and Expo took place October 17-21 and welcomed nearly 10,000 attendees from 94 countries. During a time when much of the world is connected from a distance, this year's theme of "Dynamic Collaborations in Reproductive Medicine" helped close the physical divide.
SGF: Committed to Research and Education
For the past 29 years, the physicians at SGF have made a sustained commitment to completing clinical research studies and educating physicians in training. SGF is one of only a few private practice fertility centers in the country to employ a full-time dedicated research team, which operates under Director of Research, Kate Devine, M.D., a board certified reproductive endocrinologist who sees patients in SGF's Washington, D.C., K Street location and is faculty to fellows at the National Institutes of Health (NIH) training to become Reproductive Endocrinologists and to residents at Georgetown School of Medicine training to be Obstetrician/Gynecologists. Many of the studies presented at the meeting this year resulted from collaborations between SGF and academic institutions. SGF physicians act as clinical instructors and research mentors to physicians in training from these institutions.
"SGF believes that it is our responsibility to give back to our patients by conducting high-quality research and by training the physicians who will take care of them in the future," says Dr. Devine. "The findings of our studies enable us to provide the best possible information and treatment outcomes to those struggling with infertility. The ASRM Scientific Congress and Expo is one of the largest platforms where, year after year, we combine brainpower with fellow professionals to advance modern medicine."
In addition to Dr. Devine, SGF further expanded its research capabilities with the addition of Anthony Imudia, M.D., Associate Professor of OB/GYN and REI Fellowship Program Director at the University of South Florida Morsani College of Medicine. Dr. Imudia joined SGF in 2019 and sees patients in Tampa Bay's Wesley Chapel and Westshore, FL, locations. His team of researchers contributed five of the 17 abstracts being presented by SGF this year.
"To better support patients with overcoming infertility, we must understand the root cause from a research perspective so we can tailor our treatment solutions," explains Dr. Imudia. "Research allows our physicians at SGF to stay at the forefront of making evidence-based fertility treatments possible for patients."
Remarkably, all 17 abstracts submitted to the ASRM meeting's scientific program committee were accepted for presentation. SGF's poster presentation co-authored by SGF reproductive urologist, Cori Tanrikut, M.D., on the analysis of the association between post-wash total motile sperm count and pregnancy from intrauterine insemination (IUI) was lauded as a third-place prizewinner at the event. The study, which analyzed more than 92,000 IUI cycles, provides a highly clinically useful counseling tool. Clinicians can use these data to advise patients with mild male factor infertility regarding their odds of success from IUI so that couples can make informed decisions between low-tech treatment and IVF.
SGF Physicians Recognized for Leadership
In addition to the 17 abstracts presented at ASRM 2020, SGF's own leadership team took to the virtual stage to present key findings alongside fellow leaders in the field of infertility.
SGF Co-founder and IVF Director for Maryland, Michael Levy, M.D., co-chaired two presentations at the event:

"Embryos v. Eggs? Emerging Fertility Preservation Challenges"

"The ABOG Foundation – Kenneth J. Ryan Ethics Symposium: Dilemmas in Gamete Donation: Honoring Prior Promises in an Era of Vanishing Anonymity"

Additionally, SGF Chief Medical Officer, Eric Widra, M.D., co-chaired the CME-, PEER-, and ACOG-certified symposium, "Evidence Based Embryo Transfer: Maximizing Implantation." Dr. Widra, along with Drs. Devine and Imudia, received an ASRM Star Award for sustained research contribution.
Several Abstracts Focus on Understanding Racial and Ethnic Disparities in Fertility Treatment Access and Outcomes
An important focus for SGF researchers this year was to study and understand racial disparities in fertility treatment outcomes and access to care. This has been prioritized as an area of study for the SGF research team year after year. In 2018, SGF authors, including Kate Devine, M.D., and Isaac Sasson, M.D., Ph.D., earned the Health Disparities Special Interest Group Prize Paper for their abstract, "African American patients experience reduced pregnancy, higher pregnancy loss, and lower live birth from in vitro fertilization (IVF) embryo transfers despite producing more oocytes and more transfer quality embryos than comparable Caucasian patients."

Five of the abstracts that were presented by SGF at ASRM in 2020 focus on better understanding differences in access to care and treatment outcomes experienced by minority groups.

Two of the abstracts found that both Asian and African American patients experienced lower odds of live birth from donor egg IVF relative to Caucasian patients. SGF's Frank E. Chang, M.D., co-authored the study on Asian patients.

In addition, a separate abstract, which was co-authored by Dr. Chang, found that East Asian patients undergoing IVF experienced lower odds of live birth from fresh embryos that have not been genetically tested but equivalent outcomes to Caucasians when frozen PGT-A tested (i.e., chromosomally normal) embryos were used, indicating that egg quality may play a role in the lower live birth rates experienced by these patients.

Finally, members of SGF's clinical research team, Renee Hart, M.S. and Samad Jahandideh, Ph.D., teamed up with researchers from the University of Pennsylvania and Duke School of Medicine to present two abstracts presenting data, both objective and subjective (obtained via interviews of SGF patients), regarding the systemic and individual factors that influence whether African American women pursue fertility treatment.

"Women need to be aware of these disparities, and hopefully this awareness will lead them to seek infertility treatment and consultation earlier in their journey to a healthy baby, to maximize chances of success. Furthermore, the more we understand the causes underlying poorer treatment outcomes in minority groups, the more we can work to close the disparity gap," explains Dr. Devine.
SGF Presents Novel Findings on an Expanding Embryo Donation Treatment Modality that Helps Both Couples and Single Women Achieve their Goal of Having a Family
Additional 2020 SGF abstracts present novel analyses on two important patient populations:

Those who elect to donate embryos and

Those who endeavor to achieve parenthood by receiving a donated embryo.

The studies seek to elucidate factors that lead patients to donate embryo(s) or to receive donated embryo(s), as well as to better understand outcomes from these embryos. There is little published data on embryo donation, and SGFs growing and successful embryo donation program provided the data for these much-needed analyses. In addition to demonstrating high live birth rates resulting from transfer of donated embryos, SGF's research demonstrated that women and couples who conceived using donor-egg IVF were more likely to go on to become embryo donors, perhaps due to a desire to "give back," so that others may achieve parenthood.
"SGF's analyses uncovered that 42% of patients who inquired about donating embryos, and 48% of those who ultimately went on to donate, had utilized donor eggs to create those embryos," explains Dr. Devine. "An impressive 43% of these embryo transfers resulted in successful pregnancies. Embryo donation represents a highly effective and efficient option for women of advanced reproductive age who are unable to conceive with their own eggs, especially those wishing to conceive as single moms by choice," adds Devine.
Other SGF Findings Presented

SGF's Nancy Durso, M.D., and co-authors found that obese women are less likely to proceed with fertility treatment after an initial consultation with a fertility specialist and that there is a longer average duration before treatment begins for such patients. More effective strategies for actively assisting women in this population to achieve healthy weight loss prior to pregnancy holds potential for improving fertility treatment access, fertility treatment outcomes, and enabling healthy pregnancies and deliveries for moms and babies. SGF's Wellness Center offers in-house nutrition and wellness services to patients working towards theses goals.

SGF's Jeanne E. O'Brien, M.D., and co-authors analyzed outcomes from gestational carrier cycles based on single vs double embryo transfer, finding that elective single embryo transfer (eSET) is highly successful and that double embryo transfer increases risk for preterm birth and low birth weight, even in the setting of a healthy gestational carrier. Promoting the goal of healthy singleton live birth is particularly important in this population, given that many intended parents still opt to transfer two embryos in the time and cost-intensive setting of working with a gestational carrier.

"SGF holds the goal of 'one healthy baby at a time' paramount both in its research and its clinical practice and is a national leader in its utilization and success from eSET, in service of this goal," shared Devine.
To learn more about ongoing research being conducted at SGF, visit http://www.shadygrovefertility.com/research
About Shady Grove Fertility (SGF)
SGF is a leading fertility and IVF center of excellence with more than 85,000 babies born and 5,000+ 5-star patient reviews. With 37 locations throughout FL, GA, MD, NY, PA, VA, D.C., and Santiago, Chile, we offer patients virtual physician consults, deliver individualized care, accept most insurance plans, and make treatment affordable through innovative financial options, including 100% refund guarantees. More physicians refer their patients to SGF than any other center. Call 1-888-761-1967 or visit ShadyGroveFertility.com.




START your own Wordpress site, business or personal website, or online store at www.siteground.com

Makers Nutrition was named a winner of three People's Choice Stevie Awards for Favorite Companies in The 17th Annual International Business Awards.

HAUPPAUGE, N.Y. (PRWEB) OCTOBER 21, 2020
Makers Nutrition was named a winner of three People's Choice Stevie Awards for Favorite Companies in The 17th Annual International Business Awards.
The International Business Awards are the world's premier business awards program. All organizations worldwide are eligible to submit nominations – public and private, for-profit and non-profit, large and small.
The winners of the crystal People's Choice Stevie Awards will be celebrated during a virtual awards ceremony for the 2020 IBAs on Tuesday, 1 December.
The People's Choice Stevie Awards for Favorite Companies are an annual feature of The International Business Awards. The worldwide public vote was conducted over the past month, with the highest number of votes deciding the winners in a variety of industry categories. More than 43,000 votes were cast. To win, a category's leading vote-getter had to receive at least 100 votes.
All organizations honored in the IBA's Company of the Year categories were included in people's choice voting.
More than 3,800 nominations were submitted to this year's International Business Awards by organizations in more than 60 nations and territories, for consideration in a wide range of categories. These categories included: New Product or Service of the Year, Most Innovative Company of the Year, Management Team of the Year, Best New Product or Service of the Year, Startup of the Year and Executive of the Year, among others.
This is Makers Nutrition's second People's Choice Stevie in the International Business Awards. It completes the company's biggest year for wins in the IBAs, having also been named a GRAND recipient. Makers Nutrition was named a 2020 Favorite Company in the following categories:

Manufacturing

Consumer Products

Other Industries

"The winners of the People's Choice Stevie Awards were able to activate and motivate their customers, employees, social media followers and other constituents to vote for them, and that is a testament to the healthy ties they have to those audiences," said Stevie Awards president Maggie Gallagher.
Details about The International Business Awards, the complete list of People's Choice Stevie Award winners, and the list of all 2020 Gold, Silver, and Bronze Stevie Award winners in the IBAs are available at http://www.stevieawards.com/IBA.
About Makers Nutrition
Makers Nutrition, an Inc. 5000 Fastest-Growing Company in America, is a groundbreaking provider for dietary supplement companies worldwide. Specializing in capsules, tablets, powders, softgels and gummies, Makers Nutrition provides a full-service option for all contract manufacturing, graphic design, packaging and fulfillment service needs.
About the Stevie Awards
Stevie Awards are conferred in eight programs: the Asia-Pacific Stevie Awards, the German Stevie Awards, the Middle East & North Africa Stevie Awards, The American Business Awards, The International Business Awards, the Stevie Awards for Women in Business, the Stevie Awards for Great Employers, and the Stevie Awards for Sales & Customer Service. Stevie Awards competitions receive more than 12,000 nominations each year from organizations in more than 70 nations. Honoring organizations of all types and sizes and the people behind them, the Stevies recognize outstanding performances in the workplace worldwide. Learn more about the Stevie Awards at http://www.stevieawards.com



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Researchers at Mount Sinai have proposed a groundbreaking new way to study the interaction between complex biological systems in the body and the environment. Their theory suggests the existence of "biodynamic interfaces," an intermediate entity between the two realms, as opposed to conventional approaches that analyze individual aspects of the interaction between the environment and humans in isolation, according to a paper published in BioEssays in October.

NEW YORK (PRWEB) OCTOBER 21, 2020
Researchers at Mount Sinai have proposed a groundbreaking new way to study the interaction between complex biological systems in the body and the environment. Their theory suggests the existence of "biodynamic interfaces," an intermediate entity between the two realms, as opposed to conventional approaches that analyze individual aspects of the interaction between the environment and humans in isolation, according to a paper published in BioEssays in October.
The environment impacts human health in profound ways, yet few theories define the form of the relationship between human physiology and the environment. The Mount Sinai scientists believe that such complex systems cannot interact directly, but rather that their interaction requires the formation of an intermediary "interface." The scientists believe that this theory will lead to the establishment of a new field, "environmental biodynamics," that will advance the way the environment and human health are studied.
The basis of their theory arose when they compared the time period when autistic children were exposed to toxins to how the children's brains functioned afterward. At the same time, they found distinct patterns in the intake and metabolism of essential elements and toxins, which were dependent not only on the timing and magnitude of the environmental exposure but also on what was happening within the biological systems of the child's body.
"These rhythms were driven by the properties of both the biological and environmental systems, but exhibited properties independent of either system," said Manish Arora, PhD, the Edith J. Baerwald Professor and Vice Chair of Environmental Medicine and Public Health at the Icahn School of Medicine at Mount Sinai. "They supported the existence of an interface mediating the interaction of biological and environmental systems. The interface itself, which applies constraints and passes information between interacting systems, must be the subject of inquiry because without refocusing the attention on biodynamic interfaces, how the environment impacts health cannot be discerned."
The study of the interface will allow scientists to better understand how complex systems like the environment and human physiology affect each other. Current methods using plain analysis are incomplete, the scientists say.
"The standard course of inquiry measures some aspect of the environment like lead in the water, and we'd link this to some aspect in human development like IQ," said Paul Curtin, PhD, Assistant Professor of Environmental Medicine and Public Health at the Icahn School of Medicine at Mount Sinai, an author on the paper. "We've learned a lot from environmental health using this approach, but it has its limits."
This interface also considers social, behavioral, and cultural dynamics to be a particularly fruitful avenue of research. This new theory would allow scientists to assess the interface between income and other processes, including health outcomes using dynamical systems methods. It would also define how human activities could negatively influence the environment and negatively influence their own health outcomes and further environmental impacts over time.
Dr. Arora's work was funded by a prestigious Revolutionizing Innovative, Visionary Environmental Health (RIVER) Award from the National Institute of Environmental Health Sciences, totaling $8 million over eight years to complete research on the biodynamic interface. Alessandro Giuliani, PhD, Professor of Environmental Health at the University of Rome, has made a significant contribute to the development of the theory.
"Arora, Giuliani, and Curtin's conjecture is potentially a major breakthrough, as knowing the factors that influence biological time may be the key to understanding why people age or mature at different rates, and how our early life experiences can influence our health as adults," said Robert O. Wright, MD, MPH, Ethel H. Wise Professor and Chair of Environmental Medicine and Public Health and Director of the Institute for Exposomic Research at the Icahn School of Medicine at Mount Sinai.
About the Mount Sinai Health System
The Mount Sinai Health System is New York City's largest academic medical system, encompassing eight hospitals, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. Mount Sinai is a national and international source of unrivaled education, translational research and discovery, and collaborative clinical leadership ensuring that we deliver the highest quality care—from prevention to treatment of the most serious and complex human diseases. The Health System includes more than 7,200 physicians and features a robust and continually expanding network of multispecialty services, including more than 400 ambulatory practice locations throughout the five boroughs of New York City, Westchester, and Long Island. The Mount Sinai Hospital is ranked No. 14 on U.S. News & World Report's "Honor Roll" of the Top 20 Best Hospitals in the country and the Icahn School of Medicine as one of the Top 20 Best Medical Schools in country. Mount Sinai Health System hospitals are consistently ranked regionally by specialty and our physicians in the top 1% of all physicians nationally by U.S. News & World Report.
For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

The award recognizes Enduvo's unique ability to make immersive, interactive content easy and cost-effective for anyone to create, share and consume

CHICAGO (PRWEB) OCTOBER 21, 2020
Enduvo, the company that makes interactive, immersive content easy for anyone to create, share and consume, today announced it has been named the winner of the Theron Technology-Enabled Award at the annual Chicago Innovation Awards. This award recognizes Enduvo's unique ability to enable rapid, cost-effective creation and delivery of immersive content, with its no-code augmented and virtual reality (AR/VR) content authoring and delivery platform.
"The pandemic is pushing people to find more effective virtual ways to learn, communicate and collaborate. Even though immersive content is the best way to do this, it has been much too costly, time-consuming and complex for most organizations," said Steve Garrou, Chairman and CEO of Enduvo. "We're thrilled that the Chicago Innovation Awards recognizes Enduvo's platform for revolutionizing the way organizations create and deliver affordable, high-impact collaboration and training programs."
"In this year of a global pandemic, innovation is needed now more than ever," said Tom Kuczmarski, co-founder with Chicago journalist Dan Miller of the Chicago Innovation Awards. "2020 winners are solving big problems in healthcare, community and workforce development, education, electronics, manufacturing, and more."
Enduvo enables anyone, regardless of technical know-how, to quickly create and instantaneously distribute content to people anywhere. People view the content on tablets, computers, and AR/VR devices. Military, healthcare, and education organizations, such as the US Air Force, National Institutes of Health, and University of Illinois College of Medicine, use Enduvo to significantly reduce content creation costs and deliver training, collaboration, and instructional content much faster. Enduvo's customers train Airmen to be mission-ready, collaborate with researchers on opposite sides of the world to find cures for deadly diseases, prepare medical students to be more successful practitioners, and create content to effectively teach students remotely.
About Chicago Innovation Awards
The Chicago Innovation Awards, celebrating its 19th year, is the Chicago region's foremost recognition of the most innovative new products or services brought to market each year. 272 organizations were nominated for this year's awards. As a group, these nominees are responsible for generating over $5.6 billion in new revenues, 7,322 new jobs and 1,683 patents from their nominated new products and services.
About Enduvo
Enduvo empowers everyone to create and share meaningful experiences that enrich people's lives. Our powerfully simple, immersive content platform gives people a much better way to communicate, collaborate and share knowledge. Enduvo lets anyone rapidly create, distribute and consume rich, interactive, virtual experiences. Military, government, healthcare, industrial and education organizations use Enduvo to reduce development costs, speed delivery time and boost the impact of their content.
Learn more at http://www.enduvo.com and follow us on Twitter, LinkedIn, Facebook, and YouTube



START your own Wordpress site, business or personal website, or online store at www.siteground.com

DermBiont, Inc., a clinical stage precision dermatology company targeting skin diseases at their root cause has expanded its pipeline and therapeutic modalities with the acquisition of SeylanMED, Inc. SeylanMED's lead drug candidate, a topical AKT inhibitor gel, has the potential to be the first patient-applied treatment for seborrheic keratosis.

BOSTON (PRWEB) OCTOBER 21, 2020
DermBiont, Inc., a clinical stage precision dermatology company targeting skin diseases at their root cause has expanded its pipeline and therapeutic modalities with the acquisition of SeylanMED, Inc.
"This strategic acquisition delivers multi-factorial value," said Karl Beutner, MD, PhD, Co-founder, CEO, and CMO of DermBiont. "It expands our therapeutic pipeline with a first-in-class, targeted topical small molecule as well as our mission to address skin diseases at their root cause."
SeylanMED's lead drug candidate, a topical AKT inhibitor gel, has the potential to be the first patient-applied treatment for seborrheic keratosis. Seborrheic keratosis (SKs) are benign clonal tumors with activating mutations in the RTK-P13K, Akt, mTOR signaling pathway. SKs affect over 80 million people in the US alone and are frequently seen in middle-aged and older adults. These benign tumors vary in color and can be up to an inch or more wide. They typically have a slightly elevated, waxy, or scaly appearance and can appear in both sun-exposed and sun-protected areas on the body.
The current standard of care is ablation with curettage, an effective treatment, but with several side effects including scarring, changes in pigmentation, pain, bleeding, and risk of wound infection; alternative treatments include electrosurgery or cryosurgery, which are not as effective as curettage. These procedures are costly, must be performed by a provider at a clinic, and are not often covered by insurance.
"The combination of SeylanMED with DermBiont is a welcomed combination of strengths," said Mark de Souza, PhD, CEO of SeylanMED. "This merger places a valuable and de-risked topical small molecule drug candidate in the hands of an experienced development team with a track record of advancing over a dozen programs through FDA approval."
In addition to SeylanMED's topical AKT inhibitor gel for the treatment of SKs, DermBiont plans to initiate least four other phase 2b clinical trials in 2021 with live bacterial therapeutics discovered internally from its microbiome platform technology.
"We are rapidly advancing proprietary, first-in-class, targeted topical drug candidates through clinical trials while building the next generation dermatology company," said Nichola Eliovits, DermBiont's Co-founder and Chief Business Officer. Adding, "Dermatology is an industry ripe for innovation across the value chain. DermBiont intends to change this paradigm across all major skin diseases with unmet patient needs, beginning with those in our pipeline."
About DermBiont
DermBiont is a leading precision dermatology company developing targeted topical therapeutics that treat, cure, and prevent skin diseases by addressing their root cause, beginning with biotherapeutics repairing a dysbiosis of the microbiome and targeted small molecule therapeutics with well-defined mechanisms of action.
In addition to the company's lead product (DBI-001) in development to treat atopic dermatitis, onychomycosis, and tinea pedis, the company is advancing four other topical clinical assets across a wide range of skin diseases, including seborrheic dermatitis (DBI-002) and seborrheic keratosis (SM-020).
The company's biotherapeutics discovery capabilities are powered by a proprietary computational biology platform enabling the rapid discovery of hits against pathogens from a curated library of thousands of microbes isolated from human skin and one of the world's largest and expanding data sets of Nextgen sequencing of the human microbiome across healthy and diseased skin.
About SeylanMED
SeylanMED is committed to the development of a topical Akt inhibitor as a first in class treatment for seborrheic keratosis. The company's lead drug candidate (SM-020) is the first molecularly targeted approach for the treatment of this disease. Victor Neel and Anna Mandinova, founders of SeylanMED, a company acquired by DermBiont, Inc., are key opinion leaders in seborrheic keratosis and Akt inhibition as well as the co-inventors of SeylanMED's in-licensed intellectual property.
Please send all inquiries to: press@dermbiont.com

"Dermatology is an industry ripe for innovation across the value chain. DermBiont intends to change this paradigm across all major skin diseases with unmet patient needs, beginning with those in our pipeline."



START your own Wordpress site, business or personal website, or online store at www.siteground.com

A Safe Haven of Chicago has been named a 19th annual Chicago Innovation Award Winner. A Safe Haven won in the Chicago Innovation Awards' Non-Profit Category for its COVID-19 Medical Respite Center in partnership with Chicago Department of Health (CDPH) and Rush University Medical Center (RUMC). The center provides health and behavioral healthcare services to COVID-19 positive patients, who cannot isolate at home or are homeless. There were over 9,000 people registered to participate in the inaugural virtual awards event.

CHICAGO (PRWEB) OCTOBER 21, 2020
A Safe Haven of Chicago has been named a 19th annual Chicago Innovation Award Winner. A Safe Haven won in the Chicago Innovation Awards' Non-Profit Category for its COVID-19 Medical Respite Center in partnership with Chicago Department of Health (CDPH) and Rush University Medical Center (RUMC). The center provides health and behavioral healthcare services to COVID-19 positive patients, who cannot isolate at home or are homeless. There were over 9,000 people registered to participate in the inaugural virtual awards event.
The Chicago Innovation Awards is the Chicago region's foremost recognition of the most innovative new products or services brought to market each year.
A Safe Haven was able to quickly collaborate to convert a 7,000 square feet space into a fully functional hospital grade negative air 50-100 bed medical respite isolation space to serve COVID-19 diagnosed vulnerable patients. It provides a safe place to heal under the direct medical and behavioral healthcare supervision of trained professionals and to prevent the spread of COVID-19 to others.
"In this year of a global pandemic, innovation is needed now more than ever," said Tom Kuczmarski, co-founder with Chicago journalist Dan Miller of the awards. "2020 winners are solving big problems in healthcare, community and workforce development, education, finance, agriculture, electronics, telecommunications, manufacturing, drug development, business services, and more."
Neli Vazquez Rowland, co-founder and president of A Safe Haven, expressed her gratitude to the Chicago Innovation Awards judges in selecting her nonprofit organization.
"As America is on the verge of experiencing what is predicted to become the biggest surge of homelessness this winter, due to the ravaging and ripple effects of the COVID-19 pandemic, on individuals and families that were homeless and those that were already living one paycheck away from homelessness, we are so proud to have stood up what has now become known as a national model for addressing the pandemic and homelessness among people in need of shelter," she said. "The homeless and those living in doubled up congregate living situations and in need of professional health and behavioral healthcare were among the hardest hit by the pandemic and were suddenly desperately in need of shelter and other wrap around services to address their positive diagnoses and all of their social determinants of health. Thank God, our plan to save and heal lives is working. We are proud to boast a 100% survival and success rate among the hundreds of patients and residents that we have served in the Medical Respite, so far! "
The winning organizations receive a variety of honors including the opportunity to ring the Nasdaq Bell in New York City, and meetings with the Mayor of Chicago, Governor of Illinois, Cook County President, and leaders from the United Nations Foundation.
"There were 272 organizations nominated for this year's awards," said Luke Tanen, Executive Director of the Chicago Innovation Awards. "As a group, these nominees are responsible for generating over $5.6 billion in new revenues, 7,322 new jobs, and 1,683 patents from their nominated new products and services. The winners represent the best from this very impressive group."
The complete list of this year's Chicago Innovation Award winners can be found at http://www.chicagoinnovation.com.
The Chicago Innovation Awards are supported by Founding Diamond Sponsor Theron Technology Solutions; Diamond Sponsors Wintrust, Accenture, and SMS Assist, Gold Sponsors Comcast Business and Exelon, and others.
About A Safe Haven:
A Safe Haven Foundation is a 501(c) 3 not for profit, social enterprise that helps people aspire, transform and sustain their lives as they transition from homelessness to self-sufficiency with pride and purpose.
A Safe Haven provides the tools for each individual to overcome the root causes of homelessness through a holistic and scalable model. A Safe Haven's visible social and economic impact unites families, stabilizes neighborhoods, and creates vibrant, viable communities. For information, visit http://www.asafehaven.org.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Homecare Homebase (HCHB) the nation's #1 software for home-based care is now the software provider for Carolina-based Hospice & Palliative Care Charlotte Region (HPCCR). The not-for-profit agency provides expert end-of-life care, grief support and community education to help relieve suffering and improve the quality and dignity of life through compassionate care.

DALLAS (PRWEB) OCTOBER 21, 2020
Homecare Homebase℠ (HCHB) the nation's #1 software for home-based care is now the software provider for Carolina-based Hospice & Palliative Care Charlotte Region (HPCCR). The not-for-profit agency provides expert end-of-life care, grief support and community education to help relieve suffering and improve the quality and dignity of life through compassionate care.
HPCCR President & CEO Peter Brunnick said the agency had been looking for a single, comprehensive solution to enable seamless interoperability across multiple health care systems, tackle increasingly complex compliance issues and better position the agency for continued growth.
"We asked a number of vendors who they thought we should work with – and the answer was HCHB," said Brunnick. "The fact that they could help us integrate everything from electronic documentation and physician signatures to pharmacy and medical supply orders was a priority for us. And the disciplined workflow structure means each person is highly accountable – which is the perfect fit for our culture."
Homecare Homebase President Scott Decker said his company is seeing more and more interest from agencies of all sizes – in all areas of home-based care. "At a time of increased regulation and ever-tighter margins, agencies know growth requires more than simply adding to their patient census. We're here to help empower exceptional patient care through increased efficiencies, enhanced interoperability and the compliance expertise to help them capture every available dollar."
About HPCCR
The mission of Hospice & Palliative Care Charlotte Region is to relieve suffering and improve the quality and dignity of life through compassionate hospice care for those at the end of life, palliative care for those with advanced illness and through community education. Operating since 1978, Hospice & Palliative Care Charlotte Region provides expert end-of-life care as well as grief support and community education. HPCCR is committed to offering quality of life to patients and families in their community who are coping with serious illness. Established as North Carolina's first hospice provider, HPCCR serves over 2,000 patients each day for hospice and palliative services across the Carolinas.
About Homecare Homebase, LLC
Homecare Homebase (HCHB) is a Dallas-based software leader offering hosted, cloud-based solutions to streamline operations, simplify compliance and boost clinical and financial outcomes for homecare and hospice agencies. Our customized mobile solutions enable real-time, wireless data exchange and communication between field clinicians, physicians and office staff for better care, more accurate reporting and faster payment. Founded by industry veterans in 1999, the company is now part of the Hearst Health Network. For more information visit hchb.com or call us toll-free at 1-866-535-HCHB (4242).
About Hearst Health
The mission of Hearst Health is to help guide the most important care moments by delivering vital information into the hands of everyone who touches a person's health journey. Each year in the U.S., care guidance from Hearst Health reaches 85 percent of discharged patients, 205 million insured individuals, 103 million home health visits and 3.2 billion dispensed prescriptions. The Hearst Health network includes FDB (First Databank), Zynx Health, MCG, Homecare Homebase and MHK (formerly MedHOK). Hearst also holds a minority interest in the precision medicine and oncology analytics company M2Gen. Follow Hearst Health on Twitter @HearstHealth and LinkedIn @Hearst-Health.

"We're here to help empower exceptional patient care through increased efficiencies, enhanced interoperability and the compliance expertise to help them capture every available dollar."



START your own Wordpress site, business or personal website, or online store at www.siteground.com

East Coast Cannalytics, based in Blacksburg, VA, is the first cannabis testing laboratory accredited to the standard in the state by A2LA.

FREDERICK, MD. (PRWEB) OCTOBER 21, 2020
A2LA is pleased to announce the accreditation of ECC Test Lab to ISO/IEC 17025:2017 for cannabis testing. East Coast Cannalytics (dba ECC Test Lab), based in Blacksburg, VA, is the first cannabis testing laboratory accredited to the standard in the state by A2LA.
"ECC is thrilled to be ISO/IEC 17025 accredited! In the cannabis industry ISO/IEC 17025 is a beacon for labs that have rigorously validated methods and hold the highest standards for quality," said Becky Hobden, CEO at ECC Test Lab. "As a leading cannabis lab in the southeast, we are honored to work with A2LA and demonstrate that we meet the quality standards set forth in ISO/IEC 17025. Thank you!"
"We congratulate East Coast Cannalytics on being the first laboratory to be accredited for cannabis testing in the state of Virginia," said Anna Williams, Accreditation Supervisor at A2LA. "A2LA is excited to have assisted ECC Test Lab in achieving this milestone. We are glad to see the continued growth of our cannabis program in another state, which further promotes the value that accreditation adds in ensuring quality in this emerging industry. We look forward to our continued relationship with ECC Test Lab in serving their accreditation needs."
Achieving ISO/IEC 17025 accreditation by A2LA is the pinnacle in third-party laboratory accreditation, as it confirms that laboratories have management, quality, and technical systems in place to ensure accurate and reliable analyses, as well as proper administrative processes to ensure that all aspects related to the sample, the analysis, and the reporting are standardized, measured, and monitored.
About A2LA
A2LA is a non-profit, non-governmental, third-party accreditation body, offering internationally recognized accreditation services to testing and calibration laboratories, inspection bodies, biobanking facilities, stand-alone sampling organizations, proficiency testing providers, reference material producers and product certifiers.
About ECC Test Lab
ECC Test Lab, LLC is an analytical and microbial testing lab whose mission is to support the rapidly growing cannabis industry in Virginia and the southeast. Located in Blacksburg, VA, ECC Test Lab's primary goal is to provide our customers with validated results on the safety and quality of their cannabis plants and products. We do this by building strong relationships and providing exceptional customer service, maintaining excellence in the technical capabilities of our team of scientists, and operating in the highest degree of integrity in everything we do. More information can be found at http://www.ecctestlab.com.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

This mobile biosurveillance solution allows MEMP to deploy an on-site molecular testing laboratory to any location and provide test results in four hours or less for a wide variety of microbial pathogens and other molecular targets.

FREDERICK, MD. (PRWEB) OCTOBER 21, 2020
A2LA recently granted ISO/IEC 17025:2017 accreditation to MEMP Service Corporation (Molecular Environmental Monitoring Provider). MEMP Service Corp. sought accreditation to this standard as part of the development of their cutting-edge new mobile molecular environmental monitoring services. This mobile biosurveillance solution allows MEMP to deploy an on-site molecular testing laboratory to any location and provide test results in four hours or less for a wide variety of microbial pathogens and other molecular targets. A2LA is glad to have had the opportunity to provide accreditation services to this modern and widely applicable laboratory solution. Accreditation by A2LA affirms a laboratory's competency and helps build public confidence; it is an important step in the development of this type of innovative laboratory solution.
Through a partnership with Applied Food Diagnostics, MEMP Service Corp. developed and validated the MEMP Listeria Assay and the MEMP Salmonella Assay. This collaboration resulted in features such as reagent shelf stability and a reduced footprint that made it possible for these assays to be performed in MEMP's mobile laboratories. Earlier this year, both MEMP Listeria and Salmonella assays received certification from the AOAC Research Institute.
The MEMP Service Corp. scope demonstrates conformance with the "AOAC International Guidelines for Laboratories Performing Microbiological and Chemical Analyses of Food, Dietary Supplements, and Pharmaceuticals" and the A2LA R104 – General Requirements: Accreditation of Field Testing and Field Calibration Laboratories. In addition to the AOAC PTM approved MEMP Listeria Assay and MEMP Salmonella Assay, the scope includes these validated assays; Aspergillus, Coliforms, Cronobacter, E. coli O157:H7, Generic E. coli, EHEC (Enterohemorrhagic Escherichia coli.), STEC (Shiga-toxin producing Escherichia coli), Staphylococcus aureus and Listeria monocytogenes. MEMP Service Corp. is the first of its kind mobile molecular laboratory with this type of accreditation.
"A2LA is proud to accredit MEMP Service Corporation. They are a leader in development and innovation and a prime example of a laboratory that wishes to change the status quo for the better." Said Chris Gunning, General Manager at A2LA. "The technology that they have developed will allow for faster detection and elimination of contaminants in the food production and related industries. This technology is being accepted by the reputable AOAC organization and we believe this further advances A2LA's goal of a better world through accreditation."
Achieving ISO/IEC 17025 accreditation by A2LA is the pinnacle in third-party laboratory accreditation, as it confirms that laboratories have management, quality, and technical systems in place to ensure accurate and reliable analyses, as well as proper administrative processes to ensure that all aspects related to the sample, the analysis, and the reporting are standardized, measured, and monitored.
About A2LA
A2LA is a non-profit, non-governmental, third-party accreditation body, offering accreditation services to testing and calibration laboratories, sampling organizations, inspection bodies, proficiency testing providers, reference material producers, biobanking facilities, and product certifiers. For more information about A2LA, please visit http://www.a2la.org.
About MEMP Service Corporation
MEMP Service Corporation is headquartered in Pennsylvania with regional service centers throughout the United Sates. MEMP's network of mobile laboratories is continuously expanding and increasing its routine coverage. The company is currently focusing solutions for the food and beverage industry, but its services and technology have the potential for additional communities including critical infrastructure sectors, wellness, and regulatory agencies. Learn more about MEMP Service Corp's service options at http://www.mempservices.com.
About Applied Food Diagnostics, Inc.
Applied Food Diagnostics develops and manufactures sampling and testing products specifically for the food centric sectors. Applied Food Diagnostics offers a comprehensive portfolio of innovative, rapid detection test kits, microbiological products, laboratory and sample collection supplies for food science applications. Their portfolio includes several AOAC PTM Approved pathogen detection kits. Additional information can be found at http://www.appliedfooddiagnostics.com.
About AOAC INTERNATIONAL
The AOAC Research Institute (AOAC RI) is a division of AOAC INTERNATIONAL that promotes and conducts activities to help develop, improve, and validate proprietary testing methods. Association of Official Analytical Collaboration (AOAC) International, is based in Rockville, MD, and is an independent, third-party, nongovernment administrator of the AOAC Performance Tested Methods SM Program. AOAC RI serves diagnostic producers by establishing and maintaining method validation and performance criteria.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

The Beryl Institute-Ipsos PX Pulse Finds Consumers are More Comfortable Seeking Care This Quarter Than Last Quarter

NASHVILLE, TENN. (PRWEB) OCTOBER 21, 2020
Today, The Beryl Institute and Ipsos released its findings from the fourth PX Pulse, a quarterly tracking survey and a first of its kind effort to elevate understanding and track current perspectives on patient experience in healthcare across the United States. As has been covered in previous PX Pulse releases, the COVID-19 pandemic and the various social distancing measures in place nationwide have led to a decrease in consumer engagement with healthcare; however, today's release suggests that engagement is rebounding, with a 12-percentage point increase in the number of Americans reporting a visit to their primary care provider compared to June 2020.
The latest PX Pulse also shows consumers reporting an increase in their level of comfort seeking care from their specialist provider, lab, local hospital and emergency room/urgent care center, with a 5% increase in the number of consumers that said they were "extremely comfortable" or "very comfortable."
"For the first time since 2019 and the height of COVID-19 in the U.S., we are beginning to see Americans adjusting to this "new normal" and re-engaging in their health and medical care," said Clifford Young, President of Public Affairs for Ipsos. "Delaying care has been an issue across all age groups this year, and it is reassuring to see more Americans are prioritizing care. But, with COVID-19 spiking in certain parts of the country, we may see a second wave of decreased visits to PCPs and specialists as we get into the winter months."
While consumers remain positive about the overall quality of care they receive in the U.S., they continue to state that their perspectives of government authorities have become more negative as a result of COVID-19. Americans' most negative perceptions are geared toward federal government agencies like the Center for Medicare Services (CMS) and the Centers for Disease Control (CDC), followed by state health leaders and local health leaders.
"The insights revealed in the latest release of PX Pulse reflect a very critical piece of the experience conversation," said Jason A. Wolf, President & CEO of The Beryl Institute. "People do not see themselves as passive travelers on a healthcare journey, but as active participants in a process of care in which the outcomes they achieve matter significantly. This reality has only been elevated by the healthcare and societal crisis in which we find ourselves today and reinforces both the integrated nature of experience and the critical role it plays in healthcare."
Key Findings

Consumers are starting to re-engage with healthcare providers, reporting more visits to primary care providers (+12%), hospitals (+2%), labs (+10%), and specialist providers (+3%) compared to last quarter.

Similar to the past three quarters, cost remains the most important healthcare issue to consumers. The top 3 issues include out-of-pocket costs, health insurance premiums, and having affordable insurance options.

Consumer ratings for the quality of healthcare in America and ratings of their overall care experiences within the past 12 months remain stable from the previous quarter.

Consumers remain positive about overall healthcare quality (55%) and their own care experiences (74%).

Healthcare consumers continue to say that having a good experience is important to them as patients, with 96% of people affirming that good patient experience is either "very important" or "extremely important."

The top two reasons stated for why good patient experience is important to consumers remain that patients' health and wellbeing are important to them (70%) and knowing that their physical needs are being taken seriously (61%).

To access PX Pulse, visit: https://www.theberylinstitute.org/page/PXPULSEOctober2020
###
ABOUT THE PX PULSE SURVEY
The Beryl Institute – Ipsos PX Pulse represents a first of its kind effort to elevate understanding of the current perspectives on patient experience in U.S. healthcare.
This effort will regularly capture healthcare consumer perspectives of patient experience in the United States, determine the practices and processes that have the greatest impact and influence on healthcare consumers, and track how the market sees patient experience evolving over time. More information about the core questions that will be tracked each quarter is attached.
ABOUT THE BERYL INSTITUTE
The Beryl Institute is the global community of practice committed to elevating the human experience in healthcare. We believe human experience is grounded in experiences of patients & families, those who work in healthcare and the communities they serve. We define the patient experience as the sum of all interactions, shaped by an organization's culture, that influence patient perceptions across the continuum of care.
ABOUT IPSOS
Ipsos is now the third largest market research company in the world, present in 90 markets and employing more than 18,000 people.
Our research professionals, analysts and scientists have built unique multi-specialist capabilities that provide powerful insights into the actions, opinions and motivations of citizens, consumers, patients, customers or employees. Our 75 business solutions are based on primary data coming from our surveys, social media monitoring, and qualitative or observational techniques.
"Game Changers" – our tagline – summarizes our ambition to help our 5,000 clients to navigate more easily our deeply changing world.
Founded in France in 1975, Ipsos is listed on the Euronext Paris since July 1st, 1999. The company is part of the SBF 120 and the Mid-60 index and is eligible for the Deferred Settlement Service (SRD).
ISIN code FR0000073298, Reuters ISOS.PA, Bloomberg IPS:FP
http://www.ipsos.com/

"The insights revealed in the latest release of PX Pulse reflect a very critical piece of the experience conversation," said Jason A. Wolf, President & CEO of The Beryl Institute.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Thrive Medical Alert Necklaces for Diabetics Are Being Sold On Amazon Exclusively Through First Aid Global's Prime Listings

TARZANA, CALIF. (PRWEB) OCTOBER 21, 2020
Thrive Medical Alert Necklaces are the newest and most innovative product for treatment of minor to severe low blood sugars (Hypoglycemia). The glucose-gel-filled necklace allows people with diabetes to live life without the worry of where to find a source of fast energy when the next low blood sugar event drops. Patients with Type 1 Diabetes need this necklace to avoid the risks of Diabetic Coma when too much Insulin is produced or injected, but low blood sugar swings can also occur with Type 2 Diabetes as well as in those with Metabolic Syndrome.
First Aid Global LLC now has the exclusive rights to sell Thrive Medical Alert Necklaces on Amazon. First Aid Global is already the largest supplier of Transcend Glucose Gels on Amazon and will help grow the Glucose Revival products on their platform.
"We're leaving sales outside of the Amazon realm to Glucose Revival's own website," says a company spokesperson for First Aid Global. "But for those of us who want to use our Amazon Prime Memberships to do our ordering, we've taken over those sales. You can't beat Amazon's free shipping, customer service and easy-return policies, and First Aid Global matches that perfectly as well."
EMT's currently use Glucagon, an FDA-approved drug, to quickly bring a patient out of a diabetic emergency, but not all EMT's are trained in its use and diabetics would have to wait for an ambulance to show up before getting treatment. With the Thrive Medical Alert Necklaces, or the Thrive Jr. Necklaces for children, one can simply pull the necklace off the neck by the magnetic clasp and feed the glucose gel into the mouth. The necklace's fast-acting glucose gel is a food solution and is effective within minutes, even seconds.
The pendant that hangs from the necklace is the Universal Diabetes Alert symbol, a blue circle established by the International Diabetes Federation and was adopted by the United Nations for World Diabetes Day to bring awareness to the growing Diabetes Pandemic.
Live your best life with our Glucose Medical Alert Necklaces for children or adults, the easy to use solution for emergency hypoglycemic situations.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Well-Being Division is designed to tackle the chronic disease crisis at its root causes

ROSEVILLE, CALIF. (PRWEB) OCTOBER 21, 2020
Adventist Health today announced the launch of its Well-Being Division, solidifying its commitment to lead a 21st century well-being transformation movement. With this far-reaching change, Adventist Health is further demonstrating its commitment to inspire health, wholeness and hope within the communities it serves.
In keeping with its goals, Adventist Health acquired Blue Zones in early 2020, marking the first step in the creation of its Well-Being Division, and appointed Ben Leedle, Blue Zones CEO, as division president. This month, the organizations began their first partnership Blue Zones Project, a transformational community-led well-being initiative, in Walla Walla, Washington.
"Adventist Health's launch of the Well-Being Division is an important part of our 10-year transformation strategy to move from a healthcare company to a health company," Adventist Health CEO Scott Reiner said. "Our mission to live God's love calls us to care for communities in ways that measurably and sustainably improve well-being."
This move marks Adventist Health's commitment from delivering care to improving well-being and quality of life for entire communities, which in turn improves health outcomes for individuals. It comes at a critical time during the COVID-19 pandemic and is essential to help communities and individuals recover and build long-term resiliency.
The Well-Being Division will identify and impact root causes of well-being. Collectively, it will address needs related to individuals, communities and organizations, and will impact all dimensions of well-being. That will include health, sense of purpose, security and prosperity in order to deliver results through direct interventions and by fostering change to human-made surroundings. This model is designed to improve the health of individuals and communities, and in turn, lower overall healthcare costs.
"I was drawn to Adventist Health's bold vision to reimagine the future of healthcare, and I am thrilled to be a part of Adventist Health," Leedle said. "I look forward to championing this vision and working together to further strengthen communities and empower individuals to lead healthier lives. Never before in our lifetimes has there been a greater focus on the behaviors that keep us well. Our faith-based company is poised to elevate this conversation and lead our industry."
Adventist Health's strategic vision to improve individual, organizational and community well-being is rooted in the Seventh-day Adventist cultural heritage. Since its inception in the 1840s, the Seventh-day Adventist tradition has encouraged a lifestyle of health and wellness. Additionally, Adventist Health recently acquired Blue Zones, whose proven, research-based solution improves community well-being by design. The Blue Zones model lifts well-being at the population level by making healthy choices easier in all the places people live, work, learn, pray and play. Working with Blue Zones, the Well-Being Division will empower everyone, everywhere to live longer, better lives.
The work of Blue Zones in more than 50 communities across the United States has been credited with double-digit drops in well-being risk factors such as obesity and smoking, transforming lives and achieving millions of dollars of savings in healthcare costs.
About Adventist Health
Adventist Health is a faith-based, nonprofit integrated health system serving more than 80 communities on the West Coast and Hawaii. Founded on Seventh-day Adventist heritage and values, Adventist Health provides care in hospitals, clinics, home care agencies, hospice agencies and joint-venture retirement centers in both rural and urban communities. Our compassionate and talented team of 36,000 includes associates, medical staff physicians, allied health professionals and volunteers driven in pursuit of one mission: living God's love by inspiring health, wholeness and hope. Together, we are transforming the American healthcare experience with an innovative, yet timeless, whole-person focus on physical, mental, spiritual and social healing.
About Blue Zones
Blue Zones uses evidence-based ways to help people live longer, better lives. The company's work is based on explorations and research done by founder and National Geographic Fellow Dan Buettner, who identified the blue zones regions around the world where people live extraordinarily long and/or happy lives. The original research and findings were released in Buettner's bestselling books The Blue Zones Solution, The Blue Zones of Happiness, The Blue Zones, Thrive, and Blue Zones Kitchen—all published by National Geographic books. Using original Blue Zones research, Blue Zones Project works with cities and counties to make healthy choices easier through permanent and semi-permanent changes to the community's environment, policy, and social networks. Participating communities have experienced double digit drops in obesity and tobacco use and have saved millions of dollars in healthcare costs. Blue Zones was acquired by Adventist Health in 2020. For more information, visit bluezones.com.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Heilind expands its pressure sensor offering with DLVR digital pressure sensors from All Sensors

WILMINGTON, MASS. (PRWEB) OCTOBER 21, 2020
Heilind Electronics, a leading distributor of electronic components and authorized distributor for All Sensors Corporation (an Amphenol Company), has added the manufacturer's DLVR Series mini digital output pressure sensor to its sensor offering.
The DLVR Series pressure sensors offer a fully customizable, turn-key solution for design engineers looking for a digital pressure sensing device. Product highlights include an I2C or SPI output interface with 14 bit internal resolution, 3.3 V or 5 V supply voltage, and a one percent total error band. The DLVR series utilizes All Sensors' CoBeam2 technology, which permits greater sensitivity while reducing package stress and position sensitivity – ultimately resulting in improved long-term stability.
With the ability to operate at a low supply voltage (3.3 V), the DLVR series renders itself a power-conscious device well-suited for portable applications. The product can easily be integrated into a wide range of process control and measurement systems, allowing direct connection to serial communications channels. In battery-powered systems, the sensor can enter very low power modes between readings to minimize load to power supply.
These calibrated and compensated sensors provide an accurate, stable output over a wide temperature range. In addition, a protective Parylene coating is available for moisture and harsh media protection. Applications for this device are vast and include portable devices/hand-held equipment, battery-operated devices, medical breathing, medical devices associated with low pressure, remote sensing, environmental controls, HVAC and industrial controls.
Visit Heilind's website for more information on All Sensors pressure sensors.
About Heilind Electronics
Heilind Electronics, Inc. (http://www.heilind.com) is one of the world's leading distributors of connectors, relays, sensors, switches, thermal management and circuit protection products, terminal blocks, wire and cable, wiring accessories and insulation and identification products. Founded in 1974, Heilind has locations throughout the U.S., Canada, Mexico, Brazil, Germany, Singapore, Hong Kong and China. Follow Heilind on Facebook at facebook.com/Heilind and on Twitter at twitter.com/Heilind.
About All Sensors
All Sensors Corporation is an industry leader in the design and manufacturing of MEMS piezoresistive ultra-low pressure sensors. All Sensors' product line is notable for its high accuracy and repeatability. The sensors are particularly suited for low and ultra-low pressure applications for flow measurement and control. Pressure ranges are available as low as 0.25 inH2O and as high as 150 PSI. Custom port fittings and various package options are available, as well as customizable pressure ranges and performance values.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

When the COVID-19 national health emergency was proclaimed in March of this year, telehealth skyrocketed - made possible by regulatory waivers and healthcare providers' rapid innovation. Virtual care delivery has quickly become one of the biggest success stories of the crisis, with the next phase in the development of this exciting new channel preparing for holistic patient experiences that build on the remarkable accomplishments that have already been achieved.

LAFAYETTE, CALIF. (PRWEB) OCTOBER 21, 2020
The explosive growth of telehealth since the COVID-19 crisis began has been well documented. At its peak in April, 2020, the number of claims for telehealth services were more than eight thousand percent higher than the same period the previous year. Driven by restrictions associated with the national emergency, capacity challenges, patient concerns about the safety of in-office visits and stay-at-home orders, telehealth immediately became the go-to resource for providers and patients whose interactions demanded prompt attention.
For every stakeholder in the American healthcare system, the big question now is whether this universally praised care delivery channel will become a permanent part of the healthcare landscape after the COVID-19 public health emergency. But with patients, providers, industry groups, and government all calling for permanent support, the future of telehealth and other virtual care channels looks bright.
The extreme nature of events over these last seven or eight months have compressed what might have taken years into mere weeks. In the days following the proclamation of the public health emergency, the government took steps to address a disruption in the accessibility of care. And healthcare providers responded by ramping up non-contact care delivery channels that, until then, had been little more than a sideline. What resulted was an explosion in the adoption of virtual care and the recognition of an important new operating model for a financially stressed industry.
Given how quickly this has happened, it's understandable that the wider implications of virtual care have not been given much attention. But as healthcare providers plan for the future beyond COVID-19, their virtual care strategies must expand to include every dimension of the patient care experience. By integrating patients' medical, financial and administrative experiences into one consumer-friendly digital experience, providers and patients will realize all the promise that telehealth offers – improved access and affordability for patients, and financial sustainability for providers.
The Birth of a New Healthcare Operating Model
The stunning success of telehealth during the pandemic would not have been possible without special support from Medicare and Medicaid, the largest source of healthcare revenue in the country. As part of the Coronavirus Preparedness and Response Supplemental Appropriations (CARES) Act, on March 6, Medicare introduced a temporary, emergency waiver to "ensure that all Americans – particularly those at high risk of complications from the virus that causes the disease COVID-19 – are aware of easy-to-use, accessible benefits that can keep them healthy while helping to contain the future spread of this virus."
Under the waiver, Medicare – which had previously only paid for telehealth on a limited basis – authorized payment for a wide range of healthcare services for office, hospital and other visits furnished via telehealth across the country. Essentially, by authorizing equal payment (reimbursement) for telehealth visits that would customarily have been conducted in-person, Medicare and its parent agencies created a financially viable channel for providers. At a stroke, the issuance of the waiver opened the door for patients who needed a safe, accessible way to get care and for providers whose revenues were being crushed by the cancellation or postponement of nearly all elective and nonessential services.
Medicare is not letting up. Just last week, on Oct. 14, the Centers for Medicare and Medicaid Services (CMS) expanded the list of telehealth services that Medicare Fee-For-Service will pay for during the coronavirus disease 2019 Public Health Emergency. Enacted as part of a new, expedited process published on May 1, these eleven new services are listed on the CMS website, and bring the total of telehealth services covered under the waiver to 144. Noting that it has seen skyrocketing adoption from Medicare recipients (36% of seniors had used a virtual visit), It is clear that many Americans of all ages have embraced virtual care delivery.
As noted above, the waiver authorizing expanded payments for telehealth services is temporary, but more recent CMS action has begun to permanently waive reduced pay for certain services beyond the public health emergency. In the CMS release announcing the eleven new services, CMS Administrator Seema Verna stated that, "...This revolutionary method of improving access to care is transforming healthcare delivery in America," and concludes by declaring that the administration "will not let the genie go back in the bottle."
Congressional action is also under way to help make sure the genie doesn't go back in the bottle. A bipartisan house bill, the "Protecting Access to Post-COVID-19 Telehealth Act of 2020," was introduced on July 16 to "expand the promise of virtual care, even once the pandemic has subsided, by eliminating restrictions, ensuring access and studying its ability to address disparities and improve outcomes."
The proposed legislation, which met with wide approval from healthcare groups, focuses on establishing the patient's home as an eligible distant site so they can receive care at home and doctors can still be reimbursed; preventing the sudden loss of telehealth services; making permanent the disaster waiver authority; enabling the Department of Health and Human Services (HHS) to expand telehealth in Medicare during all future emergencies and disasters; and requiring a study on the use of telehealth, including costs, uptake, outcomes and racial/geographic disparities.
Holistic Patient Care in a Consumer Driven Market
At the same time that the Center for Medicare and Medicaid Services (CMS) has been promoting the use of telehealth, it has continued to pursue improved provider resources to empower healthcare consumerism. We published analysis earlier this year that addressed these rules. In, "The American Healthcare System's 800-pound Gorilla Has Spoken," we noted CMS's tenacious pursuit of regulations to promote patient consumerism. We also noted the inadequacy of these early regulations to deliver a truly patient/consumer-centered experience.
Regardless, CMS's transparency rules and future guidance point toward healthcare's inevitable transformation into a consumer-driven industry. It is this expectation that will drive the development of holistic digital health strategies that empower consumers and meet providers' requirements for operational and financial sustainability.
The digitally-enabled consumer's demands don't begin and end with the office visit. CMS's rules, and a simple patient/consumer flow analysis make it perfectly clear that the patient's experience – digital or actual – begins when they look for care. That experience is informed by reliable information about price and quality. And the experience doesn't end until the patient's financial obligation has been fulfilled. Providers already know that patient satisfaction is influenced by much more than their clinical experiences. Now, they're awakening to the fact that their digital strategies must deliver at every patient touch point, in every dimension, throughout the patient's care journey. This is true whether care is delivered physically or virtually.
Virtual Care's Financial Win-Win
Our company, Loyale Healthcare, partners with large health systems to offer patients and staff a fully-functioning, digital, end-to-end patient financial experience. These blend seamlessly with the other dimensions of the patient's clinical and other care experiences. By integrating with multiple Medical Record and discrete payment and billing systems, the Loyale Patient Financial Manager platform enables much more than compliance with CMS's short-term rules for transparency. It gives providers the digital tools they need to fully engage with an increasingly discerning healthcare consumer. Critically, these capabilities come at a time when competition for these consumers (and their revenue) is becoming more and more prominent (Walgreens Health, CVS Health, Walmart Health, etc.)
In addition to enhanced competitiveness in an increasingly consumer-driven market, these automated systems radically reduce expenses for patient billing and collection. More importantly, their simplicity and ease-of-use make it easy for patients to understand, plan for and pay their medical bills. By connecting virtually with patients' financial experiences, Loyale clients raise their patients' satisfaction, reduce work and its associated expense and improve their financial performance.
As we look forward to the next normal following the COVID-19 pandemic, it is clear that digital, virtual experiences will become a mainstay in the portfolio of care delivery services in America. Complemented by virtual solutions affecting the non-medical elements of the patient journey, consumer acceptance will continue to grow and the opportunity to leverage this exciting new channel will expand. We're excited about that future and the role we're playing in making it a reality.
Kevin Fleming is the CEO of Loyale Healthcare
About Loyale
Loyale Patient Financial Manager is a comprehensive patient financial engagement technology platform leveraging a suite of configurable solution components including predictive analytics, intelligent workflows, multiple patient financing vehicles, communications, payments, digital front doors and other key capabilities.
Loyale Healthcare is committed to a mission of turning patient responsibility into lasting loyalty for its healthcare provider customers. Based in Lafayette, California, Loyale and its leadership team bring 27 years of expertise delivering leading financial engagement solutions for complex business environments. Loyale currently serves approximately 12,000 healthcare providers across 48 states. Loyale is proud to have an enterprise-level strategic partnership with Parallon which includes the deployment of Loyale's industry leading technology at all HCA hospitals and Physician Groups.




START your own Wordpress site, business or personal website, or online store at www.siteground.com

USA-based Technology Companies, First Line Software and eConnect, Come Together to Create Transformative Solution to Combat COVID-19

CAMBRIDGE, MASS. AND LAS VEGAS AND LOS ANGELES (PRWEB) OCTOBER 21, 2020
First Line Software announced a new COVID-19 pre-screening system, EPass with Watts Healthcare, a first of its kind web-based software application and thermal screening system in partnership with eConnect's eClear, which went live at the start of October. The healthcare technology solution, which is designed to keep employees and patrons safe upon entry of the facilities, was enabled thanks to a grant from the Oprah Winfrey Charitable Foundation in July 2020 to help the COVID-19 relief efforts in South Los Angeles, California.
As the COVID-19 crisis disproportionately threatens lower-income and medically underserved communities, the technology will help Watts Healthcare more efficiently and effectively provide care to South Los Angeles individuals at risk for contracting COVID-19. The health center primarily serves the Watts and Willowbrook neighborhoods which are comprised 99 percent minority with the highest percentage being Black and Latino. Nationally, the hospitalization rate for these ethnicities are higher, 4.7 times higher for Black individuals, and 4.6 times higher for Latino individuals compared to Non-Hispanic persons. As for what First Line's technology is now providing the health center, Watts Healthcare's president and chief executive officer Dr. Roderick Seamster explained: "The EPass and eClear solution is meeting a critical need in our organization to keep employees and patients safe during a time when COVID-19 cases are increasing nationally, and to combat associated rising labor costs with added safety protocols. We feel very fortunate to be in a better position today addressing the public health emergency for our community's most vulnerable populations."
The new EPass and eClear system is being used daily at the Watts Healthcare historic flagship clinic, the Watts Health Center, to screen its workforce of 237 employees and mitigate community spread.
EPass is a contactless, electronic visitor management and visitor pass software that helps screen people for COVID-19 symptoms prior to their visit to the facility and issues a pass to enter the facility to work or visit. The HIPAA compliant software is easy to use, replaces a paper questionnaire and can screen individuals for COVID-19 in multiple-use cases. It can integrate with a variety of systems, including HRIS, EHR, CRM and ERP, and devices like thermometers. Screening results are available on the spot or by email.
Further reducing the risk of infection for the health center, First Line Software architected a new joint technology solution with Las Vegas-based operation automation company eConnect. To help minimize human involvement, reduce labor costs and provide stronger adherence to social distancing recommendations, eConnect added their eClear solution to the EPass screening technology to deliver a comprehensive health and safety program for the hospital. eClear, a comprehensive health and safety automation solution for organizations, offers a contactless way to measure thermal temperature, count people, identify contract tracing and more, and it is fully compatible with other enterprise video or technology intelligence systems like EPass.
"EPass and eClear are the perfect match for a robust, automation solution. The Watts Healthcare project is our first integration with First Line Software and we look forward to using their advanced pre-screener tool with other health centers, hospitals and organizations across the country," said Chris Swanger, Chief Safety Officer of eConnect.
With some health experts predicting a deadly December ahead for the U.S. population, due in large part to seasonality and mask vigilance waning, it is critical for more healthcare systems and organizations across any category to continue optimization of processes and systems to stand ready for ongoing and future threats.
"Five years change in six months has become a common slogan for the pandemic, and that's been especially true in the healthcare space," said Anatoly Postilnik, First Line Software Head of Healthcare IT Practice. "We're proud to be able to jump in with healthcare systems worldwide to help transform their technology systems and stay prepared for the next wave of COVID-19 or even the flu."
EPass and eClear systems are cost-effective and can be implemented in a matter of weeks to comply with ongoing local and state mandates. Special pricing is available for organizations in underserved communities to help empower the communities that need support most.
Photo Credit: Watts Healthcare
High-Res Photos and Brand Logos Link: https://bit.ly/31q4syE
About First Line Software:
First Line Software is a premier provider of software engineering, software enablement, and digital transformation advisory services to clients across North America, Europe, Asia, and Australia. Headquartered in the US, First Line's global staff of 650+ technical experts leverages agile technological excellence to efficiently deliver complex projects in retail digitalization, web content management & eCommerce, healthcare IT & real world evidence and data, machine learning and enterprise data management. First Line is consistently recognized with industry rankings and awards from top global and regional, independent research agencies. The development team has created a number of innovative solutions for its clients, including EPass which is a contactless pre-screening software solution helping organizations screen visitors and staff for COVID-19 symptoms prior to their visit to the facility. For more information, visit First Line Software at http://www.firstlinesoftware.com.
EPass product demonstrations are available on a weekly basis and can be scheduled online at firstlinesoftware.com/epass.
About Watts Healthcare:
From a grassroots clinic that was birthed out of the Watts riots in 1965 and established in 1967, to serving those most in need in Los Angeles county, Watts Healthcare has grown to become a federally recognized health care institution offering seven clinical sites, one substance abuse treatment center and two mobile programs for dental services and mammograms. 53 years of service this month, the Watts Healthcare team strives to improve the health of the community it serves by creating easier access to quality clinical, preventative, and specialty healthcare services, including medical imaging, laboratory, women's health, HIV, mental health and more. The Watts Health Center is conveniently located on the corner of 103rd Street and Compton Avenue at 10300 Compton Avenue, Los Angeles, CA 90002. For patient care and additional information, visit http://www.wattshealth.org.
About eConnect:
eConnect is a global leader in designing, developing and distributing technologies that automate organizational processes to meet the major challenges of today and tomorrow. Leveraging twelve years of excellence, eConnect provides revolutionary technology to deliver actionable information to a wide range of operators. The company seamlessly integrates contactless thermal screening and facial recognition into processes like employee timekeeping, building and employee protection, and recognizing VIPs—all of which future proof an organization. eConnect's comprehensive suite of technology solutions improves the way companies interact with stakeholders, maximize efficiency and ultimately increase ROI. Intuitive and turnkey to implement, it's no wonder hundreds of operators worldwide choose eConnect to get to market fast. For more information, visit  http://www.econnectglobal.com.
About the Oprah Winfrey Charitable Foundation:
Guided by the intention of supporting those in need, the Oprah Winfrey Charitable Foundation (OWCF) supports organizations around the world. Since 1993, OWCF has contributed millions in grants and donations to organizations that serve children, families and communities, with a specific focus on youth education. For more information, please visit Oprah.com/OWCF.
###



START your own Wordpress site, business or personal website, or online store at www.siteground.com

RMA of Connecticut is One of Four Fertility Clinics Participating Across the Country; Deadline to Apply 11/16

NORWALK, CONN. (PRWEB) OCTOBER 21, 2020
RMA of Connecticut, a leading fertility practice whose exceptional quality and care helps couples and individuals grow their family, has teamed up with The PCOS Challenge Family Building Grant to help patients with infertility caused by polycystic ovary syndrome (PCOS) build their families, and includes a free IVF cycle. RMA of Connecticut is one of only four fertility clinics across the country participating in The PCOS Challenge Family Building Grant. The deadline to apply is November 16th. Grant recipients will be announced December 15th. Grants are awarded once per year.
RMA of Connecticut continues to bring awareness to PCOS sufferers. Last year, during PCOS month in September, RMA of Connecticut created special programming via social media, geared toward college-aged students, and they teamed up with PCOS influencers to spread the word about how to manage symptoms associated with PCOS. Dr. Ilana Ressler, a reproductive endocrinologist with RMA of Connecticut will conduct an Instagram Live this Thursday, October 22nd to help spread the word about The PCOS Challenge.
Dr. Ressler adds, "We are so excited to offer one free IVF cycle to a woman with PCOS through The PCOS Challenge Family Building Grant. PCOS affects up to 15% of women and can be the culprit of many symptoms, not least of which is irregular periods, or no periods at all. Because of this, women with PCOS may have difficulty conceiving and end up suffering from infertility. However, with the help of IVF, we can give these women a much greater chance at building their families. Many women with PCOS go on to have healthy babies, and we are so happy to assist in that."
Grant submissions should be carefully reviewed to meet the criteria prior to applying. Applicants must include a personal statement (400 – 500 words) and all supporting materials in order to complete the grant application. Applications will NOT be considered if they do not contain the requested supporting materials below:

Physician Statement(s) – Letter from applicant's physician in PDF format confirming applicant's diagnosis of infertility caused by or related to polycystic ovary syndrome (PCOS) and that IVF is indicated for the applicant.

Photo – Headshot or photo of applicant or couple

Video Statement (Optional) – Applicant may provide a short video statement about why she/the couple is applying for this grant (up to two minutes). A link to an "Unlisted" or public video on YouTube or Vimeo may be submitted.

For more information about the PCOS Challenge Family Building Grant, covered services, and eligibility criteria, read here.
About Reproductive Medicine Associates of Connecticut (RMA of Connecticut)
RMA of Connecticut is a leader in fertility care, specializing in a range of infertility treatments. Our assisted reproductive technologies (ART) include intrauterine insemination (IUI), in-vitro fertilization (IVF) and pre-implantation genetic testing (PGT). RMA of Connecticut is Fairfield County's largest fertility clinic and egg donation center. Through RMA of Connecticut's Integrated Fertility and Wellness Center, we offer nutrition counseling, individual and couples psychological counseling, acupuncture and yoga, as well as financing and support services for our patients going through infertility treatment.
Our internationally recognized Gay Parents To Be program at RMA of Connecticut specializes in LGBTQ family building. For the last three years, RMA of Connecticut has been recognized as a Leader in Healthcare Equality by the Human Rights Campaign.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

The Society to Improve Diagnosis in Medicine (SIDM) today announced that Carmel Crock, MD has been named recipient of the Mark L. Graber Diagnostic Quality Award. The award will be presented today at the Diagnostic Error in Medicine 13th Annual International Conference.

EVANSTON, ILL. (PRWEB) OCTOBER 21, 2020
The Society to Improve Diagnosis in Medicine (SIDM) today announced that Carmel Crock, MD has been named recipient of the Mark L. Graber Diagnostic Quality Award. The award will be presented today at the Diagnostic Error in Medicine 13th Annual International Conference. The call for nominations received more than 70 submissions for this honor and the Award Review Committee selected Dr. Crock for her research, advocacy and leadership in the field as well as her efforts to expand the field of diagnostic quality and safety internationally.
Dr. Crock is an emergency physician and director of the Emergency Department at the Royal Victorian Eye and Ear Hospital in Melbourne, Australia. She is an associate professor at the University of Melbourne and Chair of the Australasian College for Emergency Medicine Quality and Patient Safety committee. Her education and research interests include preventing diagnostic error, improving healthcare culture and communication, and exploring the relationship between physician wellbeing and patient safety.
Inaccurate and delayed diagnoses are the most common, catastrophic, and costly of medical errors according to an analysis published in BMJ Quality & Safety. It is estimated that 12 million adults in the United States experience a diagnostic error every year in outpatient settings alone, and diagnosis failures result in as many as 80,000 premature deaths every year in U.S. hospitals. Analysis from Dr. Crock in the Medical Journal of Australia found that in Australia, an estimated 140,000 cases of diagnostic error occur each year, with 21,000 cases of serious harm and 2,000–4,000 deaths.
"Carmel has almost single-handedly established the diagnostic quality and safety field in Australia and New Zealand," said David Newman-Toker, MD, PhD, President of SIDM. "She brings passion, real-world clinical experience, and humility to her efforts to reduce harm from diagnostic error and in doing so is transforming care delivery and improving the health and safety of Australians and New Zealanders. She is a tremendous leader and role model."
Dr. Crock has been instrumental in raising awareness of the need to reduce diagnostic error in Australia and New Zealand. She was integral to establishing SIDM's first international affiliate - ANZA-SIDM. In addition, she was the chair of the Australasian Diagnostic Error in Medicine Conference Organizing Committee in 2017 and 2019.
The Mark L. Graber Diagnostic Quality award is given to a person, group, or organization that has made important contributions to the reduction of diagnostic error. The award recognizes either a total body of work ("lifetime achievement") or a significant contribution in the field and is named in honor of Mark L. Graber, MD, FACP, SIDM Founder.
In nominating her for the honor, colleagues noted:
"Her continued work to improve diagnostic error, and her commitment to the upcoming generation of diagnostic researchers are a testament to her contribution to reducing diagnostic error now and in the future."
"Carmel is a passionate advocate of diagnostic excellence, shared decision-making and the quality and safety of patient care."
"As Chair of the Australian College for Emergency Medicine, she informs new policies to reduce diagnostic error in the ER."
"Carmel's commitment and passion for improving healthcare is phenomenal and worthy of global recognition."
"We knew that when we sought to expand the reach of the Society to Improve Diagnosis in Medicine, Carmel was the only choice to chair our ANZA-SIDM affiliate," added Paul Epner, President and CEO of SIDM. "As the world grapples with a global pandemic, the challenges of accurate and timely diagnosis have come to the fore. Carmel is a true leader in the field and is now on the frontlines helping reduce misdiagnosis of COVID-19."
###
About the Society to Improve Diagnosis in Medicine (SIDM)
The Society to Improve Diagnosis in Medicine (SIDM) catalyzes and leads change to improve diagnosis and eliminate harm from diagnostic error. We work in partnership with patients, their families, the healthcare community and every interested stakeholder. SIDM is the only organization focused solely on the problem of diagnostic error and improving the accuracy and timeliness of diagnosis. In 2015, SIDM established the Coalition to Improve Diagnosis, to increase awareness and actions that improve diagnosis. Members of the Coalition represent hundreds of thousands of healthcare providers and patients—and the leading health organizations and government agencies involved in patient care. Together, we work to find solutions that enhance diagnostic safety and quality, reduce harm, and ultimately, ensure better health outcomes for patients. Visit http://www.improvediagnosis.org to learn more. Follow us on Twitter and Facebook.

"Carmel has almost single-handedly established the diagnostic quality and safety field in Australia and New Zealand," said David Newman-Toker, MD, PhD, President of SIDM.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Cadillac Returns as Presenting Sponsor for Second Annual Event by Town Clock CDC Honoring Sheryl Lee Ralph and DV Heroes; featuring Advocates, Entertainers and #TheManStand. Being Brave 2020 will be an uplifting and inspirational broadcast on Thursday, October 22, 2020, at 7:30 PM. Lisa Guerrero, Inside Edition's award-winning, internationally acclaimed chief investigative journalist, will return to host. Performer and philanthropist, Sheryl Lee Ralph will receive the 2020 Being Brave Award for outstanding leadership in empowering women.

NEW BRUNSWICK, N.J. (PRWEB) OCTOBER 21, 2020
Long before Covid-19, survivors of domestic violence knew all too well what it was like to endure days of social distancing, to suffer years of isolation, and to yearn desperately for a cure for their lives. They longed for someone to see them, to hear them, to help them. Being Brave 2020 calls for an end to the pandemic of domestic violence by listening to survivors and then giving them the comprehensive support they need to changes their lives.
"Preliminary research shows that domestic violence has worsened during Covid-19, but we will not know the full effect for years," says Reverend Susan Kramer-Mills, executive director of the Town Clock Community Development Corporation. TCCDC is one of only 40 facilities in the US providing permanent, affordable housing with supportive services to survivors of domestic violence.
"What I do know is that we empower survivors of domestic violence to transform their lives when we provide them a safe place to live, allow them time to heal, and give them the skills they need to succeed," points out Kramer-Mills. Being Brave 2020 raises awareness for this housing-first solution.
Being Brave 2020 will be an online event (Thursday, October 22, 2020, at 7:30 p.m.) celebrating the inspiring stories of Town Clock CDC residents and other survivors. Entertainer Sheryl Lee Ralph will be honored with the Being Brave Award for empowering women through her philanthropy. New Jersey heroes to be honored for helping survivors through their community service will be: Leslie Maxie, OLY, Maxie Media Group, (Outstanding Advocate Award); Det. Danny Gallardo, New Brunswick Police Department, (Outstanding Provider Award), and Debbie Maddock, Sophie's Bistro, (Outstanding Volunteer Award). Honoree bios. The event will highlight, #HearMeSeeMe a unique art program that is helping residents find their voices. #TheManStand will feature the stories of men who stand up to domestic violence.
Returning as Being Brave's Presenting Sponsor is Cadillac. The Gold Sponsor is Sandra Soriano, Vice President, Town Clock CDC Board of Directors. The Champion Sponsor: Bentley Dock. Full sponsor list.
"We are honored to partner again with Town Clock CDC on Being Brave, especially in the midst of a global pandemic as we purpose to never stop arriving. Unprecedented times and difficult circumstances are not new to us and the community of domestic violence survivors. During times like this, we must continue to demonstrate flexibility, agility and resilience as we're on a journey to redefining the boundaries and limits of mobility through groundbreaking innovation," said Alexis Kerr, head of Multicultural Marketing at Cadillac.
Hosting again this year will be Lisa Guerrero, Inside Edition's award-winning, internationally acclaimed chief investigative journalist. Featured advocates and entertainers include: Dr. Arabia Mollette, Covid-19 physician, health expert and survivor; Melonie Daniels, international singer and performer; Dr. Melanie R. Hill, Gospel Soul violinist; Ahmed "JKing" Wallace, performer, and Lauren Weinstein, award-winning artist & cartoonist. Full lineup and bios. Initial press release.
Domestic Violence
According to the National Domestic Violence Hotline, domestic violence is a pattern of behaviors used by one partner to maintain power and control over another partner in an intimate relationship. It can include physical and sexual violence, psychological abuse and financial control. The National Coalition Against Domestic Violence finds that 57% of homeless women cite Domestic Violence as cause of their homelessness, and 33% of women have experienced domestic violence in their lifetime. The Childhood Domestic Violence Association cites that children of domestic violence are six times more likely to commit suicide, 50% more likely to abuse drugs and alcohol, 74% more likely to commit a violent crime and three times more likely to repeat the cycle of abuse in adulthood.
Town Clock CDC – 1 of 40 in US
Town Clock Community Development Corporation is a nonprofit, 501(c)3 organization http://www.townclockcdc.org. Town Clock CDC's facility (Dina's Dwellings) opened in April 2016 after the sanctuary of the 200-year-old First Reformed Church of New Brunswick was transformed into 10 long-term affordable housing units with supportive services for survivors. In October 2020, Town Clock CDC expanded its facility by transforming the church's sexton house into a home for a mother and up to five children. This housing model is one of only 40 establishments of its kind in the entire United States, and remains the largest, permanent housing program for survivors of domestic violence and their children in New Jersey. In 2019, Town Clock CDC launched the Being Brave Event & Award.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Roche and Babyscripts to collaborate on the next generation of integrated women's health solutions

WASHINGTON (PRWEB) OCTOBER 21, 2020
Babyscripts, the leading virtual care platform for managing obstetrics, today announced a commercial partnership with Roche Diagnostics, a division of the world's largest biotech company and a global pioneer in pharmaceuticals and diagnostics. Roche Diagnostics and Babyscripts will collaborate on the next generation of digital and diagnostic combinations in women's health.
Under the terms of this collaboration, Roche will partner with Babyscripts on the development of Babyscripts' remote patient monitoring (RPM) programs to leverage groundbreaking data science through the next generation of RPM in pregnancy. These programs will be focused on solving issues of blood pressure-related complications through RPM, such as prenatal hypertension. Babyscripts participated in Startup Creasphere, Roche's digital health accelerator program, which was instrumental in initiating this collaboration.
"Roche's investment in Babyscripts solutions is a tremendous validation of our vision for improving maternal care, and an example of the kind of strategic collaboration essential to moving the needle on outcomes," said Juan Pablo Segura, co-founder and President of Babyscripts. "Roche's vast expertise in the field of women's health diagnostics and clinical science combined with our on-the-ground experience in the virtual maternal health space is going to prove a game changer for rethinking how we approach prenatal and postpartum care."
Roche has a long history of innovation in the women's maternal health space, yielding a portfolio of fertility and prenatal tests that deliver highly accurate results, such as ElecsysⓇ AMH testing to help understand a women's fertility status to improve chances of conception and HarmonyⓇ non-invasive prenatal testing that assesses the probability for trisomies 21, 18, 13. These advanced diagnostic and screening tests empower couples and clinicians to make decisions from pregnancy planning to birth. Through the collaboration with Babyscripts, Roche will continue their commitment to bringing innovative, data-driven and integrated solutions to pregnant and postpartum mothers.
Babyscripts has spent the last six years building a clinically-validated, virtual care platform to allow OBGYNs to deliver a new model of prenatal and postpartum care. Using internet-connected devices for remote monitoring, Babyscripts offers risk-specific experiences to allow providers to manage up to 90% of pregnancies virtually, allowing doctors to detect risk more quickly and automate elements of care.
About Babyscripts
Babyscripts is delivering a new model for prenatal and postpartum care that is transforming the way expectant mothers use technology to work with their healthcare providers. We've spent the last six years delivering the most-implemented mobile clinical solution for remote monitoring in pregnancy, with the mission to eliminate maternal mortality and improve access to care for all mothers. Babyscripts was named to the 2020 Digital Health 150, CB Insights' annual ranking of the 150 most promising private digital health companies in the world. For more information on our virtual care solution and to request a demo, visit http://www.babyscripts.com.
Disclaimer: The Harmony Prenatal Test was developed by Ariosa Diagnostics, a CLIA-certified laboratory. As with other lab-developed tests, it has not been cleared or approved by the FDA and is not available for sale as an IVD in the US. Non-invasive prenatal testing (NIPT) based on cell-free DNA analysis is not diagnostic; results should be confirmed by diagnostic testing."



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Enovate Medical Workstations on Wheels meet FIPS 140-2 security requirements

MURFREESBORO, TENN. (PRWEB) OCTOBER 21, 2020
Enovate Medical announced today that its hardware and software have completed the rigorous NIST (U.S. National Institute of Standards and Technologies) testing. Its products are now certified to connect to the Federal Government networks, including VA medical facilities and DoD installations. With Enovate's Envoy and Encore EcoFlex clinical workstations on wheels and its cloud-based Rhythm asset management software platform passing the FIPS 140-2 security requirements, Enovate Medical is the only EHR workstation vendor to earn this recognition.
The VA and DoD Electronic Health Record (EHR) Modernization Program was established to develop the next-generation platform for a modern EHR infrastructure. This EHR modernization creates a need within the VA and DoD system for workstations on wheels that meet the government's stringent security requirements.
"The VA and DoD are in the process of modernizing their EHR infrastructure," explained Bob Brolund, CEO of Enovate Medical. "With any real-time EHR system, it is essential to have a robust digital security strategy in place – but until now, no clinical workstation on wheels vendor had received the Federal Government's FIPS 140-2 certification. Enovate Medical is proud to have met these requirements."
Secure architecture and secure data form the foundation of a modern EHR infrastructure. "Shortcuts aren't acceptable where health data is concerned," explained Mark Dalen, Enovate Medical's CTO. "Our certified, secure cloud-based approach creates a complete separation between the veteran's health information and the machine data required for operational efficiency. Enovate Medical invested a year's effort to meet the FIPS 140-2 cryptography standards on sensitive data within the Federal Government."
Enovate Medical partnered with Four Points Technology, a CVE-verified Service Disabled Veteran Owned Small Business, to deliver this EHR solution to the VA and DoD. "We have a mission to support successful care for our veterans. Partnering with Enovate Medical allows us to bring a leading-edge EHR solution to the VA and DoD that also meets their security standards," said Jason Goldberg, Four Points Technology Vice President of Sales. "We're excited about the operational and clinical benefits that Enovate Medical can introduce into the government healthcare space."
To learn more about Enovate Medical's FIPS 140-2 validated products, visit http://www.enovatemedical.com/federal
ABOUT ENOVATE MEDICAL
Enovate Medical manufactures and implements intelligent workstation on wheels solutions and services that improve clinical workflows and facilitate real-time Electronic Health Record (EHR) charting at the point of care.
Enovate's mobile power solutions allow nurses to capture patient data uninterrupted throughout their shift. Our cloud-based monitoring of workstation on wheels, real-time location, and battery health maximizes the performance of IT and clinical teams. Enovate's technology delivers fleet optimization programs to cut waste and drive down the overall cost of ownership.
Our consultative approach and a holistic view that integrates technology, service, and support, help our customers reduce costs, enhance productivity, and improve clinical outcomes.
For more information about Enovate Medical's federal solutions, please visit http://www.enovatemedical.com/federal or contact Dawn Wilson, Content and Events Marketing Manager at 888-909-8906 extension 121.
ABOUT FOUR POINTS TECHNOLOGY
Four Points Technology is a CVE-verified Service-Disabled Veteran-Owned Small Business (SDVOSB) dedicated to providing IT products, professional services, and clinical solutions to the Federal Government. By leveraging well-established relationships with major vendors, suppliers, and partners, Four Points provides custom and leading-edge information technology solutions to meet customers' unique needs. For more information about Four Points, please visit http://www.4points.com/.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Preclinical data indicate that SDX-7320 inhibits tumor growth and counteracts treatment-induced metabolic dysfunction, a safety concern that can interrupt PI3K/Akt/mTOR cancer therapy and lead to treatment resistance in tumors.

CAMBRIDGE, MASS. (PRWEB) OCTOBER 21, 2020
SynDevRx, Inc., a clinical-stage oncology company, announces the completion of a series of preclinical studies demonstrating that its anti-cancer drug candidate, SDX-7320, inhibits PI3K/Akt inhibitor-induced hyperglycemia and subsequent hyperinsulinemia in normal mice and inhibits tumor growth in multiple models of HR+ breast cancer. The company's ongoing research places them at the vanguard of metabo-oncology, an emerging field of cancer research that focuses on the role metabolic hormones play in the development and progression of many common cancers, as well as tumor resistance developed in response to certain treatments.
SDX-7320 inhibits MetAP2, a clinically validated target that plays a key role in tumor growth, metastasis, angiogenesis, and metabolic dysfunction. In a series of efficacy and safety studies in a variety of syngeneic cancer models (breast, melanoma), SDX-7320 displayed single agent anti-tumor activity while improving metabolic dysfunction (in particular, hyperglycemia, insulin resistance and leptin resistance). [1] SDX-7320 prevented the hyperglycemia and hyperinsulinemia associated with Piqray (Novartis' PI3Kα inhibitor) [2] administration in normal mice – serious side effects of drugs from these classes that have been reported to lead to treatment resistance. [3] Furthermore, in a xenograft model of ER+/Her2- breast cancer, SDX-7320 and Piqray (alpelisib), [2] administered together at low doses, showed synergy at inhibiting tumor growth.
"Piqray is an important new therapy for patients with HR+/Her2-, metastatic breast cancer whose tumors have a mutation in the PIK3CA gene. However, drugs that target the PI3K/Akt pathway frequently cause hyperglycemia in patients, especially those with high baseline fasting glucose, HbA1c, insulin resistance, pre-diabetes, type 2 diabetes or obesity. [4] Treatment-induced hyperglycemia has been reported as a safety concern that can lead to dose interruptions and/or drug holidays. In addition, the treatment-induced hyperglycemia leads to hyperinsulinemia which in pre-clinical studies has been shown to cause resistance to these drug classes." [5] said Jim Shanahan, Co-Founder and Chief Business Officer of SynDevRx. "Baseline systemic metabolic complications, such as obesity, pre-diabetes or type 2 diabetes were reported to correlate with and predict worse outcomes for many breast cancer patients taking Piqray". [3]
Preclinical studies of SDX-7320 with another drug from the PI3k/Akt class, the Akt/mTOR inhibitor, capivasertib (AstraZeneca) showed that SDX-7320 also attenuated treatment-induced hyperglycemia (in normal mice), and inhibited tumor growth in a xenograft model of HR+/Her2+ breast cancer. "Our preclinical data with alpelisib (Piqray) and capivasertib suggests that SDX-7320 may make drugs targeting the PI3k/Akt/mTOR pathway safer and more effective by controlling blood glucose and insulin levels in combination with tumor growth inhibition," he continued.
"Companies developing drugs targeting the PI3K/Akt/mTOR pathway may experience toxicity issues related to drug-induced hyperglycemia followed by hyperinsulinemia, eventually resulting in resistance to therapy. [5] SDX-7320 has demonstrated that it can help to address this problem in vivo," said Brad Carver, Co-Founder, President and CEO of SynDevRx. "Our data suggests that drugs targeting the PI3K/Akt/mTOR pathway should see better safety and better anti-tumor activity by administering SDX-7320 in combination with those agents."
To test this hypothesis, SynDevRx intends to commence Phase 2 studies in late-stage ER+, Her2- breast cancer patients. To learn more about SynDevRx clinical trials, visit: http://www.syndevrx.com/.
References
1. Abstract 4919: Preclinical activity of SDX-7320 in mouse models of obesity and obesity-driven cancer. Cornelius P, Petersen JS, Mayes B, Turnquist D, Sullivan K, Anderson-Villaluz A, Lutz R, Little S, Slee A, Carver BJ, Shanahan J. Cancer Res July 1 2018 (78) (13 Supplement) 4919; DOI: 10.1158/1538-7445.AM2018-4919
2. Abstract 2147: Synergistic inhibition of MCF-7 mammary gland tumor growth with Piqray(alpelisib) plus SDX-7320, a novel polymer-conjugated methionine aminopeptidase 2 (MetAP2) inhibitor. Cornelius P, Mayes B, Little S, Slee A, Nir R, Nir A, Carver B, Shanahan J. Cancer Res February 14 2020 80 (4 Supplement) P3-11-13-P3-11-13; DOI:10.1158/1538-7445.SABCS19-P3-11-13
3. André F, Ciruelos E, Rubovszky G, et al. Alpelisib for PIK3CA-Mutated, Hormone Receptor-Positive Advanced Breast Cancer. N Engl J Med. 2019;380(20):1929-1940. doi:10.1056/NEJMoa1813904: Fox et al., Breast Cancer Research volume 15, Article number: R55 (2013)
4. Rugo et al, 2020, Annals of Oncology: https://doi.org/10.1016/j.annonc.2020.05.001
5. Hopkins, B.D., Pauli, C., Du, X. et al. Suppression of insulin feedback enhances the efficacy of PI3K inhibitors. Nature 560, 499–503 (2018). https://doi.org/10.1038/s41586-018-0343-4
About SynDevRx
SynDevRx is a privately held clinical stage biopharmaceutical company based in Cambridge, Massachusetts focused on the research and development of treatments that address the unique and underserved needs of cancer patients with systemic metabolic dysfunction – i.e., metabo-oncology. Obesity, pre-diabetes and type 2 diabetes are known to worsen cancer patients' prognosis, but oncologists have no specific tools to deal with systemic metabolic complications except for changes in diet and exercise. SynDevRx intends to initiate a series of Phase 2 clinical studies of its drug candidate SDX-7320 to address this major, unmet medical need. Preclinical studies have shown that SDX-7320 reduces tumor growth and angiogenesis, helps to control aberrant metabolic hormone signaling, and reduces treatment resistance to certain standard cancer therapies in metabolically sensitive cancers. SDX-7320 is being developed for use in combination with standard of care therapies for a variety of solid tumors.

"Our preclinical data with alpelisib (Piqray) and capivasertib suggests that SDX-7320 may make drugs targeting the PI3k/Akt/mTOR pathway safer and more effective by controlling blood glucose and insulin levels in combination with tumor growth inhibition."



START your own Wordpress site, business or personal website, or online store at www.siteground.com

The benefits of using Artificial Intelligence, like Transpara to help improve early breast cancer detection rates are beginning to be recognized as use in the United States and around the world is gaining momentum. Transpara Breast Care is a new website dedicated to empowering women to take charge of their breast health

MADISON, WIS. (PRWEB) OCTOBER 21, 2020
With a shortage of breast radiologists in many countries along with a global increase in the incidence of breast cancer this upsurge in the use of AI for early detection comes at a critical time.
Transpara is the first deep learning AI system to be FDA cleared and CE marked for both 2D and 3D mammograms and it has been clinically proven to identify potential cancers earlier, to improve the accuracy of radiologists, and to help radiologists read more quickly. This decision support software uses a sophisticated algorithm that gives clinicians immediate objective feedback on areas of suspicion identified within a mammogram. This helps to speed up decision making and, more importantly, to increase accuracy of detection.
Nicki Bryan, Vice President of Sales for ScreenPoint Medical in the United States, said she is delighted to see this rapid adoption of Transpara. "We want to make a real difference in the lives of families by reducing the impact of breast cancer and improving survival rates. As more radiologists begin to use Transpara we can begin to recognize that goal."
"We know that Transpara works with most mammography systems and we're seeing that the software seamlessly integrates into the current workflow of the doctors using our solution. This gives us the ability to provide access to this technology to patients everywhere." "Bryan concludes by saying, "We are using the experience and knowledge of thousands of radiologists and the data from a million+ mammograms worldwide to continuously train Transpara. Improvements are ongoing so our customers are always automatically upgraded to the newest version of Transpara. This ensures that new benefits are available without adding extra cost".
To meet the growing demand for information about AI, Transpara now has its own website dedicated to empowering women to take charge of their breast health via education.: http://www.transparabreastcare.com
Nico Karssemeijer, CEO and founder of ScreenPoint Medical states,
"The launch of http://www.transparabreastcare.com will help to teach women about how AI can work hand in hand with their radiologist to deliver better care. Research shows that some women still feel apprehensive about trusting AI but the reality is, it should bring peace of mind. By providing clinically proven decision support to radiologists with Transpara, we aren't replacing the radiologist, we are arming the radiologist with a powerful tool.
We started this company to help improve breast cancer survival and we work tirelessly to ensure that breast cancer can be found faster and earlier. That is what will save women's lives."
http://www.transparabreastcare.com is an educational website that focuses on the importance of early detection, screening mammography and the benefits of Transpara AI. Transpara is an AI solution for breast cancer screening, that uses deep learning algorithms to automatically detect lesions suspicious for breast cancer in 2D and 3D mammograms. The software categorises mammograms on a 10-point scale indicating the degree of risk that cancer is present. This Exam Score can be used to help radiologists prioritise patients for further investigation. Decision support marks for calcifications and soft tissue lesions are provided to support radiologists with image interpretation. Studies have shown that Transpara matches the performance of radiologists thus acting as a second opinion which increases diagnostic confidence and accuracy. It is FDA cleared for 2D and 3D mammography.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

New campaign from Prevent Blindness raises awareness of escalated risk of digital eye strain.

CHICAGO (PRWEB) OCTOBER 21, 2020
In response to increased virtual activity during the coronavirus pandemic, Prevent Blindness, the nation's leading volunteer eye health and safety organization dedicated to fighting blindness and saving sight, today launched Screen Time-Out, an awareness campaign to encourage Americans, especially parents of young children, to introduce regular screen breaks into their daily routines.
During work, school and even personal downtime, people spend as much as 12 hours a day in front of a digital screen. This amount of screen time exacerbates the risk of digital eye strain, also known as computer vision syndrome, especially for children whose eyes are still developing. Symptoms may include tired, burning or itching eyes, dry eyes, blurred vision and/or headache. The risk of digital eye strain has recently risen to a mounting level in the United States during the coronavirus pandemic, with 53 percent of respondents in a recent survey feeling burnout on screens over the last few months.
"At Prevent Blindness, we are concerned about people spending more and more time in front of our screens," said Jeff Todd, president and CEO of Prevent Blindness. "As an organization dedicated to ensuring everyone has a lifetime of healthy vision, the Screen Time-Out campaign is meant to educate people and reduce the risk of eye strain, starting with the youngest among us."
The Screen Time-Out campaign will live on social media – Facebook, Instagram and Pinterest – where device users are already spending a lot of their recreational screen time.
According to a recent survey of American eyecare professionals, 64 percent of respondents have seen an increase in patients having issues due to more screen time. Sixty-eight percent said they have seen those issues in both children and adults.
"Digital eye strain has been a rising modern threat to people of all ages, and it is linked to myriad issues, including eye development and nearsightedness," said Dr. Linda Chous, pediatric optometrist. "It is important now more than ever to be mindful of how much time we spend with screens and take steps to reduce the impact of digital eye strain."
To reduce eye strain, Prevent Blindness recommends children and adults take regular breaks using the 20-20-20 rule: every 20 minutes, shift eyes away from the screen to look at an object at least 20 feet away for at least 20 seconds.
Other tips to avoid eye strain from the American Academy of Ophthalmology include:

Use artificial tears to refresh eyes when they feel dry. Consider using a humidifier to add moisture to the air.

Wear prescribed computer eyeglasses that allow eyes to focus specifically at computer screen distance (intermediate distance, which is about 20 to 26 inches away from the face).

Adjust screen brightness to match the level of light in the room. Also, try increasing the contrast on the screen to reduce eye strain.

Use a glare screen on the device.

Sit about 25 inches from the screen and adjust the screen height to look slightly downward.

For more information about Screen Time-Out and Prevent Blindness, visit http://www.preventblindness.org/screen-time-out.
About Prevent Blindness
Founded in 1908, Prevent Blindness is the nation's leading volunteer eye health and safety organization dedicated to fighting blindness and saving sight. Focused on promoting a continuum of vision care, Prevent Blindness touches the lives of millions of people each year through public and professional education, advocacy, certified vision screening and training, community and patient service programs and research. These services are made possible through the generous support of the American public. Together with a network of affiliates, Prevent Blindness is committed to eliminating preventable blindness in America. For more information, or to make a contribution to the sight-saving fund, call 1-800-331-2020. Or, visit us on the Web at http://www.preventblindness.org or http://www.facebook.com/preventblindness.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Dr. Benjamin Emery completes over 300 hours of continuing education. Dr. Emery and his team in Casper, WY raise awareness of the importance of seeing a dentist trained in the latest techniques to receive lasting and effective dental care.

CASPER, WYO. (PRWEB) OCTOBER 21, 2020
Respected Casper, WY dentist, Dr. Benjamin Emery has now completed over 300 hours of continuing education courses over the last five years. As the first year that Wyoming has required dentists to receive any continuing education, Dr. Emery and his team are raising awareness of the importance of choosing a clinician with knowledge of the latest trainings and techniques. In constant pursuit of breakthrough research and findings in the field of dentistry, Dr. Emery and his associates, Drs. Stuart Youmans, Melissa Youmans, and Austin Baker emphasize the importance of this accomplishment.
Dental continuing education includes trainings and courses completed after dental school. These courses help clinicians stay up to date on the latest discoveries and ensures they retire outdated techniques after more minimally invasive ones are proven. Each state requires a minimum number of continuing education hours or credits to be completed by each dentist during every renewal period in order to practice in that state. Until this year, Wyoming was the only state that did not have a set requirement for dentists.
For reference, Arizona requires 72 hours be completed every three years and South Dakota requires 100 hours every five years. Starting this year, Wyoming requires just 16 hours of continuing dental education be completed every two years.
This puts Dr. Emery's 300 hours over the last five years into better perspective. Dedicated to his craft and his community, he devotes so much of his time to furthering his education because he refuses to offer outdated care when better solutions are available. He strives to provide his patients with dental care that not only improves their health but offers a comfortable experience and lasting results.
As one of only a few dentists in Casper and Wyoming to offer full mouth reconstruction, he provides truly life-changing care with this transformative treatment all from the comfort of one practice. Dedicating over a decade of experience perfecting his craft, he restores smiles worn-down from teeth-grinding, incomplete from tooth loss, or tarnished by cosmetic imperfections by strategically blending a comprehensive list of treatments. With training from prestigious organizations such as the OBI Foundation for Bioesthetic Dentistry, he combines services like crowns, bridges, Invisalign, and dental implants, with modern technology including precise and comfortable digital scanning. By doing so, Dr. Emery and his award-winning team create functioning, lasting, and natural-looking smiles that rebuild proper health and restore self-confidence.
When choosing a dentist for care, from regular teeth cleaning to full mouth reconstruction, Dr. Emery and his team at Aspen Ridge Dental encourage patients to consider how much time the clinician has dedicated to continuing education. As uncompromising with his training and education as he is with his patients' care, Dr. Emery and his team welcome new patients to receive a personalized consultation by calling 307-224-7843. To learn more about the full mouth reconstruction treatment he offers or the other general and cosmetic dentistry services provided by Aspen Ridge Dental visit http://www.aspenridgedental.com.
About the Practice
Established in 1998, Aspen Ridge Dental is a general and family dental practice in Casper, WY that combines the high-quality and state-of-the-art care patients need and deserve with the hometown values patients expect. Drs. Stuart Youmans, Melissa Youmans, Benjamin Emery, and Austin Baker, along with their friendly and experienced team provide a comprehensive array of services including preventive dentistry, wisdom tooth extractions, full mouth reconstructions, dental implants, complex bone grafting, and orthodontics. From their digital Cone Beam CT technology for precise 3D imaging and rendering to select dental laboratories utilizing only high-quality materials and craftmanship, Aspen Ridge Dental ensures patients are not only treated with respect but with the latest advancements in dentistry as well. To learn more about the dentists, their team, or the services offered at Aspen Ridge Dental visit http://www.aspenridgedental.com. To schedule a personalized consultation, call 307-224-7843.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Intuitive and highly-configurable EHR empowers better patient care management with agile, responsive and comprehensive critical care workflows.

ATLANTA (PRWEB) OCTOBER 21, 2020
Azalea Health, a leading provider of cloud-based patient management and health IT solutions, announced the celebration of more than a year's successful partnership with L.A. Downtown Medical Center (LADMC). In February 2019, LADMC selected Azalea Health as their electronic health record (EHR) to help manage acute care patient workflows across multiple departments and a diverse patient population. LADMC, a 212-bed hospital serving a culturally diverse population across two campuses in Los Angeles County, implemented the Azalea EHR platform in under five months and is leveraging the solution to manage multiple workflows, and to bridge behavioral health and LADMC's other inpatient and outpatient services.
As the effects of COVID-19 extend beyond the immediate physical health threat, LADMC has relied on Azalea Health to help meet the sharp rise in demand for behavioral health services from patients affected by job losses, social isolation, and other challenges. LADMC is leveraging Azalea's lightweight, highly customizable workflows to keep pace with the rapidly changing needs of patients caused by the ongoing circulation of the pandemic. LADMC and Azalea Health are also building a COVID interface so the hospital can meet state reporting requirements.
"We chose Azalea Health's EHR over other EHR solutions because it's easy to implement and adapt, lightweight, and straightforward to integrate with other technologies," said LADMC executive Vicki Rollins. "We've been able to configure Azalea Health's EHR for multiple workflows without complex coding changes. This flexibility is especially important as we are a nimble, growing hospital, and now with COVID-19, as we are seeing a surge in patients struggling with the physical, social, emotional, and economic repercussions of the pandemic."
The customizable critical care templates enable LADMC clinicians to have a real-time pulse on the many unique needs of their patients, powered by integrated data visualization and reporting. The open API structure of the EHR solution enables streamlined integration and incorporation of clinical applications that, when added into the EHR, create a true system of clinical intelligence and a comprehensive view of patient care.
"We're pleased to be able to help LADMC provide better care for their patients amid these incredibly challenging times," said Baha Zeidan, CEO of Azalea Health. "Given the new nature of care, urban hospitals need technology that flexes and scales with surges in demand and changing needs. Only an interoperable, cloud-based EHR solution is capable of achieving that."
Azalea's flexible, cloud-based EHR has several modules that help a growing number of hospitals address the surges in demand and the unique new care needs of patients, including behavioral and telehealth services. Much like its behavioral health services for LADMC, Azalea has been powering modern telehealth services, which have seen accelerated adoption among providers and have helped hospitals generate new revenue streams in difficult times.
About L.A. Downtown Medical Center:
With its 212 inpatient hospital beds, LADMC provides care for a culturally diverse population at two campuses in Los Angeles County. The Downtown Campus is a welcoming community hospital located at the intersection of three of Los Angeles' oldest neighborhoods – Historic Filipino Town, Echo Park, and Silver Lake. The Ingleside Campus was established in 1918 in the San Gabriel Valley and is one of the first licensed psychiatric facilities in California. The dedicated team at LADMC is committed to providing safe, compassionate, and supportive care to all patients.
About Azalea Health:
Azalea Health (Azalea) is changing the way health IT platforms connect community-based healthcare providers and patients across the care continuum. Offering a 100% cloud-based, interoperable solution, Azalea delivers electronic health records, revenue cycle management, and a fully integrated telehealth solution designed for rural, community and urban practices and hospitals, especially those focused on underserved populations. Quick to deploy and intuitive to use, Azalea solutions ensure better care coordination and communication, and the "one patient, one record" approach provides care teams the agility to achieve better outcomes. The Azalea platform also delivers tools and resources to help providers meet their Meaningful Use requirements, and informs their strategies to navigate accountable care and alternative payment models.
Azalea PR Contact:
Lexi Herosian
lexi@scratchmm.com



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Enso Discoveries, an emerging biotech company, is proudly partnering with several global companies and distributors to bring its patent-pending regenerative medicine technologies to the veterinary and soon human health industries worldwide.

MANHATTAN, KAN. (PRWEB) OCTOBER 22, 2020
Enso Discoveries, LLC proudly announces its most recent international expansion into Costa Rica with the leading "Pan Latin American Distributor." This is just one of three major global business developments that the American based biotech company has secured or enhanced during these uncertain times.
"We are very excited to partner with the premier "Pan Latin American" distribution organization in Costa Rica. Our partner has an extensive track record of success in both the veterinary and human medical markets, which will provide both our veterinary and new human health division, Enso Doctors, LLC, an opportunity to grow, along with providing our new partner a unique and prosperous opportunity," explains Patrick Farley, CEO, Enso Discoveries, LLC.
In addition to a Latin American partnership, over the last few months, Enso Discoveries has been completing an initial assessment required by its new EU partner, based out of Germany. This means the company will be soon entering the EU markets with both the patented PRP (Platelet Rich Plasma) and PRF (Platelet Rich Fibrin) products that are currently distributed in the United States. Both products are rapidly becoming the choice for medical professions due to the ease of use, no new expensive capital needed, science-backed information, and all-inclusive kits that have made these once exclusive services now very affordable to all.
Enso Discoveries is also very proud to announce a new extended 2-year agreement with its Asian veterinary partners that will take the company into 2023, offering Board Certified Histopathology Interpretations. As the company has proven over the last two years to its current Asian partners that there is no substitute for quality interpretations, it anticipates case volume projections to be three to four times that of the current. The current market continues to expand rapidly and Enso Discoveries' partners purposely direct more cases to their lab for the best in class quality interpretations.
"With a 24-hour or less turnaround time for most cases, we are proud to be helping give veterinarians the ability to make better, faster decisions in an effort to treat their clients' beloved pets," says Farley, "As we drive each and every day here in the US to deliver our exceptional products, it is very apparent the demand outside of our country for our unique products is growing rapidly. We remain very excited to deliver the highest quality, most affordable products, to better the health of both animals and humans around the world."
With the goal of improving quality of life while generating service-based revenues, Enso Discoveries has taken the lead in accessible, unique, affordable and validated regenerative medicine products with Rebound PRP and Rebound PRF in the US and now abroad. Both Rebound PRP and Rebound PRF were designed with veterinarians and physicians in mind. They were validated in a major university, patent-pending and are adjustable therapies to produce a customized amount of PRP or PRF that a patient might need for optimum healing.
Enso Discoveries, LLC is a biotech company focused on enhancing lives through the development of relevant, cost-effective, novel technology that allows our valued customers, to offer better service to all patients and keep their hard-earned business in house. We support our products and services with scientific proof, national distribution partners, and a worldwide network of industry experienced contacts. Ask your distributor about Enso Discoveries, LLC products such as Rebound PRP and Rebound PRF or learn more at http://www.ensodiscoveries.com or http://www.ensodoctors.com.

"Having lived and worked overseas for 5 years, I feel I have a great connection to other cultures. It is a passion of mine to offer new innovative products and ideas, as well as learn from so many different cultures with their ideas," -- Patrick Farley, CEO, Enso Discoveries, LLC.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

HPI has tapped industry expert, Christopher Misuraca, as their new Regional Sales Executive. The addition of Christoper will amplify HPI's distribution channel and heighten its market development across the country.

WESTBOROUGH, MASS. (PRWEB) OCTOBER 22, 2020
Soaring ahead after another year of successful growth, HPI has tapped Christopher Misuraca as their newest Regional Sales Executive. Christopher will maximize the HPI distribution channel and take their market development to new heights across the country. He brings over 25 years of experience in the employee benefits industry including providing consultative services to a few of the region's largest brokerages.
"Chris brings great energy to the HPI team," said Drew Rozmiarek, Senior Vice President of National Sales and Emerging Markets. "His insight, creative approach to the market and client solutions, and track record for establishing excellent relationships will help take us to the next level."
Most recently, Misuraca served as Senior Account Executive at Blue Cross Blue Shield of Massachusetts, where he was responsible for managing health care, dental and ancillary products for national clients. Previously, he held a senior account executive position at Tuft's Health Plan.
"HPI is a nationally growing company known for its vision and innovation," said Misuraca. "This opportunity will enable me to draw from both my benefits and consultative experience to provide clients unique solutions. I look forward to contributing to HPI's national expansion and continuing to build successful relationships."
About HPI
HPI redefines what is possible with self-funded health plans. As a leading national third-party administrator, they partner with health plan brokers and employers to provide innovative self-funding strategies and customized plans tailored to each client's needs and population. HPI's solutions give employers greater cost transparency and control, while elevating the member experience. It is their flexible approach, entrepreneurial spirit and commitment to quality, technology, and service that enable them to deliver premium value to their customers.
For more information, visit http://www.hpitpa.com
MEDIA CONTACT:
Su Doyle, VP of Strategic Marketing
HPI
508-475-6103
sdoyle@healthplansinc.com



START your own Wordpress site, business or personal website, or online store at www.siteground.com

The Lapidus Cut Guide cutting slots are designed to reduce the amount of resection needed to prepare the joint area by providing surgeons with the flexibility to remove 3-6mm of bone and cartilage.

WARSAW, IND. (PRWEB) OCTOBER 22, 2020
Nextremity Solutions, Inc., a strategic commercialization organization with a focus on the extremity musculoskeletal space, located in "The Orthopedic Capital of the World," Warsaw, Ind., recently completed the first several cases using their newly launched Lapidus Cut Guide.
The Nextremity Solutions Lapidus Cut Guide is designed to provide anatomically intuitive resection of the first tarsometatarsal joint in preparation for a Lapidus procedure.
Brett Sachs, DPM, FACFAS of Wheat Ridge, Colorado stated, "The new Lapidus Cut Guide allows the surgeon to choose a variety of precise cutting angles to match the patient's natural anatomy. It also provides limited joint resection to minimize shortening of the metatarsal."
The Lapidus Cut Guide cutting slots are designed to reduce the amount of resection needed to prepare the joint area by providing surgeons with the flexibility to remove 3-6mm of bone and cartilage. The Lapidus Cut Guide also provides surgeons with a single instrument that allows for unconstrained angle correction based on the individual patient anatomy.
"The Lapidus procedure has seen rapidly increasing surgical options for surgeons treating patients with varying degrees of bunion deformities. This new Lapidus Cut Guide will increase a surgeon's confidence in making accurate bone cuts in preparation for performing a Lapidus procedure with various systems in the marketplace, including the InCore Lapidus Correction System," noted Michael Lee, DPM from Des Moines, Iowa.
"I began using the InCore Lapidus System because I preferred the orientation of the compression that is generated by the unique instrumentation while also eliminating patient concerns related to prominent hardware irritation. With the introduction of the new Lapidus Cut Guide from Nextremity Solutions, making parallel cuts on both the medial cuneiform and first metatarsal base will allow reproducible reduction in the inter-metatarsal angle that is the goal in every bunion surgery regardless of the deformity," commented Keith Tyson, DPM of Hanover, Pennsylvania.
"The new Lapidus Cut Guide just made the Lapidus procedure easy and predictable. It provides confidence in making accurate cuts on both sides of the joint and produced perfect cuts while removing very little bone to prevent shortening of the first ray (metatarsal). It was very easy to use the first time and resulted in great correction," added Thomas Rappette, DPM of Chicago, Illinois.
The Lapidus Cut Guide is the first technology released by Nextremity Solutions that was entirely manufactured by its manufacturing arm, Lakeland Technology. Lakeland Technology was acquired by Nextremity Solutions, Inc. in March of 2020. Through this relationship with Lakeland Technology, Nextremity Solutions was able to manufacture the Lapidus Cut Guide in a much shorter time frame than was experienced with previous manufacturers.
The patent-pending Lapidus Cut Guide is currently in a limited commercial launch and is exclusively distributed by Nextremity Solutions.
To learn more about this and other products developed by Nextremity Solutions, visit http://www.nextremity.com.
About Nextremity Solutions, Inc.
Nextremity Solutions, Inc. is a privately held strategic commercialization organization with a focus on the extremity musculoskeletal space, offering innovative solutions and Revenue Ready products for various extremity musculoskeletal applications and for the benefit of our industry partners. The Company's procedure-ready, sterile implant systems include uniquely precise, proprietary technology designed to achieve repeatable and superior clinical outcomes.

It was very easy to use the first time and resulted in great correction.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Health care leaders from IBM, Optum, and Studer Group discuss the future of health care

KANSAS CITY, MO. (PRWEB) OCTOBER 22, 2020
Caravan Health will host its fifth Accountable Care Symposium, the first held virtually, for thought leaders, decision makers, and frontline practitioners in accountable care from across the nation. From December 7-10, health care visionaries will have the opportunity to listen to keynote speakers, learn best practices from peers, and watch and support awards presentations.
Among the confirmed speakers are:

Dr. Patrick Conway, Chief Executive Officer, Care Solutions at Optum

Dr. Rahul Rajkumar, Senior Vice President Chief Medical Officer, BlueCross BlueShield of North Carolina

Dr. Kyu Rhee, Chief Medical Officer, IBM Watson Health

Joe Scarborough, MSNBC commentator and host of Morning Joe

Brock Slabach, Senior Vice President, National Rural Health Association

Quint Studer, Founder, Studer Group

"Trust and communication are at the core of any organization's success," said Quint Studer, best-selling author and health care thought leader. "In this most unusual year, learning to manage change and adapt quickly is more important than ever. I look forward to connecting again with Caravan Health and their partners as they chart a path forward in value-based care."
Dr. Kyu Rhee, the Chief Medical Officer at IBM Watson Health, has worked extensively in community health and equity while reinventing the culture of health care. He is highly-respected in the industry and has encouraged the transition from value-based care to "values based care".
"It's no longer enough to provide patient care," commented Dr. Rhee. "Using technology will open new doors so that we continue delivering high-quality, sustainable values-based care in the new year."
The four-day virtual event will combine four different learning topics geared to all levels of ACO experience and a wide range of organizational roles. These topics include program and policy updates, best practices for better patient care, strategies for financial success and sustainability and innovations in technology. On December 9, Former Congressman (R-FL) and co-host of MSNBC's "Morning Joe", Joe Scarborough, will share his perspectives on what our nation can expect in 2021.
Dr. Patrick Conway, CEO of Care Solutions at Optum, is scheduled to speak on improving patient care and will focus part of his presentation on redemption after failure. Prior to Optum, Dr. Conway was the CEO of BlueCross BlueShield of North Carolina and before that was Chief Medical Officer, Deputy Administrator and Director for Medicare and Medicaid Innovation at Centers for Medicare & Medicaid Services (CMS).
Dr. Conway added: "The symposium is an incredible opportunity for health care leaders across the country to learn how to secure their future in risk-based payment models, and connect with top practitioners and experts in population health. I'm passionate about how to improve patient care using value-based care models and looking forward to connecting with colleagues at the event."
Learn more and register today at http://www.caravanhealth.com/symposium
About Caravan Health: Caravan Health helps providers make accountable care work regardless of their size, location, history, or demographics. Caravan Health gives community health systems and providers a way to create more scale, drive more change, and generate more revenue. The 250+ health systems who have turned to Caravan achieved single-year savings greatly exceeding the national average. Health systems and providers across the country are using our proven population health programs to ensure better outcomes for their patients every day. With Caravan Health, now the numbers work. For more information visit http://www.caravanhealth.com.

"In this most unusual year, learning to manage change and adapt quickly is more important than ever. I look forward to connecting again with Caravan Health and their partners as they chart a path forward in value-based care," said Quint Studer, best-selling author and health care thought leader.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Leading Houston addiction treatment center announces the addition of Dana LaFayette as Clinical Director.

HOUSTON (PRWEB) OCTOBER 22, 2020
The Right Step Houston, a well-established provider for addiction treatment services for the last 30 years, welcomed Dana LaFayette as its Clinical Director. Dana steps into the role with over 30 years of clinical experience and expertise to help support an evidence-based and clinically balanced curriculum. Through clinical planning and thoughtful guidance, Dana will work with staff to create long-term healing experiences for clients.
With her undergrad in family relations and childhood development from Oklahoma State University and her master's in educational psychology, Dana began her career as a caseworker working with the mental health authority. She would later move on to complete her license in counseling, filling a variety of counseling and administrative roles within the mental health and substance use disorder field. During this time, Dana also assisted in writing program grants, working closely with judicial systems and creating collaborative partnerships with local government officials and community leaders in Waco, Texas. Dana worked in the Waco area for 12 years before moving on to The Right Step Houston.
Dana plans to support The Right Step by strengthening its efforts to bring high-quality, evidence-based treatment options to the Houston area. As Clinical Director, she also plans to create a healthy environment that promotes staff retention and growth. With thoughtful consolation and training, Dana will help guide staff to find the right solution for each client's unique needs.
"I love the idea of transforming lives," Dana said. "It's amazing to see how a person grows and develops in recovery. With clinically sound treatment programming, I want to inspire the hope clients need to transform into who they want to be."
As The Right Step Houston celebrates its 30th anniversary this month, the addition of Dana LaFayette as the Clinical Director reinforces the ever-growing need for clinically sound substance use treatment services that are strengthened by staff cohesion and compassion to help people. For additional information regarding all the programs offered at The Right Step Houston, please contact 844.768.0169 or visit rightsteprehabhouston.com.
About Promises Behavioral Health
Promises Behavioral Health is a family of behavioral health programs with regional brands such as The Right Step, The Ranch, and Promises. The company currently operates facilities across Texas, Tennessee, Florida, Pennsylvania and Massachusetts. Promises offers comprehensive, innovative treatment for substance abuse, sexual addiction, trauma, eating disorders, and other mental health disorders. Through its programs, the company is committed to delivering clinically sophisticated treatment that promotes permanent lifestyle change, not only for the patient but for the entire family network. For more information, please visit http://www.promisesbehavioralhealth.com.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Annual survey of employers reveals increased investment in adoption benefits

COLUMBUS, OHIO (PRWEB) OCTOBER 22, 2020
The Dave Thomas Foundation for Adoption released its 14th annual Best Adoption-Friendly Workplaces list recognizing organizations with the most robust adoption benefit programs. The Foundation partnered with RTI International, an independent, nonprofit research institute, to survey employers across the United States and score participants based on three criteria: financial reimbursement, paid leave and — new in 2020 — the percentage of employees eligible for those benefits.
More than 25 years ago, Dave Thomas, founder of Wendy's and the Dave Thomas Foundation for Adoption, led an initiative advocating for better adoption benefits in the workplace. The Foundation has carried that legacy forward through its signature Adoption-Friendly Workplace program and 100 Best Adoption-Friendly Workplaces list.
The 2020 list includes a diverse group of organizations representing 23 industries. On average, employers that completed the survey offer $10,158 in financial reimbursement, which is up 8.5% from 2019. The average amount of paid leave was 7.7 weeks, up 4% from last year.
"Congratulations to all the organizations on this year's list, and thank you for your commitment to supporting employees who grow their families through adoption," said Rita Soronen, President & CEO of the Dave Thomas Foundation for Adoption. "You are making a difference in the lives of thousands of waiting children who need the stability and support of a permanent family now, more than ever."
NVIDIA is atop the 100 Best Adoption-Friendly Workplaces list for the third year in a row. The Santa Clara, CA-based artificial intelligence company offers all full- and part-time employees unlimited financial aid to cover the cost of an adoption. NVIDIA also provides up to 20 weeks of paid parental leave to women and men welcoming an adopted child into their home.
"'One team' is a core value at NVIDIA, and this deep, shared sense of collaboration includes supporting employees' families, knowing that they are created in different ways," said Shelly Cerio, Senior Vice President of Human Resources at NVIDIA. "NVIDIA is committed to removing any barriers that employees might face in building their families, particularly for those wanting to adopt and improve lives for others. It's a true honor to be recognized by the Foundation for the third year in a row."
The Foundation also ranks employers by size, industry, best paid leave, foster care benefits and impact. The impact list recognizes organizations who employ more than 1,000 people and that provide the largest overall financial benefits for adoption to the largest number of employees.
The Wendy's Company has been designated with Forever Family emeritus status after holding the top spot on the 100 Best Adoption-Friendly Workplaces list for many years.
"Wendy's founder, Dave Thomas, was adopted and knew that the support of a loving family could help children reach their full potential. At Wendy's, we believe that offering adoption benefits to our employees is simply the right thing to do," said Todd Penegor, President & CEO of The Wendy's Company and member of the Foundation's board of trustees. "We're excited to celebrate NVIDIA atop the list once again along with so many companies who have recognized the importance of adoption benefits for their employees."
View the complete 2020 Best Adoption-Friendly Workplaces list and other adoption resources for employers at davethomasfoundation.org/AFW.
###
About the Dave Thomas Foundation for Adoption
The Dave Thomas Foundation for Adoption is a national nonprofit public charity dedicated exclusively to finding permanent homes for the more than 150,000 children waiting to be adopted in North America's foster care systems. Created by Wendy's founder Dave Thomas, who was adopted, the Foundation implements evidence-based, results-driven national service programs, foster care adoption awareness campaigns and innovative grantmaking. Learn more at davethomasfoundation.org.

"Congratulations to all the organizations on this year's list, and thank you for your commitment to supporting employees who grow their families through adoption," said Rita Soronen, President & CEO of the Dave Thomas Foundation for Adoption.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Neuro Event Labs, Inc. announces that Nelli received a Breakthrough Device designation from the U.S. Food and Drug Administration (FDA).

SAN ANTONIO (PRWEB) OCTOBER 22, 2020
Neuro Event Labs, Inc., a global diagnostic company, announced that Nelli received a Breakthrough Device designation from the U.S. Food and Drug Administration (FDA). The system is designed to automate the identification of seizure events using video, audio and sophisticated software algorithms using artificial intelligence (AI). This is the first Breakthrough Device designation for a seizure diagnostic monitoring system.
"Seizure identification and quantification are the foundation of any effective treatment plan," said Neuro Event Labs' CEO, Kaapo Annala. "Yet, approximately 86% of nocturnal seizures go unnoticed and unreported. How can patients get the treatment they need when so much of their story remains untold?"
"Unidentified and mischaracterized seizures are problems that neurologists face every day," said Dr. Jacqueline French, Professor of Neurology at NYU Grossman School of Medicine and Chief Medical & Innovation Officer of the Epilepsy Foundation. "We need more innovative diagnostic tools to get to market faster so that we can detect seizures accurately and, therefore, improve clinical care and conduct more efficient clinical trials."
"For a seizure monitoring system to be effective, it must be easy for patients to use," said Jukka Peltola, M.D., PhD, Medical Director & Co-founder of Neuro Event Labs. Peltola continued, "With Nelli, patients don't have to wear anything. They just have to turn on the camera and Nelli does the rest, automatically for both the patient and the physician. From capturing the seizure to automated classification, Nelli streamlines the diagnostic process. Quicker results means faster time to treat for the patient."
Nelli offers advantages over other types of monitoring systems. EEG-based systems are only practical for short monitoring periods, can be expensive, and have low yield. Wearable systems are limited to only the more severe seizure types. As a video-based system, Nelli can monitor for additional seizure types over weeks or months.
Peltola continued, "The more kinds of seizures a patient has, the more complex their case is. Now I can get a clean, simple report that quantifies and qualifies the seizures my patients experience in their home. I can also analyze their seizure patterns and make more patient-specific treatment plans. Also, thanks to the video recording, I can see the events that are in the report. Interactive Nelli Reports give the physician more certainty when prescribing treatments and determining their effectiveness when managing epilepsy syndromes."
Annala concluded, "Nelli's Breakthrough Designation gives us additional momentum to launching the product to the US market. We are currently enrolling patients for our pivotal trial in the US to support our 510(k) application. Everyone deserves to be in control of their life. With tomorrow being SUDEP Action Day, I want to let the epilepsy community know that we are working hard to bring a unique and breakthrough product to market to give them a chance to take back control of theirs."
About Nelli
Nelli is intended for the automated analysis of audio and video data to identify seizure events with a positive motor component in children and adults. Nelli Reports provide objective summaries of semiological components of identified events (including velocity and acceleration of movements, seizure frequency, seizure duration, heart rate, and respiratory rate). Nelli provides A/V data for physicians to characterize seizures and peri-ictal events. Nelli is CE marked and has been launched for clinical use at over 30 leading European hospitals.
About Neuro Event Labs
Neuro Event Labs is an award-winning, privately held, epilepsy monitoring company based in Tampere, Finland. It is pioneering the use of audio and video biomarkers along with artificial intelligence (AI) to improve the outcomes of patients with seizures. Neuro Event Labs has partnered with leading research hospitals and pharmaceutical companies around the world to advance epilepsy care with Nelli. Neuro Event Labs was founded on the belief that everyone deserves a good life and is guided by its vision to bring the digital health revolution to the practice of neurology.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

avoMD and PM Pediatrics join forces to create digital clinical care guidelines delivered via the avoMD mobile app.

NEW YORK (PRWEB) OCTOBER 22, 2020
PM Pediatrics ("PMP"), the nation's largest provider of specialized pediatric urgent care, is collaborating with avoMD, an app-driven platform for next-gen clinical guidelines and pathways, to improve the adoption of PM Pediatrics' evidence-based clinical care pathways.
The two parties are digitalizing PM Pediatrics' clinical guidelines into highly usable and interactive formats, which will be made available on every provider's phone via the avoMD mobile app. The collaboration will initially focus on twenty clinical targets, including multisystem inflammatory syndrome (MIS-C), urinary tract infection (UTI), acute otitis media (AOM), croup, and asthma.
"avoMD's platform is an excellent solution to help us translate our team's clinical expertise into best practice. By transforming our existing guidelines into a simple, interactive app, avoMD helps our clinicians easily access evidence-based medicine and ultimately enhances patient care," said Dr. Mordechai Raskas, Chief Medical Information Officer and Director of Telemedicine for PM Pediatrics. "Additionally, avoMD's ability to rapidly update and distribute our guidelines allows us to make changes on the fly and adapt to the rapidly changing clinical environment that COVID-19 has created."
"PM Pediatrics is a leader in evidence-based pediatric medical care and at the forefront of developing urgent care guidelines," said Dr. Yair Saperstein, CEO of avoMD. "This collaboration allows PMP providers to instantly access highly contextualized and usable clinical pathways at the point of care, when such content is needed most immediately. We are excited to join forces with PM Pediatrics in developing and delivering this content."
About PM Pediatrics
Established in 2005, PM Pediatrics is the nation's largest provider of specialized pediatric urgent care with 60 locations nationwide and over 3,000,000 visits to date. Each location is staffed by pediatric emergency specialists trained in treating newborn through college-age patients for a broad array of illnesses and injuries including asthma, fever, infections, dehydration, fractures, wounds requiring stitches and more. The company's mission is to provide outstanding clinical care with a focus on minimizing pain and unnecessary tests in a unique office environment tailored for pediatric patients. As part of their commitment to community education, Dr. Christina Johns serves as the company spokesperson and Senior Medical Advisor. As a parent, pediatrician and pediatric emergency physician with a master's in education, she shares her expertise with patients and families everywhere. PM Pediatrics accepts most types of insurance and features short wait times and convenient hours, 365 days a year. The company is proud to be a nine-time honoree to Inc. magazine's 500|5000 list of the nation's fastest-growing private companies. For more information about PM Pediatrics and a list of locations, visit pmpediatrics.com
About avoMD
avoMD is a software platform for next-gen clinical guidelines and pathways. avoMD offers a better way for clinicians to use and learn evidence-based medicine and enables hospitals to distribute and deploy standardized care pathways across its provider base. This next-gen replacement for static and unwieldy guidelines and flowcharts is available via mobile app (iOS and Android) and desktop devices. The PoC App provides clinical information – guidelines, pathways, triaging elements – to providers in highly contextualized and usable formats. avoMD also offers the avoBuilder, an easy-to-use authorship tool that enables instant pathway customization and deployment. Current avoMD partners include leading academic medical centers and urgent care providers, while over 40,000 providers have downloaded the free version of the avoMD app. Recently, avoMD was accepted into Startup Health and 500 Startups, won the annual pitch competitions at Columbia and Penn Medicine, and received a large investment from Columbia University's endowment.
For more information, visit http://www.avomd.io.
Download the iOS App or Google Play App.
Follow avoMD on LinkedIn, Facebook, and Twitter



START your own Wordpress site, business or personal website, or online store at www.siteground.com

In this webinar, the featured speaker will explain how an innovative clinical supply process reduces the number of steps required, frees up employee time, eliminates supply carrying cost and waste, has fewer risks and saves money. Real-life case study data will be presented to demonstrate proven time and resource savings. The webinar will discuss how patient, site and sponsor burden can be reduced through direct-to-patient delivery of medication and supplies, as well as processes to reimburse sites for local sourcing and procedures through existing billing workflows.

TORONTO (PRWEB) OCTOBER 22, 2020
The FDA has challenged the clinical trial industry to make research more agile and effective, which, in turn, would streamline clinical development, reduce time to market and save money.
In this webinar, TrialCard will discuss a proven innovation that meets the FDA's challenge by adding agility, efficiency and speed to the clinical trial supply process, as well as to the process used to reimburse sites for local sourcing and for procedures performed as required by a trial protocol.
Join Tom Gottschalk, Senior Director of Business Development, TrialCard, for the live webinar on Monday, November 2, 2020 at 1pm EST (10am PST).
For more information or to register for this event, visit Reducing Clinical Trial Supply Workload in Decentralized and DTP Trials.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/



START your own Wordpress site, business or personal website, or online store at www.siteground.com

In this free webinar, the featured speaker will discuss the advantages and limitations of ICS and ELISpot for clinical trials and how to design ICS and ELISpot assays for maximal data gathering. Attendees will learn about critical development and validation approaches to consider with ICS and ELISpot assays to fulfill regulatory requirements.

TORONTO (PRWEB) OCTOBER 22, 2020
Efficacy in a vaccine trial is assessed through the production of protective antibodies against the infectious agent. Measurement of the neutralizing effect of these antibodies is performed through cell-based assays. Over the past years, additional assays have been introduced in vaccine trials in order to get a better understanding of the vaccine's mode of action on the immune system. These assays allow for the monitoring of T-cell responses in subjects upon vaccination, including the humoral response (supported by CD4 helper T cells) and the elimination of infected cells by CD8 cytotoxic T cells (cellular response).
Flow cytometry and multimer detection can be used to follow an antigen specific T-cell response and reveal a specific TCR. However, this method allows one to follow only one antigen and the functional state (effector/anergic) of the cells remains unknown. Given these limitations, most trials now employ ELISpot and ICS to reveal both the antigen-specificity and the functionality of the immune response induced by the treatment.
Performing both ELISpot and ICS assays requires a lot of starting material (PBMC isolated from whole blood), which might not be accessible. The question then arises: which method to use? ELISpot or ICS? On one hand, the ELISpot is commonly considered more sensitive than the ICS assay while requiring less amount of PBMC. On the other hand, the ICS allows for the measurement of cytokines as well as surface and intracellular markers to generate a more complete cellular profile but consumes more of the precious PBMC material.
Join Philippe Pouliot, PhD, Director Development Team (Immunology), Caprion Biosciences Inc. in a live webinar on Thursday, October 29, 2020 at 11am EDT (4pm BST/UK).
For more information or to register for this event, visit ICS and ELISpot for The Study of Cell Response: Choosing the Optimal Method in Immuno-Oncology or COVID-19 Vaccination Trials.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/



START your own Wordpress site, business or personal website, or online store at www.siteground.com

After more than a year of our dedicated congressional outreach, CAARE is proud to announce that The Humane Research and Testing Act of 2020 has been introduced by Representatives Alcee Hastings (D-FL) and Vern Buchanan (R- FL). If passed into law, the bill will establish the National Center for Alternatives to Animals in Research under the National Institutes of Health (NIH).

WASHINGTON (PRWEB) OCTOBER 22, 2020
A New York-based nonprofit group, CAARE, that led the drive to create legislation to promote "cutting-edge methods" of research superior to animal-based testing, today lauded the announcement that the "Humane Research and Testing Act of 2020" has been introduced in Congress.
Landmark bipartisan legislation to promote and fund scientifically advanced, human-relevant, non-animal methods through the establishment of a dedicated center under the National Institute of Health (NIH) was introduced here Tuesday (Oct. 20) by Congressional members Alcee Hastings (D-FL) and Vern Buchanan (R-FL).
Barbara Stagno, president of Citizens for Alternatives to Animal Research & Experimentation, commends the effort, noting: "CAARE is grateful to Representatives Hastings and Buchanan for introducing this legislation that has great promise to change the current paradigm of routine use of animals in laboratories when there are available alternatives, and gives real impetus to reducing animals by establishing a center exclusively for that purpose."
The "Humane Research and Testing Act of 2020" would create a "dedicated center under the National Institutes of Health (NIH) to provide resources, funding and training to advance humane, cost-effective, and scientifically suitable non-animal methods," Stagno added.
Because the exact number of animals used in U.S. research is unknown, ranging between 17 million and 100 million annually, the "Humane Research and Testing Act of 2020" is also designed to obtain that data, and requires the NIH to outline a plan for reducing those numbers.
Congressman Hastings, the leading sponsor points out: "As science and medicine advance, we have a better understanding of the relevancy and benefits of animal-based medical research and testing on human health outcomes. We are finding methods that can better predict human results without the needless suffering of animals. This legislation will not just reduce animal testing and research but will ultimately improve medical treatments for humans as they are developed from beginning to end primarily with test subjects that replicate human biology and physiology."
CAARE is excited that the bill has received many influential endorsements including the Jane Goodall Institute, Cruelty Free International, Vanda Pharmaceuticals and Dr. Donald Ingber MD, PhD, one of the pioneers in developing organs-on-chips, a game-changing technology for replacing animals.
"I have watched for decades as millions of animals have been used in experiments of every sort that have led to insufficient knowledge gained for human medicine," said Dr. Jane Goodall, DBE, Founder, the Jane Goodall Institute & UN Messenger of Peace. "We now have the opportunity to go in a more promising direction, based on modern knowledge and innovative technologies that open up a new humane pathway for research."
Dr. Don Ingber, chaired professor at Harvard's Medical and Engineering Schools and Founding Director of its Wyss Institute for Biologically Inspired Engineering expounds, "We are reaching a tipping point in the field of in vitro human emulation technologies where they are able to recapitulate human physiology and disease states, as well as response to drugs, radiation, and toxins. A new NIH Center focused on meeting this goal would benefit this field, save animal lives, and expedite the development of more effective and safer therapies."
Cruelty Free International is one of the world's longest standing and most respected animal protection organizations and has initiated and influenced legislation around the world to eliminate animal testing and advance humane science. Monica Engebretson, Cruelty Free International's Head of Public Affairs for North America said "The need for cost-effective and reliable tools for the development of medicines and treatments has led to a wealth of 'new approach methodologies' that focus on human biology and utilize modern technologies without the use of animals. Recent global events have highlighted the need for continued investment in these modern approaches to confront public health challenges."
Citizens for Alternatives to Animal Research & Experimentation is a national 501(c)(3) non-profit organization, established to highlight and promote research without animals. CAARE's mission is to reduce animal suffering by disseminating information about the power and progress of research without animals.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Certified Physician Assistant Brandi Hernandez, PA join U.S. Dermatology Partner's Nacogdoches, Texas location

NACOGDOCHES, TEXAS (PRWEB) OCTOBER 22, 2020
U.S. Dermatology Partners is pleased to welcome Certified Physician Assistant Brandi Hernandez to its Nacogdoches, Texas office.
Brandi grew up in Sabine County and has always had a passion for returning to practice medicine in rural East Texas. She graduated from Stephen F. Austin State University, with Summa Cum Laude honors, where she earned a Bachelor of Science degree in Psychology with a minor in Biology.
Brandi graduated from the University of Texas Medical Branch (UTMB) in Galveston with a Master of Science degree in Physician Assistant Studies, earning a 4.0 GPA. While at UTMB, Brandi served as President of her class and was consistently recognized for her academic achievement and leadership abilities. After graduation, Brandi returned to East Texas with her husband, where she practiced for two years in Primary Care, Urgent Care, and Emergency Medicine.
Brandi completed a comprehensive and extensive training program in dermatology under the direction of U.S. Dermatology Partners physician Dr. Jennifer Holman. She will treat patients in the Nacogdoches office alongside Michaela Overturf, MD. Thanks to her advanced studies and clinical experience, Brandi has the knowledge and skills to diagnose and treat a wide variety of dermatologic conditions. She enjoys establishing relationships with patients to customize treatment plans to their needs. Brandi strives to deliver a warm, caring bedside manner to all of her patients. Brandi Hernandez offers general dermatology services such as acne treatment, psoriasis, rosacea, eczema, to name a few.
"I chose to practice Dermatology because these conditions can greatly impact a person's quality of life. If I can help a patient reduce their anxiety, restore their confidence, and improve their overall well-being, then I can fulfill what it truly means to be a provider." said Brandi Hernandez, PA-C
Brandi and her husband recently completed a 2,200-mile thru-hike of the Appalachian Trail, from Georgia to Maine. They are thrilled to be returning to their home of Nacogdoches, and the natural beauty of the Pineywoods. In her spare time, Brandi enjoys hiking, backpacking, brewing beer, traveling, and spending time with her friends and family. To schedule an appointment call 936-585-7700.    
About U.S. Dermatology Partners Nacogdoches
Our Nacogdoches dermatologists deliver a lifetime of skin care from childhood to middle age to the golden years. We treat conditions like acne, psoriasis, and eczema to relieve or improve symptoms that limit your comfort, health, and enjoyment. We provide specialized, highly effective treatments for a variety of skin cancers to restore and extend the quality of your life. Led by Michaela Overturf, MD, the Nacogdoches office has been serving the skin care needs of Nacogdoches and Angelina county since 2015. Whether you suffer from pain, irritation, or embarrassment from a persistent skin condition or if you've noticed a suspicious new spot or mole, we can help.
About U.S. Dermatology Partners
As one of the largest physician-owned dermatology practices in the country, U.S. Dermatology Partners' patients not only have access to general medical, surgical, and cosmetic skin treatments through its coordinated care network, but also benefit from the practice's strong dermatology subspecialty thought leaders and medical advisory board. To be the best partners to its patients, U.S. Dermatology Partners is fervently focused on providing the highest level of patient-first care, and its team, therefore, includes recognized national leaders in areas such as clinical research, psoriasis, and Mohs Surgery. To learn more, visit usdermatologypartners.com.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

RCare's founder and president, Myron Kowal, is active in the Rochester community, and was impressed by the good work Open Door Mission is doing. "Among the many challenges that homeless people face, one of the biggest is communication, and having a permanent contact number that people can use to reach them," Kowal said. "It's important for people when they're looking for a job, and for housing, and for receiving the services to help them get back on their feet. When I heard about this need, I knew we had to help."

ROCHESTER, N.Y. (PRWEB) OCTOBER 22, 2020
RCare, Inc., maker of wired and wireless nurse call systems, has made a generous donation to Open Door Mission, a Rochester-based organization serving the homeless population.
RCare's founder and president, Myron Kowal, is active in the Rochester community, and was impressed by the good work Open Door Mission is doing. "Among the many challenges that homeless people face, one of the biggest is communication, and having a permanent contact number that people can use to reach them," Kowal said. "It's important for people when they're looking for a job, and for housing, and for receiving the services to help them get back on their feet. When I heard about this need, I knew we had to help."
The donated phones are the RPhone model that RCare uses for its award-winning caregiving app, RCare Mobile. The durable phones are designed to be drop-proof and water-proof, and they have a long battery life. "We figured those same features that make this phone work so well for caregivers on the job will make them work great for the clients of Open Door Mission," said Kowal.
RCare Mobile is a caregiving app for nursing homes and senior living communities. It provides detailed information about each patient call, to help caregivers be better prepared when answering each call. The "I got it" button lets caregivers claim calls, ensuring each call is answered, and preventing the inefficiency of multiple caregivers responding to the same call. It also silences alerts for calls that have been claimed, which makes for a more pleasant living and working environment.
"Everyone needs contact with the outside world," said Chuck Brady, Shelter Manager with Open Door Mission. "Cell phones help people stay in contact with their family members, make appointments, or whatever they have to do. Gone are the days of pay phones, so these cell phones will really help."
About RCare
RCare is a global provider of nurse call and personal emergency response systems for the entire spectrum of eldercare and senior living. Our components integrate into a variety of healthcare communication systems to create efficient and verifiable responses to medical emergencies. RCare works together with distribution partners to build individualized, flexible and seamless systems to enhance both caregiving and resident quality of life. Contact info@rcareinc.com or call 585-671-4144.
About Open Door Mission
Established in 1952, the Open Door Mission is a 501(c)(3) non-profit Christian rescue mission founded to provide for the spiritual and physical needs of impoverished and homeless men, women and children of Rochester, NY by restoring hope and changing lives. Open Door Mission services include food, clothing and shelter, as well as addiction recovery support. For media inquiries and speaking engagements, contact Anna Valeria-Iseman aviseman@opendoormission.com or call 585-322-5489. http://www.opendoormission.com



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Giving Adult Eczema the Attention It Deserves.

FRANKLIN SQUARE, N.Y. (PRWEB) OCTOBER 22, 2020
Online advice for the maddeningly itchy skin condition atopic dermatitis often tells parents how to help their children. "Atopic dermatitis may appear to be a childhood ailment," notes Christopher Byrne, a certified registered physician's assistant specializing in dermatology with Advanced Dermatology PC. "In fact, millions of adults contend with this very difficult condition."
"While AD usually starts during childhood," says Byrne, "as many as fifty percent see symptoms persist into adulthood. And some have their first episode as an adult."
AD is the most common of the group of inflammatory skin conditions called 'eczema.' Research continues on its causes. Genes and environmental factors – allergens, stress, irritants – seem to trigger an immune system misfire that results in inflamed, extremely itchy skin. Left untreated, AD can lead to infections and lichenification – permanently thickened, constantly itchy skin.
"AD," explains Byrne, "damages our skin's top layer – the stratum corneum. This can create chronic problems with keeping moisture in and pathogens out."
"In the U.S.," continues Byrne, "more than seven percent of adults – over sixteen million – grapple with AD. Severe flare-ups are torturous: incessant itching that interferes with sleep and leads to damaging scratching; pain; embarrassment due to its red, scaly, weepy appearance. Unmanaged, AD can disrupt professional and personal lives – impacting job performance and intimate relationships. Adults who suffer from AD have higher rates of anxiety and depression."
Atopic dermatitis is not contagious, but its incidence is increasing. "Numbers have surged," observes Byrne. "Fortunately, we have a range of treatments to help adults control symptoms."
With this in mind, Byrne suggests the following:
Five Tips for Managing Adult Atopic Dermatitis
1. Avoid your triggers: "We want to keep flares tamped down," notes Byrne. "Working with your dermatologist, you can identify triggers. Patients have different responses to environmental factors such as detergents or product additives."
2. Build up your skin's protective barrier: "Keeping your skin moisturized," emphasizes Byrne, "helps prevent the 'itch-scratch' cycle. The catch phrase is 'Soak and Seal' because the best way to moisturize is by capturing the water on damp skin. This needs to be done carefully: baths or showers should be lukewarm, lasting about ten minutes. Cleansing must be gentle, with neutral to low-pH products, and no scrubbing. Timing is critical: an ointment or cream moisturizer should be applied within three minutes. Waiting longer will allow moisture to evaporate from our skin, leading to dryness."
3. Choose the right moisturizer: "Especially now," says Byrne, "when we're all washing our hands more due to COVID-19, effective moisturizing is essential. Lotions can dry skin out due to their high-water content, which evaporates. The higher the product's oil content, the more protective it will be. Thick ointments like petroleum jelly work well. Your dermatologist can help you find a product that you like. And the National Eczema Association's website has a 'Seal of Acceptance' list of products. Consistency is also a must: every time after your skin gets wet, which means moisturizer at every sink and a to-go tube when leaving the house. Using 'more' is key. If it feels tacky, that's OK; it will absorb within minutes."
4. Talk to your specialist about treatments: "Adult AD often requires ongoing maintenance therapy," notes Byrne. "Your dermatologist can explain different options. These include topical products, such as corticosteroids, topical calcineurin inhibitors (TCIs), and PDE4 inhibitors, all of which decrease inflammation. Your skin specialist can also explain other approaches, such as narrow-band UVB light therapy, as well as the latest 'biologic' therapies, which genetically target the proteins involved with AD. It's important to work with a specialist who can explain treatment timeframes, outcomes, and side effects, as well as those that are indicated for short-term use versus ongoing maintenance."    
5. Stay with the program: "Once a patient has an effective maintenance program," says Byrne, "they'll want to stick with it. Adult AD typically needs ongoing support to prevent reoccurrence."
"Addressing adult atopic dermatitis," concludes Byrne, "is not child's play. But for the millions who have the condition, a partnership with a trusted skin specialist can lead to lasting relief."
Bio: Christopher Byrne RPA-C is a certified physician assistant with Advanced Dermatology PC.
Advanced Dermatology P.C. and the Center for Laser and Cosmetic Surgery (New York & New Jersey) is one of the leading dermatology centers in the nation, offering highly experienced physicians in the fields of cosmetic and laser dermatology as well as plastic surgery and state-of-the-art medical technologies. http://www.advanceddermatologypc.com.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Addition of key staff members expands sales, marketing, client services, and product development teams.

LOUISVILLE, KY. (PRWEB) OCTOBER 22, 2020
SentryHealth, an industry leader in workplace health and well-being management, announced exponential growth in staffing going into the fourth quarter of 2020.
This year, additional staff members have been added to the SentryHealth team to grow and support its strong product development, client services, marketing, and sales efforts. "With extensive backgrounds in health care product development, client services, business development, and marketing, the depth and breadth of our team enables us to keep our core mission top of mind: to improve wellness and health care quality while better managing costs," remarked J. Kevin Porter, SentryHealth CEO.
In addition, SentryHealth welcomed three new members in senior leadership roles.
Michelle Fox, MBA joined SentryHealth as Senior Vice President, Business Development. Fox is a business development leader with extensive senior-level experience in sales, most recently serving as Executive Vice President of Sales for National HME. At SentryHealth, she's responsible for developing strategic business partnerships and driving new revenue sources for the WellOnMyWay health and wellness solution.
John Rainsberger also joined SentryHealth as Senior Vice President, Business Development. Rainsberger has more than 30 years' experience in sales and marketing, previously working for IBM, Banyan Technology, and most recently Giant Eagle Specialty Pharmacy as National Sales Director. Rainsberger is currently responsible for accelerating the growth and profitability of WellOnMyWay through strategic business development.
Adrianne Dubins has been appointed Senior Vice President, Product Marketing. Dubins has spent more than 20 years in health care product and release management. She most recently served as Product Manager for CRM Service at Humana. In her role at SentryHealth, Dubins defines the vision, strategy, and innovation of SentryHealth products, including WellOnMyWay.
"I'm excited about how far we've come in such a short period of time and I look forward to our continued growth into the new year as we continue to redefine what effective well-being management means for employers, providers, and their members," Porter said.

"I'm excited about how far we've come in such a short period of time and I look forward to our continued growth into the new year, as we continue to redefine what effective well-being management means for employers, providers, and their members."



START your own Wordpress site, business or personal website, or online store at www.siteground.com

The American Society of Plastic Surgeons (ASPS), the world's largest organization of board-certified plastic surgeons, named Joseph E. Losee, MD, FACS, FAAP, as its new president. Dr. Losee took office at Plastic Surgery The Meeting, the Society's annual scientific meeting, on Sunday, October 18, 2020 and will serve for one year.

ARLINGTON HEIGHTS, ILL. (PRWEB) OCTOBER 22, 2020
The American Society of Plastic Surgeons (ASPS), the world's largest organization of board-certified plastic surgeons, named Joseph E. Losee, MD, FACS, FAAP, as its new president. Dr. Losee took office at Plastic Surgery The Meeting, the Society's annual scientific meeting, on Sunday, October 18, 2020 and will serve for one year.
"I'm honored to lead the world's largest organization of board-certified plastic surgeons," Dr. Losee said. "Plastic surgery is the specialty of innovation, and I look forward to advancing patient care and member services in new and inventive ways as we confront these very uncertain and challenging times."
Dr. Losee is the Ross H. Musgrave Endowed Professor of Pediatric Plastic Surgery and Executive Vice Chair of the Department of Plastic Surgery at the University of Pittsburgh Medical Center. He served as the university's Residency Program Director for more than a decade. He is Chief of the Division of Pediatric Plastic Surgery at the UPMC Children's Hospital of Pittsburgh and serves as the Associate Dean of Faculty Affairs and an Advisory Dean of Students at the University of Pittsburgh School of Medicine.
Prior to his presidential term, Dr. Losee served as the ASPS Vice President of Education. He is past president of the American Council of Academic Plastic Surgeons, American Society of Craniofacial Surgeons, Northeastern Society of Plastic Surgeons, Robert H. Ivy Society, Ohio Valley Society of Plastic Surgeons and the American Society of Pediatric Plastic Surgery. He sits on numerous boards of directors of national societies within academic plastic surgery, including the American Society of Maxillofacial Surgery. For seven years, he served as a Director of the American Board of Plastic Surgery and as Chair of the Board in his final year.
Dr. Losee edited six textbooks, including Comprehensive Cleft Care, the authoritative text on cleft surgery in its second edition, and Pediatric Plastic Surgery, of the multi-volume Plastic Surgery text. He has authored more than 200 peer-reviewed articles and 45 book chapters. He has also performed scientific and clinical research funded by the National Institutes of Health and the Department of Defense that focused on bone and suture regulation, cranial defects in infants and the treatment of ear disease in cleft palate patients. Dr. Losee has been an invited speaker at numerous meetings and a visiting professor at more than 40 universities around the world.
Dr. Losee graduated AOA from the University of Rochester School of Medicine and Dentistry in 1994. He completed a residency in plastic surgery at the University of Rochester and a Fellowship in Craniofacial Surgery at the Children's Hospital of Philadelphia, University of Pennsylvania. He is a Fellow of the American College of Surgeons and the American Academy of Pediatrics.
About ASPS
The American Society of Plastic Surgeons (ASPS) is the world's largest organization of board-certified plastic surgeons. Representing more than 8,000 member surgeons, the Society is recognized as a leading authority and information source on aesthetic and reconstructive plastic surgery. ASPS comprises more than 93 percent of all board-certified plastic surgeons in the United States. Founded in 1931, the Society represents physicians certified by The American Board of Plastic Surgery or The Royal College of Physicians and Surgeons of Canada. ASPS advances quality care to plastic surgery patients by encouraging high standards of training, ethics, physician practice and research in plastic surgery.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

In an ongoing series called "The Krush Brain Game", Jeff Krushell talks with leading experts and industry insiders about the role of the brain in human performance and the methods and technologies that are being used with professional and elite athletes.

MONTREAL (PRWEB) OCTOBER 22, 2020
Podcaster and performance consultant, Jeff Krushell, has just released the fourth episode in his podcast series "The Krush Brain Game" in which he explores the brain body connection as it relates to optimal performance.
His belief is that, "We have come a long way in our understanding of human performance but when we look to the future, we feel, it will be new technologies and our understanding of the brain that will push human performance to new heights."
In the latest installment of the podcast, Jeff sits down with Lucas Borgo, Product Manager at Thought Technology Ltd. who is also a key figure in the development of new apps and software. The company's products have been used by Olympic and professional athletes and other high performers for decades. According to Lucas, "The use of physiological monitoring equipment can be a real game changer for both the athlete and the trainer. When you are able to see your body's physiological reaction to stress, you can more easily learn to control this reaction and be confident that the techniques you are using are having the desired effect."
Included in this ongoing series, are interviews with several influential people from the biofeedback field including: Lawrence Klein, VP and Founder of Thought Technology, Ltd.; Dr. Erik Peper, psychologist, author and president of the Biofeedback Federation of Europe; Dr. Inna Khazan who combines the use of biofeedback and mindfulness; and Dr. Leah Lagos whose focus is on HRV training for athletes and peak performers.
Click here to listen to Jeff Krushell's interview with Luke Borgo.
About Jeff Krushell
Jeff Krushell is the founder of Krush Performance and an Athlete Development Specialist & Organizational Performance Consultant. He is regarded as a noted expert in the area of talent development in sport and through his work has gained unique insights into the process of improving performance.
Over the last 25 years Jeff has worked in the world of high-performance sport helping athletes tap into their potential to truly understand what it is like to achieve Human Maximum Performance. Jeff currently consults for Major League Baseball International; CTV News, Edmonton; Vauxhall Baseball Academy; Link Management and has previously worked as the strength and conditioning coach for both the Toronto Blue Jays and Edmonton Eskimos.
About Thought Technology Ltd.
Founded in 1975, Thought Technology is the world's leading biofeedback and physiological instrument manufacturer. Its products are used as an essential part of many therapeutic treatments and clinical assessment protocols in over 85 countries and are used by tens of thousands of clinicians in thousands of medical institutions.
Always supportive of new research and development ideas, Thought Technology Ltd. has encouraged a number of special interest groups and clinicians to create cutting edge applications for its instrumentation. Thought Technology Ltd. equipment is now being used in telemedicine, web-based monitoring and biofeedback, sports training, research in human-machine interface, physiology-driven multimedia environments and virtual reality. Constantly striving to improve the quality of the products and services, TTL has obtained, and maintains, ISO 13485, and CE certification for the organization and products.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

One study is featured at the Infectious Disease Society of America (IDSA) IDWeek virtual meeting. Two studies to be featured at the upcoming American College of Emergency Physicians (ACEP20) virtual annual meeting.

SAN DIEGO (PRWEB) OCTOBER 22, 2020
AseptiScope Inc., a privately funded San Diego, California based clinical innovation company announced today that a study describing the challenge of stethoscope hygiene practices and two studies supporting the use of aseptic disk covers to protect patients from exposure to pathogens on the stethoscope diaphragm are featured at medical conferences in October.
Dr. Frank Peacock, a co-founder of AseptiScope and a co-author of the study featured at the IDSA entitled Effectiveness of Aseptic Stethoscope Barriers in Allowing Clean Contact for Clostridioides Difficile-Contaminated Stethoscope, commented "this important study builds on a body of data supporting the use of aseptic disk covers to protect patients from exposure to pathogens on the stethoscope. By now demonstrating that disk covers are an effective barrier against alcohol-resistant C. difficile spores, we have established the relevance of our solution against one of the most prominent and challenging drug-resistant superbugs that healthcare faces today," Dr. Peacock added.
"We are pleased to see these two prestigious congresses focus on the longstanding challenge of stethoscope hygiene," said Scott Mader the CEO and co-founder of AseptiScope. "The findings further substantiate the stethoscope contamination challenge while supporting the use and effectiveness of touch-free, aseptic, single-use stethoscope disk covers. With the upcoming launch of our flagship product, The DiskCover System, we look forward to bringing important innovation to this market," he added.
The details of the data presentations are as follows:
Infectious Disease Society of America IDWeek Virtual Meeting (https://idweek.org)
Poster Name: Effectiveness of Aseptic Stethoscope Barriers in Allowing Clean Contact for Clostridioides Difficile-Contaminated Stethoscope
Poster Session: HAI: Disinfection/Sterilization & Environmental Infection Prevention
Poster Number: 816
Presenter: Rajiv S. Vasudevan, BS
Date: On-Demand as of 21 October 2021
American College of Emergency Physicians Annual Meeting ACEP20 (https://www.acep.org/sa/)
Poster Name: Stethoscope Cleaning Practices and Knowledge Amongst Healthcare Providers
Track: Research
Poster Number: 255
Presenter: Sarathi Kalra, MD
Date: On-Demand as of 26 October 2020
Poster Name: Are Stethoscopes and Infection Control Enemies?
Track: Research
Poster Number: 257
Presenter: Sarathi Kalra, MD
Date: On-Demand as of 26 October 2020
About AseptiScope, Inc.
AseptiScope, formed in early 2016, is a privately funded San Diego, California based, clinical innovation company. The company is founded and led by clinical innovation experts, leading medical researchers and practicing physicians. The AseptiScope mission is to design, develop, manufacture and commercialize novel solutions that ensure "Infection Protection for Clinician & Patient." The company will introduce the first true and practical solution for the longstanding challenge of stethoscope contamination in autumn of 2020: The DiskCover System. Visit https://aseptiscope.com for more information.
AseptiScope, DiskCover, and related logos are trademarks of AseptiScope, Inc.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Crowley Solutions has expanded its pandemic response capabilities to meet the needs of small-scale government users, including local school districts, for personal protective equipment (PPE), such as certified high quality masks.

JACKSONVILLE, FLA. (PRWEB) OCTOBER 22, 2020
Crowley Solutions has expanded its pandemic response capabilities to meet the needs of small-scale government users, including local school districts, for personal protective equipment (PPE), such as certified high quality masks.
Crowley is now providing end-to-end supply chain solutions to the military and government agencies – both large and small – placing multi-million-unit orders of masks, gloves and other PPE. To ensure the high-quality, high-demand and NIOSH-approved N95 masks reach government agencies, Crowley safely and completely manages necessary logistics services including sourcing, purchasing, certifying (FDA/CDRH), transporting, customs clearance and delivery.
The company is also scaling PPE services to aid lower-volume government requests. This includes recently supporting two school districts with sourcing, procurement and delivery of certified N95 masks for the Texarkana Arkansas School District and the West York Area School District (Pa.).
"Like many districts across the state of Arkansas and the nation, one of the Texarkana Arkansas School District goals was to continue to provide a high-quality education to our students in the safest environment possible. Working with Crowley helped us reach that goal," said Dr. Genia Bullock, the district's director of public relations.
By working with Crowley's national network of transportation and operations specialists, the districts received hands-on visibility and tracking of their boxed shipments through independent carriers.
Crowley Solutions is a leading provider of energy, maritime, supply chain and technology services for governments. To learn more about Crowley's pandemic response services, including PPE procurement and supply chain services, visit http://www.crowley.com/covid19-support/.
About Crowley
Jacksonville-based Crowley Holdings Inc., a holding company of the 128-year-old Crowley Maritime Corporation, is a privately held family- and employee-owned company that provides worldwide logistics, government, marine and energy solutions. Crowley operates with four business units. Crowley Logistics is a full-service end-to end supply chain and managed transportation division that also includes ocean liner cargo services utilizing some company-owned vessels. Crowley Shipping encompasses ownership, operations and management of conventional and dual-fuel (liquefied natural gas) vessels, including tankers, container ships, multipurpose vessels, tugboats and barges; engineering, project management and naval architecture; and Crowley LNG, which provides LNG distribution, engineering and related services. Crowley Fuels provides petroleum transportation, distribution and sales primarily throughout Alaska. Crowley Solutions focuses on global government services and program management, government ship management, expeditionary logistics and government-oriented freight transportation services. Additional information about Crowley, its subsidiaries and business units may be found at http://www.crowley.com.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

ComplianceSigns.com, a leading manufacturer of regulatory-compliant safety signs and labels, announces its creation of a free voting center guide with COVID-19 safety tips for voting center administrators to help keep poll workers and voters safe from the coronavirus this election season.

CHADWICK, ILL. (PRWEB) OCTOBER 22, 2020
ComplianceSigns.com, a leading manufacturer of regulatory-compliant safety signs and labels, announces its creation of a free voting center guide with COVID-19 safety tips for voting center administrators to help keep poll workers and voters safe from the coronavirus this election season.
Because of safety regulations established for the Nov. 3 election, polling places are required to follow the protocol from the Centers for Disease Prevention and Control (CDC), which includes facemasks, social distancing, and other protective measures designed to help stop the spread of airborne germs.
The free guide, COVID-19 Safety Tips for Voting Centers, addresses CDC recommendations for safe polling activities, as well as:

5 key COVID-19 safety tips for voting centers to consider before Election Day

CDC guidelines for posting recommended signage

A checklist of recommended safety materials

and more

The guide can be downloaded here:
https://www.compliancesigns.com/safevote
CDC guidelines specify signs promoting best practices for public health and safety in key areas of all polling places. ComplianceSigns.com has developed dozens of durable and bright signs, floor markers and other items that offer guidance and instruction to help combat COVID-19 at the polls this fall. They include:

Entrance door labels

Directional and social distance floor markers

Sneeze guards

Social distance signs

Mobile partitions

Barricade tape

Facemask signs

Disposable mats

Countertop signs

Max capacity signs

Hand wash signs

Hand washing instruction signs

"As poll workers handle a daily rush of voters this election season, it is more important than ever to keep people socially distant, wearing facemasks and keep areas clean. We created the voting safety tips guide to share key safety information with voting center administrators and help protect voters and poll workers," said Douglas Stang, head of e-commerce for ComplianceSigns.com.
The company also created a special website, ComplianceSigns.com/coronavirus, as a one-stop-shop for helpful coronavirus information and products. Options include custom signs, floor labels, banners, barricades and signs related to coronavirus safety.
"Workplace safety is our main focus, and COVID-19 is a serious threat to workplace safety," said Stang. "We want to help keep people safe and prevent this deadly virus from spreading."
About ComplianceSigns.com:
ComplianceSigns.com is a leading manufacturer of regulatory-compliant safety signs and labels, parking signs, no smoking labels, Braille restroom signs and a wide variety of other workplace identification signage. The company sells its products exclusively online and all products are manufactured at its plant in Chadwick, Illinois.
https://www.compliancesigns.com
###

"We created the voting safety tips guide to share key safety information with voting center administrators and help protect voters and poll workers."



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Raising awareness to Drive Out Breast Cancer

HUNTINGTON, N.Y. (PRWEB) OCTOBER 22, 2020
The United Breast Cancer Foundation and JJ Yeley of Rick Ware Racing partnered to raise breast cancer awareness for the NASCAR community at the Hollywood Casino 400 on Sunday, October 18th, at the Kansas Speedway.
The Hollywood Casino 400 is a 400.5-mile NASCAR Cup Series stock car race and is the seventh of ten races in the Cup Series playoffs. JJ Yeley drove car #27 in a full wrap featuring UBCF's logo and vibrant pink and blue colors making it pop from anywhere in the stands. Yeley held the 34th starting position.
It was a cold and windy October day with temperatures in the mid 40s but all in attendance dressed warm and had a wonderful time! Thankfully, the race was without incident with no car crashes. Joey Logano and Kevin Harvick battled for 40 laps with Logano eventually taking the checkered flag for the win.
Yeley gained four spots finishing in 30th place. Yeley stayed after the race, " We had a positive finish for a day that started out a little on the rough side. It's wonderful having the United Breast Cancer Foundation on my Rick Ware racing Chevrolet, which was a new car that we had not run previously this year. I dealt with some handling issues in the early part of the race that cost us some valuable track position. I was hoping for more but a top 30 finish was still a positive result."
This coming Sunday, UBCF will again make an appearance on Yeley's car #27 in the Autotrader EchoPark Automotive 500 at Texas Motor Speedway. The race starts at 3:30 pm EST and can be watched on NBC Sports. Casper's Ice Cream, the title sponsor for this weekend's race, has generously donated a portion of the car to UBCF - together we can Drive Out Breast Cancer!
United Breast Cancer Foundation Executive Director, Ms. Stephanie Mastroianni shared, "UBCF is embracing our partnerships with JJ Yeley behind the wheel and the Rick Ware Racing team, as we rally for breast cancer patients and survivors in our communities. Casper's Ice Cream has generously included UBCF, coming off the Hollywood Casino 400, with our logo placement on car #27 for the Autotrader EchoPark Automotive 500 at the Texas Motor speedway race this Sunday. The NASCAR community truly is a family, and its sponsors recognize the importance and need to raise awareness about breast cancer.
UBCF's mission is to make a positive difference in the lives of those affected by breast cancer. Seven programs are offered to women, men and families nationwide. While rare, men can develop breast cancer too. UBCF encourages women and men to learn the self-breast exam (available for free) and talk to your medical provider if you detect anything abnormal, early detection saves lives.
About UBCF
UBCF is committed to offering breast health and wellness services focused on cancer prevention, screening, treatment and overall wellness. UBCF's mission is to make a positive difference in the lives of those affected by breast cancer and carries it out through seven life-supporting patient and family programs available to women, men and families nation-wide. UBCF never denies services to anyone regardless of age, race, gender, ethnicity, income or medical insurance coverage. Tax-deductible contributions may be made towards UBCF's programs. UBCF accepts vehicle and property donations as well. Combined Federal Campaign #77934. https://www.ubcf.org

The United Breast Cancer Foundation and JJ Yeley of Rick Ware Racing partner to raise breast cancer awareness for the NASCAR community



START your own Wordpress site, business or personal website, or online store at www.siteground.com

In fall 2020, the SON opened an additional state-of-the-art clinical simulation lab. The School's Simulated Learning Center (SLC) now includes three labs that span nearly 5,700 square feet on the second and third floor of Alumni Hall. The new lab space on the third floor includes an advanced simulated operating room, high-fidelity hospital simulation room, two simulation skill classrooms and a new debriefing room.

EDWARDSVILLE, ILL. (PRWEB) OCTOBER 22, 2020
As the Southern Illinois University Edwardsville School of Nursing's (SON) continues to experience rapid enrollment growth, it is expanding and enhancing its clinical simulation learning opportunities for future nurses.
In fall 2020, the SON opened an additional state-of-the-art clinical simulation lab. The School's Simulated Learning Center (SLC) now includes three labs that span nearly 5,700 square feet on the second and third floor of Alumni Hall. The new lab space on the third floor includes an advanced simulated operating room, high-fidelity hospital simulation room, two simulation skill classrooms and a new debriefing room.
The SLC offers undergraduate and graduate nursing students the realistic primary and advance practice simulation experiences they need to provide high-tech, high-quality patient care.
"The current COVID-19 pandemic increased the urgency for the School to explore alternative learning modalities that are evidence-based, cutting-edge and creative in an effort to continue to elevate our educational programs in nursing," said Kevin Stein, DNP, program director and assistant professor of the nurse anesthesia program.
"Through high-fidelity simulations designed by our faculty, students will be able to transfer the theoretical knowledge they learn in the classroom into clinical practice in a safe and controlled environment," Stein said. "This will enhance student confidence and prepare them for hands-on patient care throughout central and southern Illinois communities."
The SLC will be relocated to the University's Health Sciences Building upon the new facility's completion.
In fall 2020, the SON achieved a record enrollment of 1,877 students. With a 5% increase from fall 2019, the SON saw record enrollment for the second consecutive year.
The SIUE School of Nursing's programs are committed to creating excellence in nursing leadership through innovative teaching, evidence-based practice, quality research, patient advocacy and community service. Enrolling nearly 1,900 students in its baccalaureate, master's and doctoral programs, the School develops leaders in pursuit of shaping the nursing profession and impacting the health care environment. SIUE's undergraduate nursing programs help to solve the region's shortage of baccalaureate-prepared nurses and enhance the quality of nursing practice within all patient service venues. The School's graduate programs prepare nurses for advanced roles in clinical practice, administration and education.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Compliancy Group has added OSHA compliance to its offerings for small to mid-sized medical and dental practices. Enabling OSHA services will provide clients with a centralized location to manage both their HIPAA and OSHA compliance and employee training, streamlining the compliance process for clients.

HUNTINGTON, N.Y. (PRWEB) OCTOBER 22, 2020
Compliancy Group, the industry leader in simplifying HIPAA compliance, has applied its proven proprietary methodology, Achieve, Illustrate, Maintain, to OSHA medical and dental compliance.
Not all safety issues apply to the medical field. This is why Compliancy Group has created an OSHA manual specifically for small to mid-sized medical and dental practices. Compliancy Group's OSHA manual and OSHA training module are built into their compliance software. Their proprietary methodology verifies and validates clients' compliance through documentation stored within their compliance software. By utilizing Compliancy Group's software to train employees, administrators can track employee training to ensure that all employees complete their training in a timely manner. As always, Compliance Coaches guide clients through compliance and answer any questions that may arise.
The Occupational Safety and Health Act (OSHA) regulates employers, requiring employers to minimize potential safety and health hazards in the workplace. As such, all employers are required to implement an OSHA manual to minimize workplace hazards and increase employee safety.
In addition, part of OSHA compliance requires employees to be trained on OSHA safety standards and their organization's OSHA manual. Employee training ensures that employees are aware of potential hazards in their workplace, while minimizing employee risk as they are taught how to work safely in their work environment.
By adding OSHA compliance to its offerings, Compliancy Group's clients have the ability to manage their HIPAA and OSHA compliance, and train employees, from one centralized location.
Why use Compliancy Group for your HIPAA and OSHA Needs?

One solution for multiple compliance efforts

Proven compliance methodology

Designed for healthcare organizations, medical, and dental practices

Single login for HIPAA & OSHA

Centralized employee training

Keep up to date with OSHA and HIPAA requirements

Compliancy Group OSHA Resources:
How to Become OSHA Compliant
OSHA Privacy Policy
Compliance Training
About Compliancy Group:
Compliance should be simple. That's why Compliancy Group is the only HIPAA and OSHA software with expert Compliance Coaches holding your hand to simplify compliance. Listed on Inc. 2020 Best Places to Work and 2020 Inc. 5000 list of the fastest-growing private companies in America, you can be confident that you will receive the best possible customer service. Having dedicated employees that care about their work means that they care about your success. Compliancy Group gives you peace of mind in your compliance plan reducing risk, increasing patient loyalty, and profitability of your organization.
Visit http://www.compliancy-group.com or call 855.854.4722 to learn how simple compliance can be.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

World Wildlife Fund features DuPont Nutrition & Biosciences case study to support responsible palm oil

COPENHAGEN, DENMARK (PRWEB) OCTOBER 22, 2020
As part of its campaign to advance the responsible production of palm oil, the World Wildlife Fund (WWF) recently published over 30 case studies documenting industry efforts to transition to 100 percent sustainable palm oil. The DuPont Nutrition & Biosciences (DuPont N&B) business was featured as a case study contributing to WWF's mission.
Recently, the need for sustainable palm oil has become increasingly critical, as demand for vegetable oils – particularly palm oil - continues to grow. In 2019, The Roundtable on Sustainable Palm Oil (RSPO) certified palm oil volume increased by 13 percent.
Since 2004, DuPont N&B has been an industry leader in developing sustainable solutions to palm oil production. DuPont N&B was the first ingredient manufacturer to join RSPO and has since advocated for inclusive collaborations to transform the palm oil industry. By highlighting DuPont N&B's efforts, the WWF aims to inspire the collective action required for responsible palm oil production, trade, and consumption.
In line with the WWF's vision for the responsible production of palm oil, DuPont N&B achieved an industry first in 2017 with its offer of 100% RSPO certified palm-based emulsifiers globally, using a combination of Book & Claim, Mass Balance and Segregated.
DuPont N&B is now working towards its 2025 goal of achieving 100 percent physical certified sustainable palm of grade Mass Balance or above, alongside the phasing out of RSPO credits globally. In 2020, DuPont N&B achieved a key milestone by sourcing 100 percent physical RSPO certified palm oil and derivatives for its emulsifiers produced in Europe and North America.
In addition to sourcing certified raw materials, DuPont N&B has achieved significant progress in developing transparent and responsible supply chains, striving for 100% traceability to the mill within the next five years and implementing supplier scorecards.
Last month's discussions at the Sustainable Palm Oil Dialogue Europe reinforced the power of collective action to achieve 100 percent RSPO in the European market. This message has been endorsed on the world stage through public calls for companies to further improve their global supply chains.
The RSPO, a global multi-stakeholder initiative, is the driving force behind responsible palm oil supply chains. RSPO is a full ISEAL member and has the vision to "transform the markets by making sustainable palm oil the norm."
A recent life cycle assessment conducted by 2.-0 LCA Consultants published in the Journal Of Cleaner Production, showed that the carbon footprint of RSPO certified palm oil is 35% smaller than conventional palm oil. In choosing RSPO certified palm oil, companies can make a big dent in their upstream greenhouse gas emissions, which can be a key lever for companies whose climate goals are aligned with the Science Based Target initiative (SBTi).
DuPont N&B has joined with over 560 other companies as signatories of the Business for Nature's Call To Action. This collective is calling on governments around the world to adopt policies to reverse nature loss in the next ten years.
"We are extremely proud of our long-standing collaboration with RSPO, and the achievements we have made in leading the industry towards more sustainable palm oil," said Mikkel Thrane, Global Sustainability Leader at DuPont Nutrition & Biosciences. "It's fantastic to be featured as a case study by the WWF for our work in this field and we hope that our story will encourage the inclusive collaborations necessary for transforming palm oil supply chains across the globe."
###
More information about DuPont N&B's approach to sustainable palm oil can be found in the recent Palm Oil Score Card Report by WWF, in which the company is featured as a case study.
About DuPont Nutrition & Biosciences
DuPont Nutrition & Biosciences applies expert science to advance market-driven, healthy and sustainable solutions for the food, beverage, dietary supplement and pharmaceutical industries. We also use cutting-edge biotechnology across a range of markets to advance bio-based solutions to meet the needs of a growing population, while protecting our environment for future generations. We are innovative solvers who help our customers turn challenges into high-value business opportunities. For more information: http://www.dupontnutritionandbiosciences.com.
About DuPont
DuPont (NYSE: DD) is a global innovation leader with technology-based materials, ingredients and solutions that help transform industries and everyday life. Our employees apply diverse science and expertise to help customers advance their best ideas and deliver essential innovations in key markets including electronics, transportation, construction, water, health and wellness, food, and worker safety. More information can be found at http://www.dupont.com. Investors can access information included on the Investor Relations section of the website at investors.dupont.com.
# # #
10/22/2020
DuPont, the DuPont Oval Logo, and all trademarks and service marks denoted with , SM or are owned by affiliates of DuPont de Nemours, Inc. unless otherwise noted.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Introduced legislation (HR 8450) would make masks, surface disinfectants and hand sanitizer eligible for purchase with tax-free healthcare dollars

NEW YORK (PRWEB) OCTOBER 22, 2020
For more than 70 million Americans, flexible spending accounts (FSAs) and health savings accounts (HSAs) help pay for everyday health care costs like doctor visits and co-payments, surprise medical bills, and thousands of qualified medical products that consumers use every day. These pre-tax funded accounts have become even more vital this year, as account holders have turned to their FSAs and HSAs to help cover the costs of medical services and COVID-19 virus preparedness items like thermometers, oximeters, and more.
Unfortunately, when these same Americans tried to use their FSAs and HSAs to cover the costs of masks, surface disinfectants and hand sanitizer — recommended by the U.S. Centers for Disease Control and Prevention (CDC) as part of their guidelines for stopping the spread of COVID-19 — they were shocked to find that these products were not eligible. That's because today, PPE is not formally deemed a qualified "medical care" expense under an FSA or HSA by the IRS.
Thankfully, legislators in Washington have responded to those concerns and introduced HR 8450, sponsored by Representative John Curtis (R-UT-3), which would allow for PPE to be FSA/HSA eligible. If passed, this change will last until the end of the year in which the current state of emergency ends. For example, if the public health emergency ends in November 2020, PPE would be eligible until December 31, 2020. If it ends at any time in 2021, 2022, or a later year, it would be eligible through December 31 of that respective year.
To drive support for this legislation and ensure that American families can use their tax-free funds to cover the costs of necessary medical essentials like PPE, Health-E Commerce, the parent brand of e-commerce destinations FSAstore.com and HSAstore.com, has launched an online petition and a new FSA/HSA consumer advocacy site called TaxFreeBetter.com, and is encouraging FSA and HSA users to consider the following actions:
1.    Visit the online petition page and add your name, indicating you believe FSA and HSA users should be able to purchase medical necessities like PPE with their tax-free dollars. You can also share this link on your social media pages.
2.    Visit TaxFreeBetter.com and use one of the form letters provided to contact your member of Congress to voice your support for PPE eligibility. Simply click "Contact Your Member of Congress" at the bottom of the page and follow the directions provided.
"As consumer and public health needs change, FSA and HSA eligibility needs to be flexible to meet those challenges," said Rida Wong, president of Health-E Commerce. "We call on Congress to pass HR 8450 to give American families the ability to use their FSA and HSA dollars to cover these much-needed health necessities to protect themselves and those around them."
To learn more about this legislation or the petition to expand FSA and HSA legislation to include PPE, visit http://www.taxfreebetter.com.
Contact: Barbara Tabor / 651.230.9192 / barbara@taborpr.com
About Health-E Commerce
Health-E Commerce is the parent brand of FSAstore.com, HSAstore.com, and WellDeservedHealth.com, a family of brands serving the 70+ million consumers with tax-free health and wellness accounts. Since 2010, Health-E Commerce's brand portfolio has led the direct-to-consumer e-commerce market for tax-free health and wellness benefits and helped partners and everyday Americans benefit better through its 100% eligible product selection and easy-to-understand educational resources. Health-E Commerce plays an essential role in consumer advocacy in the tax-free health space through both advocating for eligibility of important new categories within the IRS-approved list of eligible medical expenses and leading a committee of industry experts to promote the important national conversation around product safety and authenticity.

We call on Congress to pass HR 8450 to give American families the ability to use their FSA and HSA dollars to cover these much-needed health necessities to protect themselves and those around them.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

ISPE announced its 2020 ISPE Annual Meeting & Expo, taking place virtually 2–6 November 2020, will feature an unprecedented number of regulators representing a diverse mix of global health authorities providing insights on COVID-19 and other industry-critical topics.

NORTH BETHESDA, MD. (PRWEB) OCTOBER 22, 2020
The International Society for Pharmaceutical Engineering (ISPE) announced its 2020 ISPE Annual Meeting & Expo, taking place virtually 2–6 November 2020, will feature an unprecedented number of regulators representing a diverse mix of global health authorities providing insights on COVID-19 and other industry-critical topics.
The latest addition to the speaker line-up is Stephen Hahn, MD, Commissioner, USFDA, who will deliver a keynote presentation during a gathering of the Global Pharmaceutical Manufacturing Leadership Forum and the ISPE Annual Member Meeting during the conference. Dr. Hahn was sworn in as the 24th Commissioner of the USFDA on 17 December 2019. He is a dedicated clinician, having trained in both medical oncology and radiation oncology.
Keynote speaker Amy Abernethy, MD, PhD, Principal Deputy Commissioner, FDA, will return to this leading forum to share new insights and perspectives during her Keynote Fireside Chat.
"The COVID-19 pandemic has placed a spotlight on the need for regulatory agencies and pharmaceutical companies to work closely to ensure the development of safe, effective, and high-quality medicines," said Tom Hartman, President & CEO, ISPE. "This event brings the industry and regulators together to have timely discussions and exchange thoughts openly in a 'conversational, safe forum,' which ultimately helps to advance the pharmaceutical industry's mission."
Additional Featured Regulators:

Lucinda Buhse, PhD, Acting Senior Advisor, Office of Pharmaceutical Quality, CDER/FDA

Melissa Burns, Senior Program Manager, Office of Combination Products, CDER/FDA

David Churchward, Deputy Unit Manager, Inspectorate Strategy & Innovation, Medicines and Healthcare products Regulatory Agency (MHRA)

Jeannie David, Senior Program Management Officer, Drug Shortages Staff, CDER/FDA

Matt Davis, Senior GMP Inspector - Inspections Team Leader, Therapeutic Goods Administration (TGA)

Richard Friedman, Deputy Director, Science & Regulatory Policy, CDER/FDA

Joey Gouws, PhD, Team Lead, Inspection Services, Prequalification Team, World Health Organization (WHO)

Paul Gustafson, Senior Corporate Regulatory Compliance and Enforcement Advisor, Regulatory Operations and Regions Branch (RORB), Health Canada, PIC/S Deputy Chair

Steven Hertz, MS, MBA, PE, Consumer Safety Officer, Office of Pharmaceutical Quality, CDER/FDA

Jennifer Maguire, PhD, Acting Director, Office of Quality Surveillance, CDER/FDA

Gustavo Mendes Lima Santos, General Office of Medicines and Biological Products, GGMED, National Health Surveillance Agency (ANVISA)

Tracy Moore, GMDP Operations Manager, Medicines and Healthcare products Regulatory Agency (MHRA)

Abdelaali Sarakha, Inspector, French Health Products Safety Agency (ANSM), Annex 1 Rapporteur

Seneca D. Toms, Biotechnology Specialist Investigator, ORA/FDA

The 2020 ISPE Annual Meeting & Expo has been reimagined into a virtual experience that will immerse attendees in actionable discussions around industry-critical initiatives—focusing on excellence, modernization, and harmonization in pharmaceutical science and manufacturing. Education sessions feature case studies and dedicated Q&A time with experts. In addition to global health authorities, speakers represent a diverse mix of industry stakeholders, including AstraZeneca, Eli Lilly, Kite Pharma, GSK, Vetter Pharma, and more.
To explore the education agenda and to register, please visit ISPE.org/AM20.    
About ISPE
The International Society for Pharmaceutical Engineering (ISPE) is the world's largest not-for-profit association serving its members through leading scientific, technical, and regulatory advancement across the entire pharmaceutical lifecycle. The 18,000 members of ISPE are building solutions in the development and manufacture of safe, effective pharmaceutical and biologic medicines, and medical delivery devices in more than 90 countries around the world. Founded in 1980, ISPE has its worldwide headquarters and training center in North Bethesda, Maryland USA, and its operations center in Tampa, Florida USA. Visit ISPE.org for more information.
For more information, contact:
Amy Henry
Marketing Communications Manager
International Society for Pharmaceutical Engineering (ISPE)
Email: ahenry@ispe.org
ISPE.org

The COVID-19 pandemic has placed a spotlight on the need for regulatory agencies and pharmaceutical companies to work closely to ensure the development of safe, effective, and high-quality medicines.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

A new survey conducted by Thriveworks Counseling suggests that the election is having a negative impact on Americans' mental health.

FREDERICKSBURG, VA. (PRWEB) OCTOBER 22, 2020
Amid a jarring presidential election and an overall difficult year, US adults in counseling are feeling stressed, fearful, depressed, and/or hopeless about the election. This, according to a survey conducted by Thriveworks Counseling and completed by 275 mental health professionals.
Based on survey results, the most prevalent mental health issues resulting from the election are stress and fear: Approximately 81% of participants said that their clients are currently talking about election-related stress, while nearly 78% said that their clients report feeling fearful of the outcome.
In addition, participants reported that their clients are feeling depressed and hopeless: Nearly 66% said their clients have reported symptoms of depression related to the election and 56% said their clients have reported feeling hopeless about it.
This survey suggests that US adults who are receiving counseling are experiencing a wide range of mental health issues directly related to the presidential election. Fortunately, the mental health professionals who participated in this survey report feeling prepared to address these issues with their clients.
"As therapists and contemporary healers, we are in a perfect position to address clients' confusion and worry," says one anonymous participant. "Life is very different now, compared to the past. We can help clients navigate a conflicted and uncertain world and find where they belong. When they are at their best, they can better cope and accommodate to the problems and challenges in current society."
Read more about the findings from this survey, including how mental health professionals advise their clients to work through these difficult emotions, here.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Text-to-Pay solution provides a better patient experience and helps patients stay on top of their medical bills by just using their smartphones.

ALISO VIEJO, CALIF. (PRWEB) OCTOBER 22, 2020
Mnet Health, the leader in surgical revenue cycle management and patient billing services has announced the launch of its Text-to-Pay solution to help patients pay their medical bills.
Mnet's SMS platform is designed to deliver all patient financial services — everything from payment in full to pay-plans and financing all neatly offered within the confines of a text conversation. Enabling a Text-to-Pay platform helps consumers feel they are in control over their finances and creates a better patient encounter.
A patients' perception of their overall healthcare experience is greatly influenced by the ease with which they can access their bill. As with other consumer-driven industries, patients expect to manage their healthcare billing at any time and from anywhere.
Numerous studies and surveys point to the effectiveness of text billing solutions:
65% of consumers pay their bill on first text notification and 80% of consumers who are given this payment option use it (Authvia data).
SMS (text messages) receive a 4x greater open-rate than traditional email marketing and electronic communications. Billing texts also have a 99% read-rate as most smartphones are set up to automatically show a preview of each text message. 
Mnet's Text-to-Pay solution works in both Android and iOS mobile phones to provide a seamless, contactless payment experience for patients. During the Covid-19 pandemic, Text-to-Pay has become an essential solution for healthcare facilities to provide a contactless payment method for their patients. 
The solution prompts providers to send a secure link via SMS that enables their patients to pay directly from the text conversation; eliminating both security and contamination risks.
When providers adopt effective, contactless billing and payment options; patients will be kept safe, engaged, and informed. 
"We believe every patient deserves a helpful, transparent, easy to navigate financial experience in healthcare," says David Hamilton, CEO of Mnet Health.
With the rise of high deductible health plans and the economic fallout brought about by Covid-19, many patients have become more financially burdened. This is why they need more than just an online bill pay option. 
Patients need a variety of other financial services such as payment plans and even financing. With Mnet's Text-to-Pay solution, patients will be able to make payments, set up payment plans, or apply for financing directly from their mobile phones.
Patients love SMS because it's easy to use and yields fast results. When patients text with an agent and receive answers quickly, not only do they save time, but their frustration is reduced, resulting in a more satisfying patient experience.
Americans today are increasingly connected to the world of digital information while "on the go" via mobile devices. According to Pew Research Center, the vast majority of Americans – 96% – now own a cellphone of some kind with 81% owning smartphones. 
In addition, a 2019 research study by Asurion revealed that Americans now check their phones 96 times a day or once every 10 minutes. The same study also showed that even Baby Boomers are seven times more likely to text than they are to talk in-person and are twice as likely to send a text instead of call.
Patients expect the same streamlined financial encounter in healthcare as they do in other consumer-driven industries. 
With Text-to-Pay, healthcare providers can offer a convenient way for patients, who regularly have their phone in hand or within reach, to pay their medical bills.
Many providers are now making use of the latest contactless payment solutions like Text-to-Pay with Mnet as their partner for success.
About Mnet Health
We believe every patient deserves a helpful, transparent, easy to navigate financial experience in healthcare.
Mnet is the premier revenue cycle management & technology provider to the surgical industry. We provide custom patient-pay solutions to surgical hospitals and ambulatory surgery centers. As of 2020, Mnet Health partners with over 700 surgical facilities nationwide and is the preferred vendor of both United Surgical Partners International (USPI) and Surgical Care Affiliates (SCA) – both directly with and in support of centralized billing offices.
Mnet's custom brand, PaySUITE, is a white-labeled payment technology platform that helps surgical facilities and their providers grow their business by helping patients pay. Mnet's patient-pay solutions significantly increase self-pay collections while creating a better financial experience for patients. For more information, visit https://mnethealth.com.

We believe every patient deserves a helpful, transparent, easy to navigate financial experience in healthcare



START your own Wordpress site, business or personal website, or online store at www.siteground.com

West joins launch of new technology platform, OneR, to increase trial therapies for patients.

MEMPHIS, TENN. (PRWEB) OCTOBER 22, 2020
As an affiliate of OneOncology, West Cancer Center & Research Institute now has the ability to further its clinical trial offerings and oncology research knowledge by joining the launch of OneR.
OneR is a new, unprecedented technology platform and collaboration throughout the OneOncology network that provides seamless clinical trial management, increased access to trial therapies for patients, and more oncology research information readily available to our clinicians. Patients can participate in clinical trials for specific cancer types, in an effort to decrease side effects of current treatments, or with aims to improve disease outcomes – and now, with the implementation of OneR, these efforts are supported more than ever before.
Mitch Graves, CEO of West Cancer Center states, "We are incredibly excited to join the launch of OneR! This new platform allows us to offer more clinical trials to patients in need by centralizing business functions, regulatory submissions, and clinical trial matching technology while also maintaining our flexibility to participate in other clinical trial initiatives managed by our in-house Clinical Research Department. It's an exciting time for cancer research, and this new initiative will give our patients and their families more treatment options than ever before!"
Recently, West added "Research Institute" to its name to ensure the priority and focus it has on clinical research was made apparent and embedded into its culture. This new opportunity only further promotes its many initiatives to increase oncology research across the globe.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

West now incorporates the use of SpaceOAR Hydrogel during radiation treatment for prostate cancer to combat unintended damage to the rectum. Dr. Holger Gieschen at West Cancer Center was the 1st Radiation Oncologist in the Mid-South to recognize the tremendous patient benefit and use this technology.

MEMPHIS, TENN. (PRWEB) OCTOBER 22, 2020
Prostate cancer is the most common cancer in American men, with more than 183,000 new cases diagnosed each year. More than 60,000 American men opt to treat their prostate cancer with radiation every year, but because of the proximity of the rectum to the prostate, radiation treatment can cause unintended damage to the rectum, leading some men to either surgically remove their prostate or "watch and wait."
Like the top 20 cancer centers in the U.S., West now incorporates the use of SpaceOAR Hydrogel during radiation treatment for prostate cancer to combat unintended damage to the rectum. Dr. Holger Gieschen at West Cancer Center was the 1st Radiation Oncologist in the Mid-South to recognize the tremendous patient benefit and use this technology. SpaceOAR is an absorbable gel that creates a temporary space between the prostate and the rectum, designed to reduce radiation dose to the rectum. It is inserted via a minimally invasive procedure and is naturally absorbed by the body in about six months.
This product has been heavily evaluated in clinical studies and has been shown to be safe and effective in reducing potential side effects of radiation therapy to the rectal area. In a randomized clinical study, men who underwent radiation therapy without SpaceOAR Hydrogel were eight times more likely to experience a decline in bowel, urinary and sexual function when compared to men who underwent radiation therapy with SpaceOAR Hydrogel, at a median follow-up of three years.
Worrying about the potential side effects of radiation shouldn't be a reason why men with a prostate cancer diagnosis delay treatment. At West Cancer Center & Research Institute, we are committed to providing the latest treatment options and preserving the highest quality of life for all our patients.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Miami-based Food and Beverage Distribution Company Pivots Mid-pandemic; Launches New-to-market Medical and Health Supply Company with International Network

MIAMI (PRWEB) OCTOBER 22, 2020
Medivico, a health and medical supply company that delivers the highest quality PPE and medical supplies from certified manufacturers, was proudly launched by Invico, a network of visionary companies, to bring quality PPE and medical supplies to areas across the world where resources were becoming increasingly limited. In response to the COVID-19 crisis and resulting global PPE shortage, Invico founders Arnold Thorstad, Roberto Delli and Nicolas Isopo established Medivico in February 2020 with the mission to ensure healthcare and essential workers can do their jobs without concern.
Understanding the gravity of the situation early on due to their international network and specific insights into the escalating situation in Italy, where the virus was rapidly spreading early in the pandemic, the team quickly pivoted to leverage relationships and resources within their food and beverage supply chain network to source and deliver reputable PPE products to the United States at a time when many low-grade and unusable products were being delivered by competitors.
"When the global PPE shortage was surfacing, we found a solution within our own company's network. Many other companies were delivering unregulated and unusable PPE, draining their clients' funds and resources and leaving frontline workers unprotected," said Arnold Thorstad, co-founder and President of Medivico and Invico. "We are committed to ensuring frontline and essential workers have access to regulated PPE and health supplies that meet all standards now and after the COVID-19 pandemic."
Backed by Invico's years of experience successfully operating food and beverage supply chains across the globe, Medivico has quickly become a trusted and reliable medical supplier providing necessary PPE and sanitizers to some of the most renowned hospitals and government entities in the United States. Medivico has also donated units of N95 masks and other healthcare products to Advocate Medical, St. Jude Hospital and the State of Illinois.
Medivico products are sourced from several countries worldwide through manufacturing facilities that hold only the highest standards and certifications to meet the specific needs of medical and essential workers. Medical and health supply products available through Medivico include N95 respirators, masks, gloves, gowns, disinfectants, sanitizers and more. For more information, a full list of products, or to connect to the sales team, visit http://www.medivico.com.
About Medivico:
Medivico is a health and medical supply company that delivers the highest quality medical supplies and safety products from qualified manufacturers efficiently and effectively so healthcare and essential workers can do their jobs without concern. Established in response to the growing demand for high quality PPE in the wake of the global Covid-19 pandemic, the company is backed by years of experience successfully operating supply chains across the globe and is committed to providing personal protective equipment and other healthcare supplies to ensure those on the medical frontlines continue to save lives. For more information, visit Medivico.com.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Leading designer and manufacturer of temperature management devices represents another platform investment by Havencrest

DALLAS (PRWEB) OCTOBER 22, 2020
Havencrest Capital Management, a Dallas-based healthcare private equity firm focused on partnering with founder- and entrepreneur-led businesses across the United States, announced today the completion of its acquisition of ThermoTek, Inc. ("ThermoTek" or the "Company"), a leading designer and manufacturer of temperature management devices.
Founded in 1993 and based in Flower Mound, TX, ThermoTek provides a broad range of temperature management solutions to the medical and industrial end markets, specifically cold compression devices used in post-orthopedic surgery rehabilitation and cooling units used in industrial applications. The Company leverages its extensive product portfolio with more than 70 issued patents to supply its network of 280+ medical device dealers and industrial OEMs with a variety of custom- and proprietary-branded thermal management and compression products.
"We are very excited to support ThermoTek on the next step of its journey," commented Christopher W. Kersey, M.D., M.B.A., Founding Managing Partner of Havencrest Capital Management. "The acquisition of ThermoTek represents a great opportunity to partner with a seasoned management team to further establish market leadership and drive efficiencies," according to Dr. Kersey.
Sam McSpadden, CEO of ThermoTek, Inc., added, "We are excited to have found our ideal partner with Havencrest's extensive industry knowledge and deep bench of experienced operators. Together we can accelerate growth and bring ThermoTek's long track record of delivering superior precision thermal management solutions and post-operative rehabilitation products to a rapidly-growing market worldwide."
By parlaying its blue-chip network of Operating Partners and Senior Advisors, Havencrest will seek to expand ThermoTek's product portfolio by launching new product lines, growing into adjacent medical and industrial markets and acquiring complementary private companies.
"As the founder of several global medical device companies, I am excited to assist Havencrest in this acquisition," said Havencrest Operating Partner Robert A. Kline, Founding CEO of temperature management medical device leader Medivance Corporation (acquired by Bard Corporation, NYSE: BCR). "ThermoTek's market-leading technology innovation --- as well as its unparalleled customer service --- will continue to differentiate the company from its competitors," according to Mr. Kline, who will serve as ThermoTek's Advisory Board Chairman and help guide the Company through this next exciting phase of growth.
Oxford Finance provided debt financing for the transaction. Sheppard, Mullin, Richter & Hampton LLP served as legal counsel to Havencrest Capital Management. Raymond James served as financial advisor to the Company. Financial terms of the transaction were not disclosed.
About Havencrest Capital Management
Havencrest Capital Management ("Havencrest") is a committed capital, lower middle-market private equity investment firm focused exclusively on the healthcare industry. Havencrest comprises a leading team of investment professionals, operating partners and senior advisors, including many of the nation's leading healthcare entrepreneurs, corporate executives and public policy experts.
With its unique approach to partnering with founder-owned healthcare companies with EBITDA between $2M - $10M, the Havencrest team has a successful track record in building leading companies that are changing the way healthcare is delivered in America.
Connect with us on LinkedIn.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Dr. Morad Askari joins Haute Beauty Network as an anti-aging and cosmetic expert representing the Miami/Fort Lauderdale market.

CORAL GABLES, FLA. (PRWEB) OCTOBER 22, 2020
Dr. Morad Askari is a board-certified plastic surgeon with over a decade of experience in plastic, reconstructive, and cosmetic surgery. He obtained his medical degree from the University of Pittsburgh School of Medicine. He completed general surgery and plastic surgery training in Los Angeles, California at the University of Southern California where he trained with world-renowned surgeons in Beverly Hills. After completing another fellowship at the Mayo Clinic, a center of excellence in medical education and practice, he moved to Miami, Florida, where he worked as an associate professor of plastic surgery for six years at the University of Miami before starting a private practice.
He currently enjoys running a busy reconstructive and cosmetic plastic surgery practice with patients from local, national, and international locations.
Learn more about Dr. Morad Askari by visiting: https://hauteliving.com/hautebeauty/member/dr-morad-askari-hoda-askari/
ABOUT HAUTE BEAUTY NETWORK:
Haute Beauty is affiliated with the luxury lifestyle publication Haute Living. As a section of Haute Living magazine, Haute Beauty covers the latest advancements in beauty and wellness, providing readers with expert advice on aesthetic and reconstructive treatments through its network of acclaimed doctors.
For more about Haute Beauty, visit https://hauteliving.com/hautebeauty/

Dr. Morad Askari is a board-certified plastic surgeon with over a decade of experience in plastic, reconstructive, and cosmetic surgery.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Dr. Kathryn Alcarez joins Haute Beauty Network in the Medspa category representing the New York market.

NEW YORK (PRWEB) OCTOBER 22, 2020
Dr. Kathryn Alcarez is a Manhattan-based, Internal Medicine Physician and has a combined 14 years of experience and specialized training in Aesthetic Medicine, Obesity Medicine, and Preventative Medicine. She is the founder and Medical Director of Aesthete Medical Wellness and Medspa.
Dr. Alcarez received her medical degree at the University of New England College of Osteopathic Medicine in Maine and completed her residency in Internal Medicine at Lenox Hill Hospital. She is affiliated with Mount Sinai Beth Israel and NYU Langone Medical Center.
Using a holistic and evidence-based approach to medicine, Dr. Alcarez seeks to ensure that her patients receive the best medical care to maintain long-term health and wellness. She considers physical, mental, and aesthetic health as integral to patients' overall wellbeing. For this reason, Dr. Alcarez offers comprehensive aesthetic consultations that include botox for medical purposes like migraines and hyperhidrosis, botox and fillers for anti-aging, radiofrequency skin tightening (Inmode Optimas), and radiofrequency body contouring (Inmode Contoura and Cutera's Trusculpt ID offered at the downtown location).
Learn more about Dr. Kathryn Alcarez by visiting: https://hauteliving.com/hautebeauty/member/dr-kathryn-alcarez/
ABOUT HAUTE BEAUTY NETWORK:
Haute Beauty is affiliated with the luxury lifestyle publication Haute Living. As a section of Haute Living magazine, Haute Beauty covers the latest advancements in beauty and wellness, providing readers with expert advice on aesthetic and reconstructive treatments through its network of acclaimed doctors.
For more about Haute Beauty, visit https://hauteliving.com/hautebeauty/

Dr. Kathryn Alcarez is the founder and Medical Director of Aesthete Medical Wellness and Medspa.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Dr. Mariano Busso joins Haute Beauty Network as a skin expert representing the Los Angeles market.

BEVERLY HILLS, CALIF. (PRWEB) OCTOBER 22, 2020
Dr. Mariano Busso is a Diplomate of the American Board of Dermatology and a Fellow of the American Academy of Dermatology. He is recognized as one of the world's leading experts in cosmetic fillers as acknowledged in the prestigious Journal of the American Academy of Dermatology (JAAD) by the president of the American Academy of Dermatology, Dr. C. William Hanke. Dr. Mariano Busso was honored to be a part of the FDA advisory panel that developed national guidelines for the use of cosmetic fillers. Over the past three decades, Dr. Busso has developed one of the largest cosmetic practices in the U.S. based in Miami, Florida, and has since expanded his practice to Beverly Hills, California to serve his celebrity clientele.
Dr. Mariano Busso was born and raised in Buenos Aires, Argentina, and received his medical degree from the University of Buenos Aires School of Medicine, where he graduated top of his class with Honoris Diploma, the highest academic honor. He went on to study molecular biology for three years in the Department of Dermatology at Mount Sinai Medical Center in Miami while making major contributions in the field of AIDS. He later completed his Internship in General Surgery and then completed his Fellowship in Dermatology at the University of Miami. As a Dermatology resident, Dr. Busso received the highest awards a resident can receive: the George Ioannides Teaching Award and the Upjohn Research Award. He then became a Voluntary Assistant Clinical Professor in the Department of Dermatology at the University of Miami. He was made Chief of Dermatology at Mercy Hospital in Miami and remains a Senior Medical Attending.
Dr. Mariano Busso has made numerous breakthrough discoveries throughout his career, with multiple contributions in the research field. He is viewed as a thought leader in his specialty and his views are sought-after by industry leaders including Allergan, Merz, Galderma, BTL, and NovaThreads. Dr. Busso developed multiple original published techniques for filler injections in the cheeks, temples, forehead, and hands. Notably, the scale to evaluate volume loss in the hands is called the "Busso Hand Volume Severity Scale." Dr. Busso also developed a worldwide used technique to add lidocaine to fillers as well as adjust their viscosity to the treated area, a discovery that revolutionized the industry. He has also made major contributions in the field of energy devices, helping to develop treatment protocols for Ultherapy, Vanquish ME, and EMSCULPT. He participated in multiple clinical trials as a Clinical Investigator for Artefill (Bellafill), Radiesse, Luminex, EMSCULPT, and EMTONE.
Today, Dr. Mariano Busso continues to pursue the development of new cosmetic procedures and techniques. Physicians from all over the U.S. and across the globe have been trained by Dr. Busso in fillers and Botox techniques. After years of experience working with threads and fillers, he has developed the BussoLyft, which removes dark circles and combines filler and threads to reduce jowls. His technique is proving to be the latest game-changer in rejuvenation.
Learn more about Dr. Mariano Busso by visiting: https://hauteliving.com/hautebeauty/member/dr-mariano-busso/
ABOUT HAUTE BEAUTY NETWORK:
Haute Beauty is affiliated with the luxury lifestyle publication Haute Living. As a section of Haute Living magazine, Haute Beauty covers the latest advancements in beauty and wellness, providing readers with expert advice on aesthetic and reconstructive treatments through its network of acclaimed doctors.
For more about Haute Beauty, visit https://hauteliving.com/hautebeauty/

Dr. Mariano Busso is recognized as one of the world's leading experts in cosmetic fillers as acknowledged in the prestigious Journal of the American Academy of Dermatology (JAAD) by the president of the American Academy of Dermatology, Dr. C. William Hanke.




START your own Wordpress site, business or personal website, or online store at www.siteground.com

Expert team sets brands up for success in the digital environment

PHILADELPHIA (PRWEB) OCTOBER 22, 2020
The speed at which therapeutic advances have been made in a digitally transformed COVID 19 world requires industry acumen and marketing expertise that can guide brand leaders in the life sciences to commercial success. Celebrating one year as the healthcare consulting practice under the BW Health Group umbrella of enterprises, BW Consulting is built to respond with speed, scale and expertise. While expanding their reach across a range of therapeutic categories, BW Consulting remains hyper-focused on its core offering: a toolkit for diagnosing launch preparedness followed by a customized path to launch excellence for life sciences clients.
In the past year, the consulting team of former pharma commercial leads and strategists has spent a lot of time helping clients reimagine engagement strategies for the virtual world. At the same time, they have built a rigorous platform that supports clients through product prelaunch, launch and post-launch, the latter of which can be a critical make-or-break milestone for brands.
"Only 20% of products improve their sales trajectories 6 months post-launch," explained Joe Medel, SVP Strategy for BW Consulting. "It's critical to set the right course well in advance to ensure sustained success for the brand going forward."
Therapeutic experience among the team includes orphan drugs, gene therapy, immunotherapies in oncology and novel treatments in rare disease. Many of the smaller to mid-size companies innovating in these areas struggle with resources, budgets and prioritization of commercial goals. BW Consulting specializes in providing solutions to clients who may lack the infrastructure or budget to support a marketing team.
"We've been in their shoes and can understand what they are confronting and what they need," said Tom McDonnell, President of BW Health Group. "We become the extended team."
"Some of the biggest innovations are coming from small life sciences firms that need that kind of strategic augmentation to help their brands get off the ground," Medel added. "There is no substitute for effective prelaunch prep, ever—especially in this COVID19 world."
More information on the specifics of the firm's launch excellence approach, as well as a launch navigation tool designed to begin the conversation on launch readiness, can be found on their new website, ConsultBW.com.
####
About BW Consulting
BW Consulting is a healthcare consulting team consisting of management consulting pros, former pharma commercial leads, technology experts and scientists. BW consultants leverage their experience as brand leaders to help small to mid-size innovators in the pharma, biotech and medical device space to achieve launch excellence and sustained success for their brands through the use of a focused set of tools that diagnose and help customize launch planning and execution.
For additional information, please call 800-536-4670 or visit ConsultBW.com
About BW Health Group
BW Health Group is dedicated to advancing the commercial goals of life sciences clients through a family of companies providing award-winning strategy, creative, and execution for life sciences brands as well as pharmaceutical distribution, technology and commercialization services. BW Health Group includes Benchworks, a full-service marketing and communications agency and BW Consulting, a life sciences consulting division. BW Health Group also has a strategic partnership with Occam Health, an independent patient services provider. For additional information, please visit http://www.bwhealthgroup.com.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

The organization has changed its name to The REDC Consortium to encompass the wider spectrum of eating disorder care represented

NEW YORK (PRWEB) OCTOBER 23, 2020
REDC, which was originally formed as a professional association of residential eating disorder treatment providers, has opened its membership to all higher levels of care, including partial hospitalization programs (PHP) and intensive outpatient programs (IOP).
Since its founding in 2011, REDC has established itself as an authority in the eating disorders field, taking action in the critical areas of standards, accreditation, ethics, collaborative research, and policy. Its work has secured improved inclusion of treatment for eating disorders in legislation, insurance coverage, and accreditation, as well as paved the way to improved standards and ethics for eating disorder programs across the field.
"We are pleased to be able to offer the benefits of REDC membership to PHP and IOP providers so we can work toward continued progress," said Jillian Lampert, president of REDC. "We currently represent about 85% of beds for people in residential eating disorder treatment and the majority of PHP care in the U.S., so we are well-poised to offer membership to providers of all higher levels of care."
The organization has adopted a name change to clarify that it is a consortium representing eating disorder treatment across a wider spectrum of care than just residential. REDC, established as the Residential Eating Disorders Consortium, will remain REDC in parlance, yet with this wider scope, the name has changed to REDC Consortium, reflecting its identity as "a consortium representing eating disorders care". The website has changed to http://www.redcconsortium.org.
The membership shift, which was solidified after a unanimous vote by the board, also received strong support from Center Road Solutions, REDC's policy team in Washington, DC. "This expansion of membership and name change will have beneficial impacts on our policy work and will provide robust support for the people we serve who are in need of eating disorder treatment," said Katrina Velasquez, Managing Principal at Center Road Solutions. "It will be clear that we are a unified consortium representing a spectrum of eating disorder care."
The REDC Consortium views the expansion as the beginning of a new era. "We feel energized to continue and expand on the important work of this organization," said Lampert. "And we still have much more to do—continual refinement of standards, ethics, and criteria for centers of excellence, conduct of more collaborative research, leading the way with ethics work, and ongoing partnership with the Eating Disorders Coalition in the policy realm, to ensure quality, accessible care for people with eating disorders."
For more information on the REDC Consortium, visit redcconsortium.org.
###



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Oakworks Shield is designed to reduce the risk of infection via aerosols and droplets by providing a barrier between aestheticians and clients. It is also effective in separating clients from one another in multi-station rooms.

NEW FREEDOM, PA. (PRWEB) OCTOBER 23, 2020
The Oakworks Shield allows services to be done more safely that require aestheticians to be close to clients. The optically clear film can be easily positioned to create a barrier between two people while not restricting access to the client. Portable and easy to move, the Oakworks Shield can be rolled into place when needed; no need for expensive, permanent acrylic barriers that get in the way. Adjustable in height, you can easily find the balance between access and safety.

48" wide x 36" high barrier to aerosols and droplets

Comes with enough film to make 25 barriers

Optically clear film permits detailed aesthetic work

Stable design on wheels can be easily positioned

Oakworks Shield is designed to provide many months of crystal clear protection for your staff and clients from a single roll. Instead of expensive permanent installations of clear acrylic or plexiglass that get cloudy over time from scratches and get in the way, the shield is very flexible to meet the needs of individual aestheticians and the services they provide.
About Oakworks Spa
Our design philosophy is really quite simple; build beautiful products that support therapist's ergonomic health and client's comfort while insuring good value through high quality construction. Our innovative designs have been selected as the brand standard by leading spas, and are found wherever excellence in construction, comfort, and customer service is required. The Signature Collection is tried and true with classic designs and style. Used in hundreds of locations world-wide, from day-spas to remote destination resorts, Oakworks Spa is an industry favorite. With Style, Ease, and Grace, the Masters' Collection features hundreds of finish combinations that can be configured in the revolutionary on-line design tool, STUDIO. An industry leading warranty and service solutions support our commitment to our customers and their business. For more information, visit http://www.spatables.com



START your own Wordpress site, business or personal website, or online store at www.siteground.com

To elevate public awareness that there are over 35,000 licensed acupuncturists treating ailments throughout the U.S., the American Society of Acupuncturists (ASA) and the National Certification Commission for Acupuncture and Oriental Medicine (NCCAOM) are collaborating to promote nationwide observations of the 17th annual Acupuncture Medicine (AM) Day taking place on October 24.

WASHINGTON (PRWEB) OCTOBER 23, 2020
During this challenging and uncertain time, it is reassuring to know that qualified board certified and state licensed acupuncturists are open and available to treat a variety of conditions and ailments to include pain, stress, mental disorders, immune issues, and general well-being. To elevate public awareness that there are over 35,000 licensed acupuncturists treating these ailments throughout the U.S., the American Society of Acupuncturists (ASA) and the National Certification Commission for Acupuncture and Oriental Medicine (NCCAOM) are collaborating to promote nationwide observations of the 17th annual Acupuncture Medicine (AM) Day taking place on Oct. 24. In honor of AM Day, both organizations have joined forces to elevate acupuncture services as a nonpharmaceutical, safe, effective and economically feasible treatment for so many of the ailments that are plaguing Americans today such as stress, immune issues, PTSD, and depression in the face of this global pandemic.
"This year's observance of Acupuncture Medicine Day is more than a celebration of the profession and its practitioners, it's a call to action to come together to demonstrate and reassure all patients, old and new, that they can be treated in a safe and COVID-free environment due to the careful re-opening measures that have been taken, stated Mina Larson, NCCAOM CEO.
"Acupuncture Medicine Day celebrates the acupuncture profession's unlimited potential as leaders by visibly demonstrating what is possible in the medical field no matter the illness or environment." Said Olivia Hsu Friedman, ASA Chair.
To highlight the safe practice of acupuncture, NCCAOM and ASA also sponsored a Video Voting Contest 2020 to boost exposure and shed light on National Board Certified and state licensed acupuncturists' efforts to be part of this historic time. You can view the Voting Contest 2020 videos at: https://bit.ly/AcupunctureMedicineDay2020VideoContestVoting.
About ASA
The Mission of the American Society of Acupuncturists is to promote the highest standards of professional practice for acupuncture and EAM in the United States, thereby to benefit the public health. Through strengthening the profession at the state level while promoting collaboration nationally and internationally, the ASA provides its members, the public, legislators, and regulators resources for ensuring the best expression of this ancient and modern medicine. Please visit https://www.asacu.org/ for more information.
About NCCAOM
The National Certification Commission for Acupuncture and Oriental Medicine (NCCAOM) is a non-profit 501(c)(6) organization established in 1982. NCCAOM certification or a passing score on the NCCAOM certification examinations are documentation of competency for licensure as an acupuncturist by 46 states plus the District of Columbia which represents 98 percent of the states that regulate acupuncture. All NCCAOM certification programs are currently accredited by the National Commission for Certification Agencies (NCCA). To learn more about how acupuncture can help alleviate or relieve different health conditions, visit the NCCAOM's Acupuncture and Oriental Medicine News and Resource Center. To find an NCCAOM National Board-certified Acupuncturist in your area, click on Find a Practitioner at http://www.nccaom.org.
For more information on AM Day, please visit http://www.acupuncturemedicineday.org.




START your own Wordpress site, business or personal website, or online store at www.siteground.com

Harmony Foundation, a longstanding Colorado-based nonprofit addiction treatment center, has announced that it has partnered with Anthem Blue Cross Blue Shield and is now in-network for their subscribers. This change gives the over 42 million Anthem cardholders more affordable access to the program during the current COVID-19 pandemic, who previously would have to pay a considerable portion of the cost if they wanted to seek the medical detox, residential or intensive outpatient levels (IOP) of care at Harmony.

ESTES PARK, COLO. (PRWEB) OCTOBER 23, 2020
Harmony Foundation, a longstanding Colorado-based nonprofit addiction treatment center, has announced that it has partnered with Anthem Blue Cross Blue Shield and is now in-network for their subscribers. This change gives the over 42 million Anthem cardholders more affordable access to the program during the current COVID-19 pandemic, who previously would have to pay a considerable portion of the cost if they wanted to seek the medical detox, residential or intensive outpatient levels (IOP) of care at Harmony.
Anthem has a strong presence in Colorado and Wyoming, two states that drive thousands of phone calls each year to Harmony Foundation from families hoping for treatment at the program or from professionals seeking to refer patients. Established in 1969, Harmony Foundation has helped those with substance use disorders find lifelong sobriety in its secluded mountain setting in Estes Park, Colorado. One year ago this month, expansions helped to provide an IOP level of treatment at its Fort Collins Recovery Center where it also offers activities and support for the recovery community-at-large, regardless of how they found sobriety. Harmony has received the Gold Seal from the Joint Commission, the highest level offered by the global healthcare accreditation body.
Harmony is also a regular partner with universities that send clinical, medical, and pharmaceutical doctoral students to its treatment center for rounds to help provide first-hand experience. Additionally, the campus hosts ongoing lecture events awarding continuing education credits to other licensed professionals in the community.
"In our mission to save lives and provide the treatment necessary for lasting recovery, the Anthem partnership opens the door for so many to access this level of care here," said Jim Geckler, Harmony Foundation CEO. "We are so grateful to be able to serve those feeling particular strain in these times and prepare them to better navigate the challenges of the future with confidence and wellness."
 
About Harmony Foundation
Harmony Foundation is a nonprofit alcohol and drug addiction recovery program that serves in a collaborative and respectful treatment environment. Harmony promotes physical, emotional, and spiritual healing, empowering their clients to embark upon the lifelong journey of recovery. Visit https://harmonyfoundationinc.com to learn more.

We are so grateful to be able to serve those feeling particular strain in these times and prepare them to better navigate the challenges of the future with confidence and wellness.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

EUROPEAN AIR AMBULANCE (EAA) has introduced new streamlined procedures to deal with the transportation of patients with Covid-19.Using experience gained during the summer pandemic peak when, at the request of the Luxembourg government EAA transported Covid-19 patients between hospitals in France where health services were overstretched, they are now able to roll the service out on a wider international basis.

LUXEMBOURG (PRWEB) OCTOBER 23, 2020
EUROPEAN AIR AMBULANCE (EAA) has introduced new streamlined procedures to deal with the transportation of patients with Covid-19.Using experience gained during the summer pandemic peak when, at the request of the Luxembourg government EAA transported Covid-19 patients between hospitals in France where health services were overstretched, they are now able to roll the service out on a wider international basis.
One of Europe's largest and most respected specialised air ambulance operators, European Air Ambulance (EAA) - https://www.air-ambulance.com/ - has developed the protocols to ensure the safety of patients confirmed or suspected to have the virus, and the medical and flight crews treating and transporting them.
Didier Dandrifosse, Head of Medical Department, said: "At EAA we are first of all committed to ensuring safe working environment for our personnel together with the safety and quality of care for our patients. Our responsibility is also to avoid at all cost the additional spreading of the virus. Our clients can be reassured that we take all the necessary precautions on every mission."
The control centre will activate different protocols depending on whether the patient has a confirmed positive or negative diagnosis and depending on their general condition, with additional procedures for those whose Covid-19 status is unknown.
In some cases, the use of an IsoPod or Infectious Disease Unit (IDU) may be required. EAA's IDU is a ground-breaking tent-like module originally designed for the safe transport of Ebola patients, but which use has been adapted for Covid-19.
It gives the patient space to move around, and allows for non-intensive treatment while still being completely isolated from the surroundings. An IsoPod is a smaller individual barrier-type unit, suited to patients not needing treatment, but which protects the medical team from infection. Due to restricted size inside, the IsoPod is not suitable for obese patients or patients who suffer from anxiety or claustrophobia.
The safety-first approach underlines the commitment to patient and staff care that underpins every mission flown by Luxembourg-based EAA.
Dandrifosse added: "Protecting patients and staff is our number-one priority. Thanks to our experience transporting infectious disease patients in the past, we have been able to put these new Covid-19 procedures in place to allow us to continue to do that - but on a much wider basis - through these difficult times."
Website: https://www.air-ambulance.com
LinkedIn: https://www.linkedin.com/company/european-air-ambulance

Our responsibility is also to avoid at all cost the additional spreading of the virus. Our clients can be reassured that we take all the necessary precautions on every mission.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

A recent survey of 400 Kentucky residents showed that 46% of people oppose drug testing welfare recipients while only 29% supported it.

LEXINGTON, KY. (PRWEB) OCTOBER 23, 2020
A survey conducted by Drug Test City and published on their own website earlier this year showed that public support for drug testing welfare recipients is falling. The majority of the public, even in a state that has a high level of conservative policy support in regards to welfare, does not support widespread drug testing for welfare recipients.
According to the survey 46% of respondents were against drug testing welfare recipients outright, 29% supported it, and 25% were unclear.
Among the answers given by respondents providing for hungry children was a common thread in opposing drug tests, and fairness in regards to people who are required to drug test for employment was the most common reason people supported drug testing welfare recipients.
Since 2011 there have been more than 15 states enact laws that would allow welfare recipients to be subject to drug testing. The groups that have studied the success of these programs mostly conclude that the costs do not justify the results, however as Drug Test City points out most of the groups that published analysis are heavily biased.
In a departure from publishing a biased report in support of their industry, Drug Test City concluded that the public did not support drug testing welfare recipients and in most cases the costs did not justify the benefits, but they also pointed out some of the flaws that non profit groups made in their analysis as well as the success of programs that seemed to be managed better.
It was also noted that the response was not split along party lines as most hot button political topics are, and the group that showed the most support for drug testing welfare recipients was recovering drug addicts.
In 2013 the state of Utah spent $30,000 on drug testing welfare recipients, but only 12 people tested positive. 250 others did not meet the testing requirements. Governor Brad Wilson stated that denying benefits to those applicants saved the state over $350,000. It is also hard to pinpoint the effect drug testing had on applications.
It is clear that to know whether or not a drug testing program actually provides benefits then a more comprehensive analysis by a third party that does not have an obvious bias or vested interest is required. However, it's also clear that even in a state like Kentucky that has a long tradition of self sufficiency and drug abuse, public sentiment is not in favor of drug testing welfare recipients.

Among answers given by respondents providing for hungry children was a common thread in opposing drug tests



START your own Wordpress site, business or personal website, or online store at www.siteground.com

The YMCA of Pawtucket invites all in the community to participate in a free six-week STRONG challenge designed to help transform spirit, mind and body. With locations in Pawtucket, Lincoln and Woonsocket, this year's STRONG program was designed to help fight the isolation and wear down COVID-19 has caused on our community.

PAWTUCKET, R.I. (PRWEB) OCTOBER 23, 2020
Sick and tired of feeling sick and tired in these COVID-19 times? The YMCA of Pawtucket, with locations in Pawtucket, Lincoln and Woonsocket, invites all in the community to participate in a free six-week STRONG challenge designed to help transform spirit, mind and body. "Now, more than ever before we need to recharge and refocus," said YMCA of Pawtucket CEO Charlie Clifford. "The COVID-19 pandemic has worn us down. It's isolated us in so many ways. This challenge provides an opportunity to get active and healthier by yourself or as a Strong family."
Visit our website and Facebook page for details on how to join in. Program begins October 19th so sign-up now. You can opt-in to the free challenge by texting STRONG to 855-520-6222. Follow the prompts to sign-up and you will receive three texts a week filled with motivation, challenges, workouts and more. You will also be able to attend the Y for one day each week to enjoy swimming, working out and a variety of classes.
Everyone in the community is also invited to workout wherever you are, taking free YMCA FacebookLive online classes like Zumba, yoga and HIIT. The complete weekly schedule is available at ymcapawtucket.org. You can also participate in a variety of outdoor activities, like pop-up classes and nature walks. Visit the website https://myy.org/strong/challenge/ and learn more about the STRONG challenge.
"It's the perfect time to take back our lives, reenergize, achieve goals, feel better and stronger," added Clifford.
About the YMCA
The Y is one of the nation's leading nonprofits strengthening communities through youth development, healthy living and social responsibility. Across the U.S., 2,700 Ys engage 22 million men, women and children – regardless of age, income or background – to nurture the potential of children and teens, improve the nation's health and well-being, and provide opportunities to give back and support neighbors. Anchored in more than 10,000 communities, the Y has the long-standing relationships and physical presence not just to promise, but to deliver, lasting personal and social change. The YMCA of Pawtucket is comprised of five branches across the state: Pawtucket Family YMCA and Heritage Park YMCA Early Learning Center in Pawtucket, MacColl YMCA in Lincoln, Westwood YMCA in Coventry and Woonsocket YMCA



START your own Wordpress site, business or personal website, or online store at www.siteground.com

In this free webinar, the featured speakers will discuss the available data assessing reproducibility of liver biopsy reading in NASH and explain how to leverage lessons learned from other liver indications. Attendees will learn about potential mitigation strategies to minimize the inter- and intra-subject variability, how training standards can be implemented and statistical strategies to maximize power and minimize the impact of this variability.

TORONTO (PRWEB) OCTOBER 23, 2020
Liver biopsy (LB) sample evaluation is an essential part of clinical studies in non-alcoholic steatohepatitis (NASH). However, LB remains a vastly controversial and debated subject. Histologic lesions of NASH are unevenly distributed throughout the liver parenchyma. Therefore, sampling error in liver biopsy can result in substantial misdiagnosis and staging inaccuracies. Additionally, though previous data suggested substantial or moderate concordance for some key histological NASH features (e.g fibrosis, ballooning degeneration), poor concordance in these components were reported in a recent trial.
The panel will present available data assessing reproducibility of liver biopsy reading in NASH, methodological aspects in the interpretation of data and potential limitations, discuss how to leverage lessons learned from other liver indications, brainstorm about potential central reading options and evaluate potential mitigation strategies to minimize the inter- and intra-subject variability.
Join Claudia Filozof, MD, PhD, Vice President, Liver Therapeutic Area Head, Global Clinical Development, Covance, Troy Johnson, MS, Statistical Fellow, Biostatistics, Covance, Pierre Bedossa, Professor of Pathology, Liverpat and Arun Sanyal, MD, Professor of Medicine at Virginia Commonwealth University (VCU) School of Medicine, Richmond, VA in a live webinar on Monday, November 9, 2020 at 11am EST (4pm GMT/UK).
For more information or to register for this event, visit Reliability of Liver Biopsies in NASH Clinical Studies: What is Known So Far? What's Next?
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/



START your own Wordpress site, business or personal website, or online store at www.siteground.com

With $6.3 million in seed funding, CareRev gives more control to hospitals and more money to frontline care providers while pandemic's impact remains uncertain.

VENICE, CALIF (PRWEB) OCTOBER 23, 2020
CareRev, founded in 2015 to prepare the healthcare industry for the future of work, has seen growth accelerate dramatically as American hospitals and healthcare systems struggle to meet the demands of COVID-19 while simultaneously evolving care protocols for routine healthcare. The labor transformation solution was built by a Registered Nurse (RN) to streamline shifting labor needs; CareRev enables healthcare systems to optimize their workforce and increase operating margins while also empowering healthcare professionals to take control of their careers and earnings. Since the pandemic began in March, CareRev has helped fill nearly 15,000 shifts nationwide, putting over $4 million dollars in nurses' pockets and securing new partnerships with Broward Health (Florida), Froedtert Health (Wisconsin) and SSM Health (Missouri).
"CareRev was born when I realized I could call a ride, order groceries and get delivery through a mobile app, but nothing so simple existed for scheduling per diem shifts that were key to managing my career and paying off school loans," said Will Patterson, former trauma RN and CEO/co-founder of CareRev. "The goal was to simplify communication between healthcare systems and the myriad caregivers who treat patients, and today's COVID reality makes our fast and flexible solution as essential as the nurses and other caregivers on the frontline of this crisis."
As the country prepares for the third wave of COVID-19 to surge across the nation, technology companies like CareRev are helping hospitals navigate an expected increase in case count -- specifically in metros where coronavirus cases are rising the fastest. Policies around opening businesses and schools, mask wearing and other protocols are decided at county or state levels, healthcare systems and their frontline workers are the ones who need to be ready to react to rising infection rates
Of the nearly 15,000 shifts CareRev has helped fill since March, Certified Nursing Assistants are the most requested, followed by Telemetry RNs, and RNs for the Intensive Care Unit. Overall, positions were filled across dozens of specialties from respiratory therapists to psych nurses to surgical techs, and for all types of shifts.
Prior to CareRev, healthcare systems had to balance staffing needs through a solution of full-time employees, part time staff, travel nurses and staffing agencies whose primary role is to slot in to cover changing needs. The puzzle was complicated and the cost extremely high, all while the nurses and other caregivers had very little control or insight into scheduling and earnings.
"CareRev has provided me the freedom to choose where I work, when, and for whom while making more money per shift," said April Duncan, a Certified Nursing Assistant in Southern California. "CareRev is a far superior experience than any staffing agency I've worked with. It's truly changed my life."
CareRev creates a more flexible, efficient workforce, increases operating margins for healthcare institutions, and improves retention and recruitment all through lightweight mobile technology.
"We are excited to partner with CareRev for the opportunity to take practical innovation and apply it towards our goal of creating an on-demand workforce - without the cost and time burden of doing it ourselves," said Grady Brimley, VP of Health Care Transformation at SSM Health. "With their dedication to streamlining onboarding and getting qualified healthcare professionals in the door faster, we now feel confident about reducing our reliance on costly long-term travel contracts while leveraging our local community of quality professionals."
How it Works:
CareRev's mobile-friendly technology allows hiring managers to post shifts to their internal resource pool and, when needed, cascade them to CareRev's local pool of professionals. To make it even easier, implementation is fast, configured to each system or department's needs, and doesn't require an IT resource. The benefits are immediate:
Healthcare systems can quickly and easily:

Increase operating margins through better internal float management

Create a more flexible, efficient workforce, by optimizing the internal team while leveraging the flexibility of a fully-vetted, local talent pool when needed

Improve medical recruitment and engagement to decrease turnover

"CareRev is transforming our workforce by giving us a cost effective and flexible staffing option that allows us to efficiently address fluctuating patient volumes. We can more fully optimize our internal clinical staff while utilizing what is, in effect, our own qualified local per diem pool, as needed," said Eric Humphrey, Senior Vice President and CHRO of Froedtert Health. "After just a few months, CareRev has already helped us reduce our dependence on costly travel contracts. We're looking forward to even more savings and efficiency in the future."
Frontline Healthcare Professionals get:

Unmatched Pay: CareRev offers the highest rates in the industry, paid via direct deposit 2x a week.

Complete Flexibility: Whether supplementing a full-time job with extra shifts, or working with CareRev full-time, professionals decide how much and when they want to work, and can take time off when they need it... or put in extra hours when they have a big goal or financial commitment.

A Simple and Stress-Free Solution: See all available shifts and choose what to work - all from the phone. When hospitals favorite someone, they're the first to hear about new openings. Use the app to upload docs, review orientation materials, and clock hours. No midnight calls necessary!

"There is no paperwork for payroll and there has not been a single error in pay. I am able to advocate for myself directly at facilities and have the freedom of choice to be hired directly by the facilities I work at, if I so choose," continued Duncan. " However, given the high pay rate and freedom I have working through CareRev, I have no desire to do so. I really do think that the CareRev system/platform is perfect."



START your own Wordpress site, business or personal website, or online store at www.siteground.com

CISCRP (Center for Information and Study on Clinical Research Participation) hosted its AWARE for All - Philadelphia virtual community health care event on October 1st. AWARE for All event shares how clinical research plays into advancing public health. The online event featured a keynote and panel discussion about clinical research participation. A virtual health fair with exhibits from local Philadelphia-area health and wellness organizations was also part of the event.

PHILADELPHIA (PRWEB) OCTOBER 23, 2020
The Center for Information and Study on Clinical Research Participation (CISCRP) hosted its AWARE for All – Philadelphia virtual community event on October 1. 300 individuals attended to learn more about the clinical research process and the role it plays in developing new treatments and vaccines. This free event brought clinical research education directly to patients and the public and featured Philadelphia-based study participants, research professionals, advocates, and industry stakeholders.
The AWARE for All online event featured a keynote and overview presentation followed by a panel discussion; virtual health exercises—a Tai Chi guided demonstration and Mindful Meditation; and a virtual health fair with exhibits from local Philadelphia-area health and wellness organizations.
Keynote speaker, Dr. Edith Mitchell, Clinical Professor of Medicine and Medical Oncology; Director of the Center to Eliminate Cancer Disparities; and Associate Director of Diversity Affairs at Sidney Kimmel Cancer Center in Philadelphia described how as a young girl growing up in rural eastern Tennessee she saw her family develop a schedule to personally care for her ill great grandfather because they believed he was more likely to survive under their care than at the local hospital as a Black man. That experience triggered her desire to become a physician and battle medical inequalities.
"Thanks to clinical research volunteers, we are all living longer, healthier lives, but we still need to increase the diversity of those who participate in clinical research," said Dr. Jonathan Jackson, Ph.D., Director of the Community Access, Recruitment, and Engagement (CARE) Research Center. "The success of clinical trials also depends on including a diverse and inclusive group of people representative of those who may receive the new therapy if it is approved for use."
Jackson described the need for increased minority participation in COVID-19 clinical trials in part because the virus has disproportionally impacted minority communities. He also explained that some COVID-19 trials are moving faster than research on other diseases because research done on similar viruses is informing the COVID-19 research.
The COVID-19 pandemic has impacted clinical trials in a variety of ways, but they are generally continuing under new safety protocols to minimize contact and maintain patient and physician safety including in-home, virtual visits and telemedicine appointments.
The panel discussion was led by Ken Getz, founder and board chair of CISCRP. Study participants and researchers focused on clinical research experiences and misconceptions, health advocacy and equity, and how the pandemic has impacted clinical trials.
During the panel discussion, study volunteers Mary Reppart and Ashley Kulp shared challenges when participating in a clinical trial, but they stated that it has always been worthwhile for them participate. They encouraged prospective study volunteers to be aware of potentially long sessions or treatments and they suggested ways to manage stress and transportation to the clinical trial site. Kulp said receiving her medication mail order and going to a local lab for blood tests has been a huge relief during the pandemic.
Jamie Houde, Senior Manager of Clinical Strategy and Innovation at EMD Serono, a panel member, described how her organization has redesigned its studies to better reflect patient diversity. She said research is a partnership between researchers and patients, and patients should always share ideas or ask questions to better understand the study in which they are participating.
Panel member Andy Lee, SVP Head of Global Clinical Trial Operations at Merck, said he appreciates AWARE for All's focus on patient education, evaluating the decision to participate, and fully understanding what it means to participate because that underscores the philosophy of clinical research: patient safety is the first tenet of medical research.
"Our medical advances can only happen through the efforts of many people, especially the patients who volunteer for clinical trials. They are our partners in research," said Lee.
CISCRP is a non-profit organization dedicated to educating the general population and patient communities about clinical participation. They work with local advocates around the country to plan and host educational events about the clinical research process. Anyone interested in learning more about participating in clinical trials can obtain information from CISCRP at 1-877-MED-HERO or http://www.ciscrp.org.
CISCRP offers a free service designed to help patients and caregivers find clinical trials within their medical condition and location at http://www.searchclinicaltrials.org. CISCRP also recommends that individuals consult with a trusted health professional for more information and review key websites devoted to clinical trials:

ClinicalTrials.gov is a site maintained by the National Institutes of Health (NIH) that includes trial and enrollment information.

ClinicalTrials.gov/COVID-19 is also a site maintained by the NIH listing COVID-19 clinical trials.

Cancer.gov is a site managed by the National Cancer Institute.

SearchClinicalTrials.org and ResearchMatch.org to learn about clinical trials and connect with study teams.

CISCRP recently launched informational videos about the different phases of clinical research participation and highlights why it takes so long to develop new therapies. The first video of the series can be viewed here: https://www.youtube.com/watch?v=iid3BMqopMM.
Supporters of the AWARE for All - Philadelphia event include Albert Einstein Healthcare Network, Drexel University College of Medicine, Greenphire, Lazarex Cancer Foundation, National Alliance on Mental Health – Montgomery County chapter, Allergy & Asthma Network, Fox Chase Cancer Center, TREND Community and the AWARE Industry Consortium.
About CISCRP
The Center for Information and Study on Clinical Research Participation (CISCRP) is a 501(c)(3) non-profit organization dedicated to engaging the public and patients as partners in the clinical research process. Visit http://www.CISCRP.org for more information or to participate in CISCRP's educational initiatives. For additional questions about AWARE for All, contact awareforall@ciscrp.org or call 877-633-4376.

Jamie Houde, Senior Manager of Clinical Strategy and Innovation at EMD Serono, a panel member, described how her organization has redesigned its studies to better reflect patient diversity.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Elegant Dentistry Once Again Voted Best Dental Office in the Argonaut Newspaper's "Best of the Westside" Issue

MARINA DEL REY, CALIF. (PRWEB) OCTOBER 23, 2020
For the second year in a row, readers of The Argonaut newspaper have voted Marina del Rey's Elegant Dentistry the best dental office in the Los Angeles Westside. The listing can be seen at the online version of the paper on the lower portion of the "Health and Fitness" page; readers can also see a new advertisement for the dental office on page 21 of the physical edition (click here and go to page 21 to see the ad online). Elegant Dentistry says it is proud and thankful to both the publication and its readers to be able to accept the honor for a second time. The dental office says the acknowledgment is even more meaningful this year as the ongoing public health crisis has made health care a more challenging field than it's been in living memory.
Elegant Dentistry says that meeting and surpassing the community's standards for excellent dental care, especially now, is its primary goal. The office notes that it continues to offer personalized service, and, while that may look a little bit different nowadays, the quality of patient care remains unchanged.
From general dental services like routine checkups and teeth whitening procedures to more specialized procedures such as dental implants and periodontics, the center says that it works hard to ensure that it can cater to all its patients' dental needs. In fact, few dental offices in the area are capable of offering the same range of services in a single location, it adds.
Elegant Dentistry notes that many of its patients return time and again because of its efforts to provide a personalized experience every single time a patient walks through its doors, pandemic or otherwise. The office says that establishing an ever-welcoming and encouraging atmosphere is important as not every patient shares its passion for dental work.
About The Argonaut
Since 1971, The Argonaut newspaper has been covering events in and around West Los Angeles, including Marina del Rey, Playa del Rey, Mar Vista, Del Rey, Westchester, Venice, and Santa Monica. Every year the Argonaut highlights the best businesses and services in the area, for which Elegant Dentistry has been featured three times consecutively (starting in 2018 winning second place).
Readers can visit https://elegantdentistry.net/ or call 310-881-8676 to schedule an appointment or learn more about Elegant Dentistry's services, including cosmetic and restorative dentistry.




START your own Wordpress site, business or personal website, or online store at www.siteground.com

Dr. Lina Al-Chaar brings a wealth of experience and skill in multiple facets of dentistry. She will officially start on November 1st, 2020. https://www.mariettadentalpros.com/

MARIETTA, GA. (PRWEB) OCTOBER 23, 2020
Marietta Dental Professionals is located at 2551 Roswell Rd., Building 100 in Marietta, GA. The modern practice, led by Dr. Dipesh Patel, was established with the mission of providing high-quality dental care in a stress-free and rewarding environment. This family-centered dental practice offers a wide menu of services in general, cosmetic and restorative dentistry. Marietta Dental Professionals provides cutting-edge dental technology and relaxing amenities, keeping patients comfortable at every step in the treatment process.
Dr. Lina Al-Chaar is originally from Champaign, Illinois. She completed her undergraduate studies at the University of Illinois, majoring in molecular and cellular biology with a minor in chemistry. Soon after, she earned her doctorate from the University of Illinois at Chicago College of Dentistry. Dr. Lina Al-Chaar was honored with multiple awards during her time at the dental school, including recognition in teaching dentistry, excellence in diagnosis and treatment planning and in advocating for health literacy. Although enjoying her life in the Midwest, she decided to make a move down to the warmer weather of Georgia. At Marietta Dental Professionals, she will be performing many dental procedures, including cosmetic dentistry, root canals, extractions and fixed/removable prosthetics. Dr. Al-Chaar's ultimate goal is to create healthier and happier smiles while making patients feel confident and well informed.
"I am excited to join this talented dental team and develop long-lasting relationships with my new patients," says Dr. Lina Al-Chaar
More about Marietta Dental Professionals:
At every stage of life, patients can receive the dental care they need and deserve, ranging from preventative dental cleanings for kids to full-service dental implants for aging adults. Dr. Dipesh Patel and his skilled team are also qualified to offer a number of specialized treatments, such as sleep apnea treatment, emergency dental care, smile makeovers, clear orthodontics and more. To support patient comfort and improve treatment accuracy, the office has invested in some of the most advanced dental technologies in modern dentistry, including advanced soft-tissue lasers, the Isolite suctioning device and groundbreaking imaging systems like the 3D panoramic cone beam and Trios intraoral scanner. To ensure every patient receives an exceptional level of care, the Marietta office is also staffed with a Spanish-speaking dental team.
For more information about the services offered at Marietta Dental Professionals, please visit http://www.mariettadentalpros.com or call (770)514-5055.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

The Plastic Surgery Foundation (The PSF), which supports the research and international activities of the American Society of Plastic Surgeons (ASPS), named Gayle Gordillo, MD, FACS, as its new president. Dr. Gordillo took office at Plastic Surgery The Meeting, the Society's annual scientific meeting, and will serve for one year.

ARLINGTON HEIGHTS, ILL. (PRWEB) OCTOBER 23, 2020
The Plastic Surgery Foundation (The PSF), which supports the research and international activities of the American Society of Plastic Surgeons (ASPS), named Gayle Gordillo, MD, FACS, as its new president. Dr. Gordillo took office at Plastic Surgery The Meeting, the Society's annual scientific meeting, and will serve for one year.
"This is a tremendous honor," Dr. Gordillo said. "I look forward to leading The PSF during the coming year to advancing our scientific research and establishing international partnerships.
"One of my goals for this year is to develop a way to tell the story of The PSF to multiple stakeholders," she adds. "If we want to remain innovative and continue to do the work that is unique to plastic surgery, we need to communicate the value of The PSF. We have a great story to tell."
Noting The PSF's growing focus on global outreach, Dr. Gordillo says the recently established formal relationship between The Foundation and the College of Surgeons of East, Central and Southern Africa (COSECSA), an independent body that provides postgraduate education in surgery and provides surgical training throughout that region, is a strong starting point to develop such relationships – as well as mentorship and surgical capacity building opportunities – with other nations.
The PSF awarded more than $1 million in grants with support from members, other plastic surgery specialty societies and industry partnerships in 2020, and Dr. Gordillo says she wants to continue expanding The Foundation's ability to finance plastic surgery-specific research.
Dr. Gordillo is the Chief of Plastic Surgery and Medical Director of Wound Services at Indiana University School of Medicine. Her medical specialties and research areas include chronic wounds, burns, reconstructive surgery and regenerative medicine.
Prior to joining Indiana University, Dr. Gordillo served as professor of plastic surgery, medical director of wound services and director of clinical research at The Ohio State University. Her research has been continuously funded since 2004 by sources such as the National Institutes of Health and the Department of Defense.
Dr. Gordillo earned her undergraduate degree in psychology at Stanford University and her medical degree at The Ohio State University. She completed a residency in plastic surgery plus a post-doctoral research fellowship in transplantation at The Ohio State University.
About ASPS
The American Society of Plastic Surgeons (ASPS) is the world's largest organization of board-certified plastic surgeons. Representing more than 8,000 member surgeons, the Society is recognized as a leading authority and information source on aesthetic and reconstructive plastic surgery. ASPS comprises more than 93 percent of all board-certified plastic surgeons in the United States. Founded in 1931, the Society represents physicians certified by The American Board of Plastic Surgery or The Royal College of Physicians and Surgeons of Canada. ASPS advances quality care to plastic surgery patients by encouraging high standards of training, ethics, physician practice and research in plastic surgery.
About The PSF
The Plastic Surgery Foundation (The PSF), founded in 1948, supports research, international volunteer programs and visiting professor programs. The foundation's mission is to improve the quality of life of patients through research and development. The PSF accomplishes its mission by providing invaluable support to the research of plastic surgery sciences through a variety of grant programs. The PSF works in concert with the American Society of Plastic Surgeons (ASPS).



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Music has a way of connecting us with others and bringing us together in these times of social distancing. Sing Together and Share the Thanks

SOMERSET, N.J. (PRWEB) OCTOBER 23, 2020
HearingLife has launched a Virtual Choir to bring together their team members, customers, and anyone who wants to join in to share the joy of music. HearingLife wants to thank their valued customers for taking the steps necessary to achieve better hearing and recognize their team members for the outstanding care they provide. It is free and easy to join in and anyone can participate. According to Dean Pappous, HearingLife's President, "With this song, we highlight the importance of connecting friends and family during these challenging times and beyond, and to thank you all for being a part of our world-wide hearing care network."
Giving Back
For every share of the final video on social media, HearingLife will be donating an extra $5, up to $25,000, to the Campaign for Better Hearing Give Back program which provides hearing aids to those in need. This is an opportunity for all of us to join together in a virtual choir singing: "Thank You For Being A Friend" made popular by the inclusive and uplifting TV show, The Golden Girls.
Free to Join In
It is free to join in. Submissions are now open to anyone who wants to participate. HearingLife encourages all to submit their video as soon as they feel confident with the song. Keep an eye on their Facebook page for closing deadlines.
Hearing Health
Hearing has never been more important than it is in today's world where we rely on technology such as Bluetooth and video calls to communicate with friends and loved ones. Those who have noticed a decline in their hearing ability are advised to take an online hearing test or schedule an appointment which would include a full evaluation and diagnosis using the most advanced testing methods available. Early diagnosis and intervention may help prevent cognitive decline, according to experts. Family and friends who notice someone is struggling to hear are also encouraged to suggest an appointment.   
Safety protocols are in place at all HearingLife Hearing Care Centers for the utmost patient care, so visitors can attend clinics in safety and confidence. Those inquiring about an urgent appointment now, or who wish to book a consultation, can call 844-836-5003 for help. 
HearingLife is a Demant company, a world-leading hearing healthcare group, that was founded on care. We have a long history of making life-changing differences through hearing health. HearingLife is one of the largest groups of hearing care centers in the U.S. with more than 600 centers nationwide across 42 states. We follow a proven, results-oriented approach to hearing health where skilled professionals deliver the best hearing care, tailored to the unique needs of each customer.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

SGF is honored to have Dr. Selma Amrane join its Towson location, which offers excellence in fertility care to the Baltimore region.

ROCKVILLE, MD. (PRWEB) OCTOBER 23, 2020
Shady Grove Fertility (SGF) is proud to announce that reproductive endocrinologist, Selma Amrane, M.D., has joined the practice's Towson medical team. Dr. Amrane will join Drs. Stephanie Beall, Eugene Katz, Cori Tanrikut, and Ricardo Yazigi, and will begin seeing patients at SGF's Towson location in late November 2020.
Dr. Amrane specializes in the diagnosis and treatment of infertility, including gynecologic endocrine issues, such as polycystic ovary syndrome (PCOS), male-factor infertility, and infertility from endometriosis.
"I am most proud of the level of hard work and dedication of each and every team member at SGF," says Dr. Amrane. "I think this has to do with how passionate each team member is about the extraordinary, noble goal of helping patients' families grow, and I am proud to be a part of such a talented group."
Dr. Amrane earned her medical degree from University of Maryland, School of Medicine and completed her residency in obstetrics and gynecology at Weill Cornell Medical Center. Following, she completed a 3-year fellowship in reproductive endocrinology and infertility at Columbia University Medical Center.
Dr. Amrane has been an advocate for patient access to fertility treatment and has participated in lobbying on Capitol Hill with organizations such as RESOLVE, the National Infertility Association. She is a member of several professional organizations, including the American Society for Reproductive Medicine (ASRM) and the American Congress of Obstetricians and Gynecologists (ACOG). She has also presented her research on multiple gestation and in vitro fertilization at several national meetings.
"I believe that a little bit of extra time and comfort goes a long way," says Dr. Amrane. "The process of fertility testing and treatment is not easy. I lend an ear to listen and answer all the questions my patients may have so we can provide the best treatment possible in response to their unique experiences."
Patients have access to 12 SGF Maryland locations, with the Towson office offering full-service care including an embryology laboratory, IVF center, and new patient video consults.
"Dr. Amrane brings immense value to our SGF Towson medical team with her extensive knowledge, compassionate care, and fluency in Spanish and French," says Dr. Eugene Katz. "Together, our team will continue to offer the diverse community of Baltimore County access to the most advanced fertility treatment possible."
Patients may schedule an appointment with Dr. Amrane at SGF's Towson location by calling 1-877-761-1967 or submit this brief form. Patients also have access to SGF Towson's unique financial options, such as the 100% refund program for IVF, that help make fertility treatment more affordable.
About Shady Grove Fertility (SGF)
SGF is a leading fertility and IVF center of excellence with more than 85,000 babies born and 5,000+ 5-star patient reviews. With 37 locations throughout FL, GA, MD, NY, PA, VA, D.C., and Santiago, Chile, we offer patients virtual physician consults, deliver individualized care, accept most insurance plans, and make treatment affordable through innovative financial options, including 100% refund guarantees. More physicians refer their patients to SGF than any other center. Call 1-888-761-1967 or visit ShadyGroveFertility.com.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

SynchronyHR, a boutique HR outsourcing firm based out of St. Louis, MO, is excited to announce partnership with Anthem Blue Cross and Blue Shield, one of Missouri's top health insurance providers, to offer choice medical plans and products to business owners throughout the state.

ST. LOUIS (PRWEB) OCTOBER 23, 2020
SynchronyHR, a boutique HR outsourcing firm based out of St. Louis, MO, is excited to announce partnership with Anthem Blue Cross and Blue Shield, one of Missouri's top health insurance providers, to offer choice medical plans and products to business owners throughout the state.
The offering consists of a variety of Anthem master medical plans including Blue Access Choice and Blue Preferred Select (available at different price points), and High Deductible Health (HDHP) and PPO options. Additional features include the Sydney mobile app, LiveHealth online services, the Future Moms program, and the 24/7 NurseLine.
In a move made to increase their presence within the St. Louis broker community, SynchronyHR will offer these benefit solutions exclusively through local, referral-based broker relationships. "We are extremely proud of our partnership with Anthem, and fortunate to be able to arm local businesses with these medical offerings. We are also extremely proud to partner with some of Missouri's finest insurance brokers to share these plans," said Kyle R. Kelly, CEO of SynchronyHR.
SynchronyHR currently works with brokers across the U.S. to share their HR outsourcing services with business owners and managers. As part of the relationship, SynchronyHR offers all broker partners commission, a "No Trespassing" policy, residual compensation payouts, a team of trusted industry professionals, and other benefits.
Through this distribution method, Kelly hopes to benefit both brokers and their clients. "By offering strong medical offerings, such as those of Anthem's, our broker partners can help their clients with administrative difficulties such as tricky open enrollments, retention, and navigating ACA," said Kelly. "At the same time, brokers with clients in the MEWA or already with Anthem can have additional value, and therefore loyalty, while earning extra revenue. It's a win-win! Our hope is that brokers will soon think of SynchronyHR as St. Louis's 'Broker's PEO.'"
Brokers can contact SynchronyHR's team to learn more about their partnership offerings and relationship with Anthem Blue Cross and Blue Shield.
About SynchronyHR
SynchronyHR is a human resources outsourcing firm, often referred to as a professional employer organization (PEO), based out of St. Louis, MO. From payroll and HR to benefits and risk management, our professional services have helped hundreds of business owners create efficiencies, cut down on costs, strengthen their internal teams, and avoid tedious tasks and employer-related headaches. Learn more at http://www.synchronyhr.com



START your own Wordpress site, business or personal website, or online store at www.siteground.com

corecubed, a Nationally Recognized Marketing Company For In-home Care and Senior Care Providers, is Pleased to Announce Promotions of its Key Leadership Team.

ASHEVILLE, N.C. (PRWEB) OCTOBER 24, 2020
corecubed, a nationally recognized marketing company for in-home care and senior care providers, is pleased to announce the following promotions of its key leadership team:

Merrily Orsini, Board Chair

Marissa Snook, President/CEO

Amy Selle, Vice-President

"Results speak volumes, and Marissa Snook and Amy Selle have consistently delivered in their tenure as managing directors of corecubed," said Merrily Orsini, former President/CEO and now Board Chair. "It thrills me to see them taking the helm, and I look forward to corecubed assisting many in the care at home industry to thrive under their new responsibilities and leadership."
Marissa Snook, President/CEO shared, "It is my great honor to be a part of the amazing team we have at corecubed. Merrily Orsini's visionary mentorship has led us to become the leader in home care marketing, and I look forward to continuing that legacy into the future."
"I am excited to continue my leadership for corecubed, but more importantly, I'm honored to be able to help exceptional care providers connect with those who need their services," added Amy Selle, Vice-President.
corecubed leverages industry expertise and experience to create unified, seamless, and integrated marketing communications and sales strategies that support the growth and profitability of quality in-home care providers. To learn more about corecubed and their award-winning approach, visit http://www.corecubed.com.
###
About corecubed
corecubed is a full-service home care marketing and sales consulting firm specializing in helping aging care service businesses and home care agencies grow with innovative, industry-specific, integrated marketing strategies and solutions. Our team members are located around the United States and have extensive experience in home care, home health, and aging care operations and marketing. For more information visit http://www.corecubed.com or call 800-370-6580.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Radsource, a leader in radiology clinical services and provider of Picture Archiving and Communication Systems (PACS), completed 9 installations of ProtonPACS for new customers in the third quarter of 2020.

NASHVILLE, TENN. (PRWEB) OCTOBER 25, 2020
Radsource, a leader in radiology clinical services and provider of Picture Archiving and Communication Systems (PACS), completed 9 installations of ProtonPACS for new customers in the third quarter of 2020.
In the third quarter, Radsource installed ProtonPACS at an outpatient surgical center in South Carolina, a large specialty practice with multiple locations in Utah, and an interventional vascular radiology practice in Florida, among other sites throughout the U.S.
Located in San Rafael, CA, Marin PET/CT Imaging is a new facility offering state of the art diagnostic imaging to the Marin County community. As a startup imaging center, Marin was in search of a PACS solution that could seamlessly integrate with their existing PET viewing software while providing additional functionality and workflow optimization. They selected ProtonPACS and went live with the installation in Q3.
"ProtonPACS has all of the features and functionality we needed to establish an efficient workflow," said Tammy Karnan, Managing Director at Marin PET/CT Imaging. "Furthermore, the Physician Portal allows us to quickly and securely share reports and images with our referring physicians. Our staff and colleagues have been very pleased with the system as well as the training and support from the Radsource team."
About Radsource
Radsource is a nationwide leader in MRI interpretation and PACS development. Building on its clinical success in MRI interpretation, Radsource developed ProtonPACS, a PACS specifically engineered to overcome the challenges users face with other systems. ProtonPACS provides hospitals, imaging centers and physician practices advanced tools to optimize imaging workflow and increase profitability. The company is uniquely positioned to provide expertise in all aspects of medical imaging.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

After seeing the results of a commissioned survey, the computer repair company urges people to learn how to properly disinfect their devices to stop the spread of COVID-19 and avoid liquid damage.

BILLERICA, MASS. (PRWEB) OCTOBER 26, 2020
The COVID-19 global pandemic is heightening everyone's awareness of keeping surfaces clean and disinfected: Kitchen counters, coffee tables, and, of course, electronic devices. After all, a device like a smartphone, tablet, or laptop will accumulate bacteria that could cause the coronavirus. Unless someone is wiping the device down properly, the virus could spread through a house or office.
MicroReplay, a specialized computer repair company with expertise in fixing liquid damaged MacBooks and providing service parts to schools and other computer repair companies, wanted to know how their customers are taking precautions to stop the spread of COVID. The staff was curious to know if anyone who owns expensive "high-touch" devices are keeping them disinfected.
The company found that in a commissioned survey with over 300 device owners in the US, nearly everyone is taking the right precautions to clean their devices. Over three-fourths of respondents use the recommended isopropyl alcohol and are not spraying it directly onto the device. However, several answerers said they are using products that will damage their devices or cleaners not known to kill the virus that causes COVID. Other survey takers said they are not following the manufacturer's instructions and are keeping their devices too wet. Both situations can lead to liquid damage, which affects internal components.
"The results of our survey were surprising," said Joseph Kouyoumjian, President of MicroReplay. "While many people said they are cleaning their devices in a way that prevents the spread of COVID, several respondents did not know what these products do to their new tablet or smartphone is eye-opening. This points to a need to further educate device owners on how to go about cleaning their devices. After all, no one wants to clean their laptop, accidentally break it and have to pay for repairs."
Aside from doing research-based cleaning, the company is busy repairing Chromebooks and supplying service parts for other computers and tablets for schools going remote.
____________________
About Us: MicroReplay is a specialized computer repair company that has more than two decades of repair experience. Founded in 2006, the company repairs hundreds of liquid-damaged computers for other computer repair companies, in-house service organizations, extended warranty companies, and individuals. In addition to those repairs, MicroReplay helps thousands of school districts with support and repairs of Apple, Lenovo, Dell, and HP products.
Social Media
------------------
Twitter: https://twitter.com/microreplay
Facebook: https://www.facebook.com/MicroReplay
LinkedIn: https://www.linkedin.com/company/microreplay-inc/



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Pat Fry, former President and CEO of one of the nation's largest healthcare systems, has joined KitoTech Medical's Board of Directors.

SEATTLE (PRWEB) OCTOBER 26, 2020
KitoTech Medical, manufacturer of the microMend Wound Closure Product, announces today that Pat Fry, an experienced veteran of the healthcare industry, has joined its Board of Directors. Pat served as President and CEO of Sutter Health, one of the nation's leading healthcare systems, from 2005 to 2016, and has over 30 years of experience in healthcare. He was Chairman of the Board of Vizient, which is the largest Group Purchasing Organization in the US, and continues to serve on its Board. Pat was a member of the Board of TeamHealth, one of the country's largest providers of physician services. Pat has a wealth of knowledge on the delivery of healthcare, where he has focused on improving quality and reducing costs. He brings a provider's perspective on the critical issues faced by medical device companies today.
Pat Fry said, "I am truly excited to join a dynamic company that strives to improve both the cost and quality of healthcare. KitoTech's ingenuity is an example of innovation at its best. I look forward to helping support the company as it expands the use of microMend products throughout hospitals, clinics, and other medical facilities."
Ed Truitt, Chairman of the Board of KitoTech, stated: "We are honored to have Pat join our Board. He brings a strong healthcare background and considerable expertise in the medical industry. We look forward to his valuable input and support as we continue to grow and make microMend the go to wound closure product."
About KitoTech Medical and microMend
KitoTech Medical is a medical device company that has developed and commercialized a revolutionary wound closure product, microMend. It consists of an array of miniature staples (Microstaples) attached to an adhesive backing that combines the holding strength of a suture with the simplicity of applying a bandage. microMend is designed to provide medical personnel with a cost-effective, time saving and easy-to-use option for closing lacerations, skin tears, surgical incisions, and other wounds. microMend's consumer products make it possible for people to close lacerations at home, in the outdoors or elsewhere without the inconvenience and costs associated with ER and Urgent Care Clinic visits.
Additional product and company information can be found online at http://www.micromendskinclosure.com.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Dr. Michael Zahalsky and Dr. Christopher Hollowell with Z Urology Designated as a Center of Excellence for Rezūm Water Vapor Therapy, a Treatment for Benign Prostatic Hyperplasia (BPH), or Enlarged Prostate

CORAL SPRINGS, FLA. (PRWEB) OCTOBER 26, 2020
Z Urology today announced that Dr. Michael Zahalsky and Dr. Christopher Hollowell have been designated as the first dual provider Center of Excellence for Rezūm Water Vapor Therapy treatment in the United States and the world. Rezum - a minimally invasive in-office procedure for benign prostatic hyperplasia (BPH). Rezūm Therapy uses natural water vapor to reduce the size of the prostate and provide lasting symptom relief from BPH without invasive surgery or some of the potential side effects of prescription drugs.1 The Center of Excellence designation recognizes both Dr. Michael Zahalsky and Dr. Christopher Hollowell's high degree of experience with Rezūm Water Vapor Therapy and commitment to delivering significant, lasting symptom relief to men suffering from benign prostatic hyperplasia (BPH).
BPH is a condition in which a man's prostate enlarges and squeezes the urethra, causing frustrating symptoms such as frequent or urgent urination, a weak or interrupted urine stream, and the need to get up several times a night to urinate. It affects about 50% of men by age 60, and up to 90% of men by age 85.
"Being designated as a Rezūm Center of Excellence is a meaningful recognition for us, as we strive to provide the best possible treatment of urological conditions for patients in the Coral Springs, Pompano and Ft. Lauderdale and the surrounding Broward area," said Dr. Michael Zahalsky with Z Urology. "For years, the primary options for treating BPH were through behavior modifications, medications or invasive surgery. However, medications may not work for everyone and may have undesirable side effects such as dizziness, sexual dysfunction and lower sex drive.3 With Rezūm Therapy, we're able to provide relief of BPH for men who do not want to take medication or want to avoid invasive surgery and implants."
During Rezūm Therapy, which takes place during one short office visit, natural water vapor is released throughout the targeted prostate tissue. When the steam contacts the tissue and turns back to water, it releases energy, killing the excess prostate cells that squeeze the urethra. Over time, the body's natural healing response removes the dead cells and shrinks the prostate. With the extra tissue removed, the urethra opens, relieving BPH symptoms while preserving erectile and urinary function. The procedure does not require general anesthesia and is performed under oral sedation or local anesthesia.
"I was so thankful when my physician told me that Z Urology began offering Rezūm Therapy," said a patient who received Rezūm Therapy recently. "After years of waking up multiple times a night to use the bathroom and not being happy with the results of my medications, it was truly life-changing to have an effective, minimally invasive therapy available to me that didn't require hospitalization. The best part is I was back to doing the activities I love just a few days after the procedure."
Rezūm Therapy has undergone extensive clinical trials to evaluate the safety and efficacy of the treatment. It is now included in the American Urological Association's BPH treatment guidelines and has four-year follow-up data showing it's ability to treat prostates with hyperplasia of the central zone, lateral lobe and/or median lobe.
Rezūm Therapy is currently being used in many leading urology practices throughout the United States. To date, more than 55,000 patients around the world have been successfully treated with Rezūm Therapy.
About Z Urology
Z Urology was founded in 2005 by Dr. Michael P. Zahalsky , who some may know as "Dr. Mike" from his 37 days stint on the hit TV show Survivor, . and has since grown adding Mini Varghese, MD, Christopher Hollowell, MD, FACS, Michael Tyler, MD and Laurel Sofer, MD along with a team of dynamic Physician Assistant's. Z Urology prides itself on providing State of the art Urologic care to South Florida with a focus on both male and female urology. Our practice specializes in all urologic procedures specifically minimally invasive methods. Z Urology's goal is to provide exceptional urologic care, tertiary academic medicine to our South Florida community.
Our Practice has specialty trained allied health professionals. This includes Melissa Marchand, MCMSc , PA-C, Monika Kulik, MMS, PA-C and Linda Calderon, MS.Ed, PA-C. Our Allied Health team conduct physical exams, diagnose and treat illnesses, order and interpret tests, counsel on preventative health care, assist in surgery and prescribe medications.
Z Urology recognizes the importance of the patient provider relationship. We strive to provide our patients with a top-quality, comfortable experience in our office, the hospital and the skilled nursing facility. We recognize the importance of communication and meeting the needs of all of our patients, in doing so our staff speaks a variety of languages that include English, Spanish and Creole.
For more information, visit http://www.zurology.com or https://www.rezum.com/home.html.
Follow Dr Z on Instagram @MikeZahalsky
Follow the Z Urology Office @ZUrology

"Center of Excellence Recognizes High Degree of Experience with New Technology"



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Ni2o RapidTest is a saliva based test detecting three antibodies with results displayed under 5 minutes. The ni2o RapidTest has been selected as one of the semi-finalists for the XPRIZE Rapid Covid Testing Competition.

WASHINGTON (PRWEB) OCTOBER 26, 2020
Ni2o, Inc. is pleased to announce that its COVID-19 ni2o RapidTest has been selected as one of the semi-finalists for the XPRIZE Rapid Covid Testing Competition that has been launched to locate and support innovative testing methodologies to alleviate the global challenges of the coronavirus pandemic. With tests being inaccessible, too expensive or too slow, communities are being forced to shut down. Economies are crippled due to COVID-19.
Ni2o's RapidTest is composed of a unique package containing an easy to use device accompanied by a smart microfluidic cartridge and a saliva collection tube. The user simply deposits his or her crude saliva into the receptor tube, caps it and places it into the smart cartridge. Then the user inserts the cartridge into the portable device, which quantifies SARS-CoV-2 antibodies - IgG, IgM, and IgA. The whole process takes under 5 minutes to display the results on the device's digital screen. The user can further attach their device to a PC or mobile device via the USB connection to instantly report the results.
The ni2o RapidTest will be reasonably priced, and, over the long term, our device will easily accommodate other pathogens to test against. As we struggle to return to normal, antibody testing is emerging as an important assessment tool to identify asymptomatic cases, better understand immunity, and identify potential COVID-19 hotspots. The rapid quantification of antibodies provides users an understanding of the stages of infection and immunity they have. Ni2o RapidTest can detect early, ongoing, or late stage infection, whether or not the user has symptoms. Further, ni2o RapidTest provides insight into individual differences in immune responses to the virus which will facilitate vaccine development. Ni2o RapidTest is planned to evolve to a multiplex test platform. For more information visit https://ni2o.com/ni2o-rapidtest/
Ni2o's RapidTest is a culmination of extensive combined efforts of award winning chemists, engineers, and scientists from the University of Nebraska, Lincoln, Georgetown University, University of Kansas and Oxford University in England.
XPRIZE, a 501(c)(3) nonprofit, is the global leader in designing and implementing innovative competition models to solve the world's grandest challenges. Active competitions include the $20 Million NRG COSIA Carbon XPRIZE, the $10 Million Rainforest XPRIZE, the $10 Million ANA Avatar XPRIZE, the $5 Million IBM Watson AI XPRIZE, $5 Million XPRIZE Rapid Reskilling, XPRIZE NextGen Mask Challenge, and $5 Million XPRIZE Rapid COVID Testing. For more information, visit xprize.org.
Ni2o, Inc. http://www.ni2o.com is a leading neuromodulation and medical device developer and manufacturer that focuses on producing proprietary technologies combining the latest artificial intelligence and scientific discoveries to alleviate society's burden of managing prevalent diseases.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Online guide highlights senior living communities with quality programs and top features

NAPLES, FLA. (PRWEB) OCTOBER 27, 2020
MemoryCare.com, a comprehensive resource for caregivers and older adults living with memory impairment, has announced the Best Memory Care Facilities in Naples, FL. The guide identifies 10 memory care communities based on location, access to experts, facility features and amenities.
According to the Alzheimer's Association, 5.6 million people age 65 and older are living with Alzheimer's dementia. In Naples, the number of senior deaths related to Alzheimer's increased by 30 percent between 2013 and 2017. Memory care facilities offer activities and therapies to help delay or halt cognitive decline. They also give family members and caregivers peace of mind by providing a safe environment for loved ones.
There's a high demand for quality memory care all across our nation; specifically, in cities like Naples, which experienced a rapid increase in Alzheimer's related deaths, says Joyce Collins. MemoryCare.com provides free resources to help families find the best facilities.
Through hours of research and an intensive selection process, MemoryCare.com was designed to help caregivers find effective solutions for their loved ones. The website not only highlights the best facilities in the city, it also shares information about cost, reviews from residents, type of care offered and more. For a detailed listing of the Best Memory Care Facilities in Naples, FL, please visit https://www.memorycare.com/naples-fl-facilities
2020 Best Memory Care Facilities in Naples, FL (in alphabetical order)
Arden Courts of Lely Palms
Phone: (239) 417-8511
Address: 6125 Rattlesnake Hammock Rd., Naples, FL 34113
Web: arden-courts.com
Barrington Terrace of Naples
Phone: (239) 231-1902
Address: 5175 Tamiami Trail E., Naples, FL 34113
Web: arborcompany.com
Bayshore Memory Care
Phone: (239) 213-9370
Address: 1260 Creekside Blvd. E., Naples, FL 34109
Web: bayshorememorycare.com
Beach House Assisted Living and Memory Care
Phone: (239) 307-1800
Address: 1000 Airport-Pulling Road S. Naples FL 34104
Web: beachhousenaplesseniorliving.com
Brookdale Naples
Phone: (239) 308-0487
Address: 770 Goodlette Rd. N., Naples, FL 34102
Web: brookdale.com
Juniper Village at Naples
Phone: (239) 598-1368
Address: 1155 Encore Way, Naples, FL 34110
Web: junipercommunities.com
Keystone Place at Naples Preserve
Phone: (239) 354-7081
Address: 3490 Thrive Dr., Naples, FL 34105
Web: keystoneplaceatnaples.com
Memory Care of Naples
Phone: (239) 403-0826
Address: 2626 Goodlette Frank Rd., Naples, FL 34103
Web: memorycarenaples.com
Naples Green Village
Phone: (239) 514-0300
Address: 101 Cypress Way E., Naples, FL 34110
Web: naplesgreenvillage.com
Terracina Grand
Phone: (239) 455-1459
Address: 6825 Davis Blvd., Naples, FL 34104
Web: terracinaseniorliving.com
ABOUT MEMORYCARE.COM
MemoryCare.com provides tools and resources to help adults living with memory impairment and their families. The online guide uses data-driven research and expert evaluations to identify the best facilities across the nation. The MemoryCare.com team includes medical and elder care professionals as well as board of directors. For more information, visit https://www.memorycare.com/.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Savannah's Opioid Epidemic Prompts Growing Demand for Accessible and High-Quality Facilities

SAVANNAH, GA. (PRWEB) OCTOBER 27, 2020
Help.org, a trusted online resource for individuals who struggle with addiction and their loved ones, has announced the Best Rehab Facilities in Savannah, GA for 2020. The informational guide recognizes the top 6 rehab facilities based on cost, treatment options, location, accompanying services, and more.
According to recent studies, drug overdose is the leading cause of death among people under age 50. In Savannah, deaths related to opioid abuse increased significantly from 2011 to 2015. Substance abuse among adolescents is also escalating in Savannah with 55 percent of high school students reported using alcohol, 38 percent reported using marijuana, 8 percent reported using prescription drugs without a valid prescription, and 2 percent reported using heroin. With the growing need for accessible and high-quality rehab programs, Help.org has developed a unique ranking process to help connect individuals with treatment providers that meet their needs.
The Help.org research team analyzed thousands of facilities across the country and then identified the most cost-effective and highest-rated programs in larger cities like Savannah. Each facility was evaluated based on rehabilitation services, treatment approaches, cost, special programs for unique demographics, and ancillary services. The website also provides information about drug use and side effects as well as educational articles. For a detailed listing of the Best Rehab Facilities in Savannah, GA please visit https://www.help.org/drug-and-alcohol-rehab-centers-in-savannah-ga
2020 Best Rehab Facilities in Savannah, GA (in alphabetical order)
Assisted Recovery Center of Georgia
308 Commercial Drive
Savannah, GA 31406
912-205-6337
Coastal Harbor Treatment Center
1150 Cornell Street
Savannah, GA 31406
912-354-3911
Old Savannah City Mission Recovery Services
2414 Bull Street
Savannah, GA 31401
912-232-1979
Recovery Place
835 E. 65th Street
Savannah, GA 31405
912-355-1440
Salvation Army Savannah
3100 Montgomery Street
Savannah, GA 31405
912-651-7420
Savannah Mission Bible Training Center
1000 E. Victoria Drive
Savannah, GA 31405
912-234-7000
ABOUT HELP.ORG
Help.org is an online resource for individuals who struggle with addiction and their loved ones. The website provides the latest research through scientifically proven methods, community recovery resources as well as information about local financial assistance. Help.org's team of researchers, activists, and writers work together with addiction counselors and other professionals to offer useful and accurate resources to help individuals seeking recovery. To learn more, visit https://www.help.org/.



START your own Wordpress site, business or personal website, or online store at www.siteground.com